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ABSTRACT 
The studies presented in this thesis were designed to identify, examine, and manipulate potential 
factors associated with the development of porcine testis cells and tissue using in vitro and in vivo 
culture systems. The objective of the first in vitro study was to examine several conditions for 
short-term culture of testis cells to optimize the maintenance and propagation of neonatal porcine 
gonocytes. We found that culturing testis cells at 3.0 × 104 cells/cm2 containing ~40% gonocytes 
in DMEM+10% FBS, at 37 °C, and without changing the medium for 7 days, improves in vitro 
maintenance, proliferation, and formation of gonocyte colonies. The goal of the second in vitro 
study was to apply these optimized conditions for prolonged culture to study the behavior, colony 
formation, and ultrastructure of gonocytes. We observed that gonocytes extensively migrate after 
developing various cytoplasmic projections, rapidly propagate, and form pluripotent embryoid 
body-like colonies (EBLC). The first in vivo study was designed to establish an efficient method 
for implantation of neonatal porcine testis cell aggregates under the back skin of recipient mice, 
and to explore the use of ultrasound biomicroscopy (UBM) for the non-invasive in vivo evaluation 
of implants. We showed that the subcutaneous injection approach, as compared with the 
conventional surgical approach, offers a less invasive route for implantation of cell aggregates, and 
results in a more consistent de novo formation of testis tissue in the implants. UBM proved to be a 
unique means for the non-invasive monitoring of implants and the prediction of the outcomes. The 
second in vivo study was aimed at utilizing this improved cell implantation model to examine the 
effects of pre-implantation exposure of testis cells to various growth factors (i.e., EGF, GDNF, 
FGF2, FGF9, VEGF, LIF, SCF, and RA) on de novo morphogenesis of porcine testis tissue. We 
observed that each growth factor had a distinct effect on development of the testis tissue, ranging 
from enhanced development to improved gonocyte survival, and promotion of certain types of 
seminiferous cords. In summary, we discovered several critical elements for the in vitro and in vivo 
culture systems for the development of testis cells and tissue. 
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 CHAPTER 1   
INTRODUCTION  
Male germline stem cells (MGSC) are progenitors of all male germ cells, and form the foundation 
of spermatogenesis and male fertility. As putative multipotent stem cells, MGSC may also give 
rise to non-reproductive cells and tissues. However, our understanding of their biology and 
potential is limited, and due to the complexity of the testis architecture and cellular interactions, 
the study and manipulation of MGSC require proper in vitro and in vivo models.  
Gonocytes are a transient population of MGSC after the mitotic arrest of primordial germ cells 
(PGC) and prior to differentiation into spermatogonial stem cells (SSC). In the neonatal testis, 
gonocytes are easily identified, because they are the only germ cells present in the neonatal testis, 
and have a distinct morphology (McGuinness and Orth, 1992). The presence of gonocytes in the 
postnatal testis continues for several days or up to several years, depending on the species (Hughes 
and Varley, 1980; McLean et al., 2003; Li et al., 2012). Based on the aforementioned 
characteristics, gonocytes are considered as the precursors of all germline lineages in the postnatal 
testis.  
The study and manipulation of MGSC necessitates the development of high fidelity in vitro and in 
vivo models. This stems from the complex structure of the testis tissue, interactions of various 
somatic and germ cells, and involvement of for instance numerous known and unknown growth 
factors. As with other MGSC, gonocytes possess self-renewal and proliferation capacities, which 
can be manipulated in vitro. Gonocytes have been successfully maintained and propagated for long-
term (~6 months) in culture (Han et al., 2009; Lee et al., 2013; Sahare et al., 2016). Under certain 
conditions such as in the presence of retinoic acid (RA), differentiation of gonocytes to SSC can 
initiate (Wang and Culty, 2007; Zhou et al., 2008). In addition, gonocytes form germ cell colonies 
that express pluripotency markers in culture (Han et al., 2009; Fujihara et al., 2011). Pluripotent 
stem cells are capable of giving rise to specialized cells and tissues of the three germinal layers 
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(i.e., mesoderm, endoderm, and ectoderm) (Evans and Kaufman, 1981; Thomson et al., 1998). 
Therefore, as a first step, we conducted a systemic study to examine and optimize a number of 
factors that can affect the maintenance and proliferation of porcine gonocytes in culture, as an in 
vitro system for their study and manipulation (Chapter 3). We then used these optimized culture 
conditions to examine porcine gonocytes further in terms of their in vitro behavior, ultrastructure, 
colony formation, and expression of pluripotency markers (Chapter 4). 
An example of relevant in vivo models is the ectopic xenografting of testis tissue from diverse 
donor species into recipient mice, which is capable of promoting development of the grafted tissue, 
resulting in ultimate production of functional spermatozoa in the grafts (Honaramooz et al., 2002a; 
Schlatt et al., 2002a; Gassei et al., 2006; Abbasi and Honaramooz, 2012). Therefore, ectopic testis 
tissue xenografting has provided an in vivo culture system for the study of testis function, 
development, and spermatogenesis. In addition, this system could be used as a potential tool for 
the preservation of genetic material. Dissociated cells, at least initially lack the structural 
framework that could maintain and support their transformation into a functioning tissue. However, 
rather surprisingly, de novo (i.e., ‘to restart from the beginning’) formation of functional testis 
tissue was observed after ectopic implantation of dissociated porcine testis cells under the back 
skin of mouse hosts (Arregui et al., 2008; Honaramooz et al., 2007). The heterogeneous 
populations of implanted testis cells were fully capable of organizing themselves, and undergoing 
extensive rearrangement to once again form seminiferous cords, indistinguishable from those in 
the intact testis. This phenomenon opened an opportunity for the introduction of a new in vivo 
model, which is unique in that testis cells could be manipulated before implantation to study the 
potential factors involved in testis tissue morphogenesis. In this thesis, we set out to investigate 
several factors that could potentially improve the testis cell implantation model, and lead to more 
consistent results (Chapter 5), before utilizing it to examine the effects of various growth factors 
on de novo formation of testis tissue after implantation of cell aggregates (Chapter 6).  
The laboratory mouse has long been used as an accessible and convenient model for biomedical 
research, and has contributed in a significant way to the understanding of human biology (Morse, 
2007). The mouse also offers low maintenance costs, ease of management, and pronounced genetic 
similarities to humans (Waterston et al., 2002). Most of our understanding of the biology of MGSC 
has been deciphered from the mouse model. The availability of transgenic, knockout/knockin, 
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mutant, and immunodeficient mice has also contributed significantly to the advancement of MGSC 
research and technologies. However, rodents are not an ideal animal model for the recapitulation 
of most human diseases and disorders (Seok et al., 2013), and might respond differently to 
experimental interventions due to their marked pathophysiological differences with humans 
(Perlman, 2016). For this reason, the pig is considered a superior model for human biology and 
diseases (Kuzmuk and Schook, 2011).  
Being omnivore and of comparable size to humans, pigs are also more closely related to humans 
in terms of anatomy, physiology, metabolic regulation, and predisposition to different disorders 
(Panepinto, 1996; Tumbleson and Schook, 1996; Spurney et al., 2006; Kuzmuk and Schook, 2011; 
Swindle et al., 2012; Dalgaard, 2015; Huppertz et al., 2015). More specifically for the purpose of 
this thesis, the pig offered great advantages as a donor of testis cells and tissue for the study and 
manipulation of MGSC. Fresh neonatal pig testes could be obtained in large quantities at the time 
of routine castration of piglets at the University of Saskatchewan Prairie Swine Center. The 
collected testes can be processed to obtain large numbers of MGSC, particularly gonocytes. 
Compared with rodents (1-4 dpp), gonocytes in pigs are present for much longer periods of time 
(2 months) (Hughes and Varley, 1980; Russell, 1980; McLean et al., 2003). This unique temporal 
pattern coupled with the availability of specific surface markers for pig gonocytes, such as Dolichos 
biflorus agglutinin (DBA) (Goel et al., 2007), provide unequivocal means for identification of 
gonocytes. Improved methods for isolation and enrichment of pig gonocytes have also been 
introduced in recent years, allowing the isolation of high proportions of gonocytes (~40%), which 
could be further enriched (to ~90%) using density gradient centrifugation and differential plating 
(Yang et al., 2010; Yang and Honaramooz, 2011). Pigs have also served as a donor species for the 
development of testis tissue xenografting model, as well as the ectopic cell implantation model 
(Honaramooz et al., 2002a, 2007), and therefore were suited for the studies outlined in this thesis. 
Gonocytes possess many potential applications in the fields of assisted reproductive technologies 
and regenerative medicine. For instance, gonocytes could be preserved (cryopreserved or 
‘biobanked’) as a source of genetic material for fertility preservation, restoration, and conservation, 
as well as for the generation of induced pluripotent stem cells (iPSC) for cell-based therapy. On 
the other hand, gonocytes that fail to migrate to proper stem cell niches in the seminiferous tubules 
have been associated with cases of testicular carcinoma in situ (Skakkebaek et al., 1987; Hoei-
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Hansen et al., 2005). Taken together, extensive research is required to understand further the 
biology, feasibility of manipulation, and safety of using gonocytes prior to their applications. 
Ironically, gonocytes are the least studied cells among MGSC, and hence are the subject of this 
thesis. Therefore, the overall objective of the present work was to study in vitro and in vivo culture 
systems for the development of porcine testis cells and tissue.
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CHAPTER 2  
LITERATURE REVIEW AND OBJECTIVES 
2.1 Anatomy and Physiology of the Testis  
2.1.1 Origin and Development of the Testis 
Embryonic development of the mammalian testis is unique because, in addition to complex folding 
of the germinal layers (i.e., mesoderm and ectoderm) and migration of individual cells, it involves 
the formation and assembly of both germ cells and somatic cells (Svingen and Koopman, 2013). 
Based on the mouse model, development of the indifferent gonad begins with the formation of a 
paired thickening of the epithelial layer overlying the mesonephros (at 9.5 days post-coitum, dpc). 
The thickenings are due to the proliferation of the coelomic epithelium, which lead to the formation 
of the gonadal/genital ridges at 10-10.5 dpc (Svingen and Koopman, 2013; Tanaka and 
Nishinakamura, 2014). This coelomic epithelium also gives rise to the somatic cell lineages of the 
gonad. Formation of the genital ridge is known to be triggered by several genes including the 
steroidogenic factor 1 (Sf1) and Wilm’s tumour-associated gene 1 (Wt1) (Hammes et al., 2001; 
Wilhelm and Englert, 2002; Ozisik et al., 2003; Buaas et al., 2009). Primordial germ cells (PGC) 
that form the germ cell component of the gonad are derived from the epiblast cells, and can be 
found at the posterior primitive streak at 6.25 dpc (Tanaka and Nishinakamura, 2014). These cells 
are passively translocated from the mesoderm to the endoderm at 7.5 dpc, where they gain motility 
prior to their migration towards the genital ridges. PGC begin migrating toward the genital ridges 
at 8.5 dpc, via the hindgut, and reach the genital ridges at 10.5 dpc (Anderson et al., 2000; 
Molyneaux et al., 2001; Hara et al., 2009). 
Migration and proliferation of PGC occur through signals from chemo-attractants released by the 
developing genital ridges (Martineau et al., 1997) and specific proteins expressed along the 
migratory route (Patni et al., 2017). During this migration, PGC undergo extensive proliferation, 
increasing from an initial 50-80 cells to ~30,000 by the time they reach the genital ridge (Bendel–
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Stenzel et al., 1998; Wylie, 1999). Once arrived at the genital ridges, PGC become immotile and 
transform morphologically (lose cytoplasmic processes) to convert to gonocytes (Baillie, 1964; 
Donovan et al., 1986). Development of the porcine testis follows the general mammalian pattern; 
the genital ridges are formed at ~18 dpc, and the indifferent gonads are completely formed by ~25 
dpc (Hurst et al., 1991). At this point, regardless of the genetic make-up (XX or XY), the primitive 
gonad is bipotential, equally capable of developing into a testis or an ovary depending on the 
molecular cues (Koopman et al., 1991; Vidal et al., 2001; Barrionuevo et al., 2006). Differentiation 
of the indifferent gonad is initiated by the sex-determining region Y (SRY) protein, a testis-
determining factor (TDF) encoded by the Sry found on the Y chromosome, and expressed by the 
pre-Sertoli cells (derived from the coelomic epithelium) (Gubbay et al., 1990; Sinclair et al., 1990; 
Koopman et al., 1991). Expression of SRY activates the testicular genes, leading to deactivation 
of the ovarian genes (Li et al., 2014). The duration of SRY expression is very short, lasting only 
~6 h in mice (at ~11 dpc) (Hiramatsu et al., 2009). Transient expression of SRY upregulates the 
expression of Sry-box 9 (SOX9) by the pre-Sertoli cells and leads to their differentiation into 
Sertoli cells (Sekido et al., 2004; Wilhelm et al., 2005). The expression of SOX9 also upregulates 
the expression of fibroblast growth factor 9 (FGF9) and anti Müllerian hormone (AMH) by Sertoli 
cells. While SOX9 and FGF9 drive the formation of the testis cords and proliferation of Sertoli 
cells, AMH prevents the formation of the Müllerian ducts (Josso, 1992; Kim et al., 2006a). The 
persistent expression of SOX9 during testis development is crucial and is achieved via feedforward 
loops with FGF9 and prostaglandin-D2 (PGD2) (Kim et al., 2006a; Moniot et al., 2009).  
Activation of Sox9 and its upstream genes (e.g., Fgf9) initiates the aggregation of Sertoli cells 
around germ cell clusters at 11.5 dpc (Combes et al., 2009; Svingen and Koopman, 2013). 
Concurrently, FGF9 expression attracts the migration of endothelial and peritubular myoid cells 
from the mesonephros into the gonad (Martineau et al., 1997). By 12.5 dpc (27 dpc in the pig), 
germ cells are completely surrounded by Sertoli cells, which in turn are enclosed by peritubular 
myoid cells to form testis cords (Hurst et al., 1991; Combes et al., 2009). At this point, germ cells 
begin undergoing mitotic arrest (Escalante-Alcalde and Merchant-Larios, 1992). Formation of 
testis cords results in the establishment of the interstitial compartment, which later hosts Leydig 
cells, mesenchymal cells, and blood vessels (Combes et al., 2009). Growth of the early testis is 
rapid compared with the early ovary, because by 13.5 dpc the testis is twice the size of the same-
age ovary (Schmahl et al., 2000; Park and Jameson, 2005). 
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The origin of Leydig cells remains poorly understood; however, they are presumed to be derived 
from precursor cells of the coelomic epithelium and mesonephros mesenchyme (Merchant-Larios 
and Moreno-Mendoza, 1998; O’Shaughnessy et al., 2006; Söder, 2007), regulated by AMH and 
other Sertoli cell signals (Patni et al., 2017). Under the influence of SF1 and GATA4, Leydig cells 
express several genes for encoding enzymes such as steroidogenic acute regulatory protein (StAR), 
Cyp11a1 and Cyp17 (cytochrome P450 hydroxylases), and hydroxysteroid dehydrogenase 
(3ßHSD), required for testosterone biosynthesis (Park and Jameson, 2005; Patni et al., 2017). 
Testosterone acts on the cranial and caudal portions of the mesonephric duct to form the epididymis 
and ductus deferens, respectively. The mesenchyme between the testicular cords then forms septa, 
which give rise to the lobulated structure of the testis parenchyma (Patni et al., 2017). Later, the 
testis descends into the scrotum through two phases; the transabdominal phase, which in the mouse 
occurs between 15.5 and 17.5 dpc, and the inguinoscrotal phase, which occurs after birth at ~6 dpp. 
In the pig, these processes take place at 55 dpc and 85-90 dpc, respectively (Klonisch et al., 2004). 
2.1.2 Testis Structure and Function 
The mature testis is responsible for the production of male gametes and sex hormones, via the inter-
related processes of spermatogenesis and steroidogenesis, respectively. These processes occur in 
distinct compartments of the testis parenchyma; spermatogenesis takes place in the seminiferous 
tubules and steroidogenesis happens in the interstitial compartment by Leydig cells. The activities 
in these compartments are regulated by a feedback system known as the hypothalamic-pituitary-
gonadal (HPG) axis (Weinbauer et al., 2010). 
The testes are paired oval-shaped organs enclosed within the scrotum that are attached to the body 
via the spermatic cord. The cremaster muscles covering the spermatic cord is responsible for raising 
and lowering the testes for thermoregulation (Kayalioglu et al., 2008). In most species (i.e., 
mammals, amphibians, and birds), the testes are asymmetrical where the left testis is larger than 
the right testis (Birkhead et al., 1997; Yu, 1998; Liu et al., 2012). Surface of the testis is covered 
by a complex multi-layered tissue. These layers include the tunica vaginalis, which extends from 
the peritoneum and forms a lining that covers both the scrotal cavity (parietal tunica vaginalis) and 
the tunica albuginea (visceral tunica vaginalis). The fluid-filled space (i.e., tunica vaginalis cavity) 
created by these two sub-layers allows the testes to move freely in the scrotum. The tunica 
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albuginea is a tough fibrous connective tissue that forms the outer surface of the testis and 
encapsulates it. Branching of the tunica albuginea (i.e., septa) divide the testis parenchyma into 
several lobes and lobules that contain seminiferous tubules and interstitial tissue (Miller et al., 
1983; Sprengel et al., 1990). In addition to acting as a protective physical barrier for the testis, the 
tunica albuginea plays a significant role in spermatozoa transport, testis vascularization, and 
maintenance of testis structure. The inner surface of the tunica albuginea is covered by the tunica 
vasculosa, an area enriched with blood vessels that facilitates the blood supply to the testis (Leeson 
and Cookson, 1974; Setchell et al., 1994). 
The testis parenchyma can be divided into two main compartments, namely the seminiferous 
tubules and the interstitial tissue. Seminiferous tubules are structures with a lumen and a 
seminiferous epithelium lining, made up of sustentacular Sertoli cells and germ cells in various 
stages of development (Siu and Cheng, 2004a; Jiang et al., 2013). Germ cells form close contacts 
with Sertoli cells via N-cadherin and galactosyltransferase (GalTase) expressed on the surface of 
both cells (Newton et al., 1993; Pratt et al., 1993). During spermatogenesis, Sertoli cells nourish 
and facilitate the development of germ cells, establish dynamic interactions, regulate the 
environmental milieu within the seminiferous tubules (Griswold, 1998), and eliminate the residues 
produced during germ cell differentiation via phagocytosis (Yefimova et al., 2013). Sertoli cells 
are joined together by tight junctions formed by basal cytoplasmic processes, creating a physical 
impediment commonly known as the blood-testis barrier. This structure provides an anatomical, 
physiological, and immunological barrier that divides the seminiferous tubule epithelium into a 
basal compartment and an adluminal compartment. The basal compartment consists of a 
specialized microenvironment, known as the stem cell niche, where Sertoli cells support and 
regulate the self-renewal and differentiation of spermatogonial stem cells (SSC) (De Rooij, 2009), 
while the adluminal compartment houses more advanced stages of germ cells. Thus, the blood-
testis barrier provides an immunoprivileged environment to protect the haploid germ cells, while 
ensuring that nutrients reach these cells. In addition, the blood-testis barrier may have a role in 
preventing harmful substances from entering the adluminal compartment (Pelletier and Byers, 
1992). 
Fully developed seminiferous tubules have a constant number of Sertoli cells per unit length; 
although, the diameter and luminal volume of tubules change depending on the stage of the 
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spermatogenic cycle (Wing and Christensen, 1982). Seminiferous tubules are circumferentially 
enclosed by contractile cells known as the peritubular myoid cells, which contain an abundance of 
actin filaments and cytoskeleton proteins (Maekawa et al., 1996). The contractile action of 
peritubular myoid cells assist the propulsion of spermatozoa and testicular fluid along the lumen 
of seminiferous tubules toward the rete testis, efferent ductules, and epididymis. The epididymis 
acts as temporary storage, where the maturation of spermatozoa continues (King, 1993; Hafez, 
2000; Almeida et al., 2006). 
The interstitial compartment of the testis is mainly populated with the androgen-producing Leydig 
cells, along with other cells such as fibroblasts, mast cells, and macrophages (Schulze, 1984). 
Leydig cells are polygonal in shape and, being a steroid-producing cell, rich in smooth endoplasmic 
reticulum and mitochondria (Weinbauer et al., 2010). Unlike adult germ cells and Sertoli cells, 
where the development continues from their preexisting predecessors of the embryogenic stage, 
adult Leydig cells are believed to be derived from stem Leydig cells, which are morphologically 
and functionally distinct from fetal Leydig cells. For instance, stem Leydig cells are originally 
spindle-shaped and lack LH receptors and steroidogenic-cell markers, but under the influence of 
growth factors and hormones they undergo transitional steps to ultimately differentiate into 
immature, and at puberty into adult Leydig cells. Most fetal Leydig cells regress shortly after birth 
and are not involved in the production of testosterone (Ge and Hardy, 1997; Faria et al., 2003). The 
production of testosterone by Leydig cells is LH- and FSH-dependent, where testosterone has a 
significant influence on Sertoli cells and spermatogenesis (O’Shaughnessy et al., 2009). 
2.1.3 Spermatogenesis  
Spermatogenesis is a complex cyclical process where MGSC undergo a series of mitotic and 
meiotic divisions, eventually resulting in the production of mature spermatozoa (Russell et al., 
1993). Molecular cues for the initiation of spermatogenesis are poorly understood, but they also 
extend beyond the testis and involve the hypothalamus and pituitary gland. Regulation of 
spermatogenesis involves a systematic interplay between the hormonal/endocrine and 
paracrine/autocrine systems (de Kretser et al., 1998); for instance, in mice, this process is triggered 
by the bone morphogenetic protein 8B (BMP8B) released by spermatogonia during the onset of 
puberty (Zhao et al., 1996). 
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During spermatogenesis, germ cells develop into successively advanced stages, spanning from the 
basal compartment (during mitotic divisions) at the periphery of the seminiferous epithelium 
toward the adluminal compartments (for meiotic divisions). Prior to puberty, gonocytes and later 
spermatogonial stem cells (SSC) are the only germ cells in the testis. 
Spermatogenesis begins at the basement membrane with mitosis of SSC. Spermatogonia type 
Asingle (As) comprise a rare and relatively quiescent population of cells that represent ‘true’ SSC, 
because they uniquely manage to retain their pluripotency and capability to undergo both self-
renewal and differentiation (De Rooij and Russell, 2000). These cells can undergo division to form 
either two new As (for self-renewal) or a pair of spermatogonia that remain connected Apair (Apr, 
destined for differentiation). In rodents, differentiation of type As to Apr is followed by a series of 
divisions that lead to the formation of type Aaligned (Aal) spermatogonia which remain 
interconnected and can have chains of 4, 8, or 16 cells. While all are considered ‘undifferentiated’ 
spermatogonia, Apr and Aal cells are on their way toward differentiation and hence are sometimes 
referred to as ‘transient amplifying progenitor’ cells. The next steps involve transition without cell 
division of Aal into A1 differentiating spermatogonia, followed by five synchronized cell divisions 
to form A2, A3, A4, intermediate (In), and type B spermatogonia. Undifferentiated spermatogonia 
(types As, Apr, and Aal) have similar cellular morphology; however, transition from Aal to A1, which 
marks the beginning of differentiated spermatogonia is accompanied by significant morphological 
and mitotic behavior changes (de Rooij, 1998). Further differentiation of type B spermatogonia 
gives rise to spermatocytes and subsequently to haploid spermatids, which eventually develop into 
spermatozoa (Russell et al., 1993; De Rooij and Russell, 2000).  
Prior to further development, the resultant B-spermatogonia must leave the basal compartment by 
physically passing through the blood-testis barrier. Once in the adluminal compartment, B-
spermatogonia undergo another mitotic division to produce primary spermatocytes that 
immediately enter the first phase of meiosis. During the long prophase of the first meiosis, the 
DNA undergoes complete replication to form tetrads, followed by crossing-over of homologous 
chromosomes to ensure genetic heterogeneity of the resultant germ cells. At the end of the first 
meiosis, each primary spermatocytes has produced two secondary spermatocytes (haploid, N), 
which are relatively short-lived and immediately undergoes the second meiotic division. Meiosis 
II leads to subdivision of each secondary spermatocyte into two haploid round (spherical) 
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spermatids, after which time, no further cell division will occur, instead they undergo extensive 
morphological differentiation to transform into spermatozoa via a process known as 
spermiogenesis. During the differentiation process, dramatic changes need to take place to 
transform round spermatids into elongating/elongated spermatids and spermatozoa, before they are 
released into the lumen of seminiferous tubules to be transported out of the testis (King, 1993; 
Dym, 1994; Gilbert, 2000; Hafez, 2000; Almeida et al., 2006). 
2.1.4 Regulation of Spermatogenesis  
At the onset of puberty, the release of gonadotropin-releasing hormone (GnRH) by the 
hypothalamus drives the release of gonadotropins, FSH and LH, from the pituitary gland. These 
gonadotropins initiate the first wave of spermatogenesis, which begins shortly after birth in mice 
and ~5-8 months of age in pigs (Vergouwen et al., 1993; Almeida et al., 2006; Gartner and Hiatt, 
2006). FSH exerts its effect on Sertoli cells to promote their function in nourishing germ cells and 
facilitating spermatogenesis, while LH acts on Leydig cells to stimulate the production of 
testosterone. In turn, testosterone and inhibin-B (produced by Sertoli cells) act through a negative 
feedback mechanism to temporarily inhibit further release of GnRH, FSH, and LH (Boepple et al., 
2008).  
During the first wave of spermatogenesis, the testis experiences sudden changes at the structural 
and hormonal levels. One of the most significant events occurring at this period is a massive Bax-
dependent germ cell apoptosis, which is believed to establish a proper germ-Sertoli cell ratio 
(Rodriguez et al., 1997; Print and Loveland, 2000). FSH and testosterone play a significant role in 
altering the rate of apoptosis during this process to bring about a balance (Rodriguez et al., 1997; 
Ruwanpura et al., 2007; Walczak-Jedrzejowska et al., 2011). Reduced FSH levels during this 
period may result in significant increases in germ cell death (Billig et al., 1995; Meachem et al., 
2005; Ruwanpura et al., 2007), while supplementation of testosterone can have the opposite results 
(Rodriguez et al., 1997). 
During the subsequent spermatogenic cycles and throughout adulthood, FSH and testosterone seem 
to work in an independent, synergistic and/or overlapping manner to ensure completion of 
spermatogenesis (Saito et al., 2000; Haywood et al., 2003; Matthiesson et al., 2005). FSH is 
important in ensuring the optimum spermiation output by maintaining or increasing (via 
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proliferation) the number of spermatogonia and thereby the population of more advanced germ 
cells (Zirkin et al., 1994; Griswold, 1998; Simorangkir et al., 2009; Walczak-Jedrzejowska et al., 
2011). Using transgenic mouse models lacking FSH or its receptor, it has been shown that although 
the mice can remain fertile, the number of germ cells and their survival rate are reduced (Dierich 
et al., 1998; Meachem et al., 1999; Abel et al., 2000; Wreford et al., 2001; Matthiesson et al., 
2005). Similarly, an increase in the number of spermatogonia and spermatocytes can be observed 
after FSH treatment of hypophysectomized and/or GnRH-immunoneutralized rats (Russell et al., 
1993; McLachlan et al., 1995). Within seminiferous tubules, FSH receptors are only found on 
Sertoli cells, suggesting that any FSH effects on germ cells is likely achieved by modulating the 
Sertoli cell function (McLachlan et al., 1995; Asatiani et al., 2002). FSH, however, has no or 
limited direct effect on completion of meiosis and spermatogenesis (Russell et al., 1993; 
McLachlan et al., 1995). 
Testosterone also plays a role in maintaining the population of spermatogonia; however, its most 
crucial function in spermatogenesis seems to be related to the transition of spermatocytes to 
spermatids (Welsh et al., 2009; O’Shaughnessy et al., 2012). Studies have shown that both 
testosterone withdrawal and lack of androgen receptors can result in male infertility, due to the 
failure to generate post-meiotic germ cells (Haywood et al., 2003; Welsh et al., 2009; 
O’Shaughnessy et al., 2012). Using a hypophysectomized rat model, it was shown that while FSH 
supports the development of germ cells up to the step 7-8 spermatids, spermiogenesis was not 
observed in the absence of testosterone (Bartlett et al., 1989; Kerr et al., 1992). Furthermore, 
treatment with testosterone successfully recovers spermatogenesis of mice that have a mutation of 
the gonadotropin-releasing hormone gene, suggesting that this recovery is LH- and FSH-dependent 
(Cattanach et al., 1977; Singh et al., 1995). Similar to FSH, any effect of testosterone on germ cells 
is indirect and mediated through somatic cell populations, because androgen receptors are absent 
in germ cells but found abundantly in Sertoli, peritubular myoid, and Leydig cells (Skinner et al., 
1989; De Gendt et al., 2004; Abel et al., 2008). 
A potential role has also been suggested for estrogen in the regulation of spermatogenesis; 
however, the mechanism by which estrogen acts to regulate this process is poorly understood. 
Androgens are converted to estrogens via aromatase activity in the testis (Dorrington et al., 1978), 
where estrogen receptors-α and ß (ERα and ERß) as well as aromatase are found in abundance 
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(Couse et al., 1997; Rosenfeld et al., 1998), and the lack of ERα or aromatase leads to 
spermatogenesis impairment in mice (Lubahn et al., 1993; Korach, 1994; Eddy et al., 1996; Honda 
et al., 1998; Robertson et al., 1999; Toda et al., 2001). Activin and inhibin are peptide growth 
factors mainly produced by Sertoli cells which participate in the regulation of spermatogenesis. As 
their names suggest, these structurally-related proteins have opposing biological effects; while 
activin has a stimulatory effect (Mather et al., 1990; Nagano et al., 2003), inhibin exerts inhibitory 
effects on proliferation of spermatogonia (Meachem et al., 2001). 
2.2 Origin and Development of Male Germline Stem Cells 
2.2.1.  Primordial Germ Cells  
Primordial germ cells (PGC) are the progenitors of both male and female germline, which arise 
from a small population of epiblast cells distributed throughout the primitive streak (Anderson et 
al., 2000; Yabuta et al., 2006). This event occurs during gastrulation (~6.0-6.5 dpc in mice), under 
the influence of bone morphogenetic proteins (BMP4 and BMP8b), produced by the cells of 
extraembryonic ectoderm and visceral endoderm (Ginsburg et al., 1990; Saga, 2008; Ying et al., 
2000). These BMP induce the expression of PR-domain-containing protein 1 (PRDM1), also 
known as B-lymphocyte-induced maturation protein 1 (BLIMP1), which allows the specification 
of the epiblast cells to become PGC. This is achieved by promoting the expression of germ cell-
specific genes (e.g., Stella and Fragilis) and repressing the expression of somatic genes (e.g., Hox) 
(Ohinata et al., 2005; Saitou, 2009). Later, PGC develop cytoplasmic extensions and migrate to the 
base of the allantois (through the mesoderm and endoderm), where they are present as a cluster of 
alkaline phosphatase positive cells, at 7.0-7.5 dpc in mice (Chiquoine, 1954; Ginsburg et al., 1990) 
or 22 days of gestation in humans (Falin, 1969). At this point, PGC are known as the pre-migratory 
PGC since they are about to begin their journey to the genital ridges.  
Migration of PGC to the genital ridges occurs between ~8.5 and 13.5 dpc in mice (by 4.5 wk of 
gestation in humans). This migration is driven by chemotaxis and PGC undergo extensive 
multiplication while traveling along the hindgut, via the mesenchyme or dorsal mesentery (Tam 
and Snow, 1981; Francavilla et al., 1990; Rabinovici and Jaffe, 1990; Anderson et al., 2000). 
Migratory PGC maintain the expression of STELLA and also express the pluripotency markers 
OCT4, NANOG, SOX2, and stage-specific embryonic antigen-1 (SSEA-1) (Chuma et al., 2005; 
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Hayashi et al., 2007; Tilgner et al., 2008; Saitou and Yamaji, 2012). Once in the gonadal ridges, 
the deleted in azoospermia-like protein (DAZL) ensures the population of PGC remain constant 
and healthy by preventing apoptosis and terminating abnormal PGC (Lin and Page, 2005; Chen et 
al., 2014). Once residing in the gonadal ridges, PGC are subjected to sex determination.  
Uniquely, the fate of PGC is not determined by their chromosomal sex, but largely by the 
surrounding somatic cells; therefore, PGC have an equal capacity to become gonocytes or oocytes 
(Adams and McLaren, 2002; Chiquoine, 1954; McLaren et al., 1995; Molyneaux et al., 2001; 
Tilgner et al., 2008). Several studies have shown that PGC will enter meiosis if not co-cultured 
with embryonic testis tissue or if the testis architecture is disrupted in culture (Dolci and De Felici, 
1990; McLaren and Southee, 1997; Yao et al., 2003). Molecular cues involved in the sexual 
determination of PGC are poorly understood. During this phase, the sex determination genes are 
upregulated and the pluripotency genes are suppressed (Hu et al., 2015). The DAZL is believed to 
be one of the important factors that promote this process, because its absence results in maintenance 
of pluripotency and inhibition of differentiation into advanced germ cells (Gill et al., 2011). The 
presence of Sertoli cells also influences the sexual determination of PGC (Bowles et al., 2006). 
Gender-specific behavior of PGC can be seen at ~12.5 dpc in mice; in male (XY) embryos, PGC 
are arranged in rows, while they are arranged in random arrays in female (XX) embryos (Jost et 
al., 1973; Hilscher et al., 1974; McLaren and Southee, 1997; McLaren, 2001). The male PGC 
undergo several rounds of mitotic divisions before entering a mitotic arrest in the G 0/G 1 phase of 
the cell cycle, where they become known as gonocytes and remain quiescent until after birth 
(McLaren, 2001). In the female, after several rounds of proliferation, PGC undergo arrest at the 
diplotene stage of prophase I of meiosis (Tam and Snow, 1981). 
2.2.2 Gonocytes  
As the only type of germ cells present at birth, gonocytes are crucial for the development of more 
advanced stages of germ cells, ensuring the continuity of male germline throughout life (Culty, 
2009; 2013). Gonocytes are a transitional population of MGSC found between the stages of PGC 
and SSC (de Rooij, 1998; Jiang and Short, 1998). They appear at ~13.5 dpc in rodents, and 7 wk 
of gestation in human embryos (McLaren, 2003; Culty, 2009) and their development is hormone-
independent (Baker and O’Shaughnessy, 2001; O’Shaughnessy et al., 2012). Concurrent with the 
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establishment of testis cords and upon activation of the germ cell nuclear antigen 1 (GCNA1), PGC 
are committed to adopting male germ cell fate and becoming gonocytes. This transition is marked 
by the complete suppression of the alkaline phosphatase activity at ~14.5 dpc in mice (Enders and 
May, 1994; Richards et al., 1999). Gonocytes undergo several rounds of proliferation between 13.5 
and 18 dpc in rodents, and at 18 wk of gestation in human embryos, before they undergo mitotic 
arrest and enter the quiescent stage (Ginsburg et al., 1990; Vergouwen et al., 1991; McLaren, 2003; 
Oatley and Brinster, 2008; Western et al., 2008; Culty, 2009).  
Gonocytes have heterogeneous subpopulations that can genetically and behaviorally overlap with 
both the preceding and subsequent stages (Nagano et al., 2000). Based on mitotic activity and 
temporospatial distribution, gonocyte subpopulations can be more accurately categorized into: 1) 
Multiplying (M)-prospermatogonia; the population of gonocytes immediately following the PGC 
stage and prior to their mitotic arrest in the embryonic gonad. 2) Primary transitional (T1)-
prospermatogonia; quiescent gonocytes in the first state of transition between M-prospermatogonia 
and A-spermatogonia that reside at the center of testis cords. 3) Secondary transitional (T2)-
prospermatogonia; mitotically active gonocytes in the second state of transition to A-
spermatogonia that have migrated to the basement membrane of cords (McLaren, 2003).  
The proliferative activity of gonocytes (M-prospermatogonia) prior to their mitotic arrest has been 
suggested to occur under the influence of retinoic acid (RA). An increase in the number of rat 
gonocytes was observed after RA treatment in 12.5-14.5 dpc gonadal tissue cultures, but the 
opposite happened when RA was added to 16.5 dpc gonadal tissues (Livera et al., 2000a; 
Trautmann et al., 2008). The mechanisms involved in the mitotic arrest of gonocytes remain 
unknown; however, gonocytes enter the G1-S phase, and dephosphorylation of retinoblastoma 
protein (RB) occurs at 13.5 dpc in rodents (Western et al., 2008; Spiller et al., 2010). The quiescent 
stage of gonocytes (T1-prospermatogonia) has been observed in all examined mammalian species 
except in sheep (Hochereau-de Reviers et al., 1995). This quiescent state lasts for days, weeks, 
months, or years after birth, depending on the species (Russell, 1990; Olaso and Habert, 2000; 
Shinohara et al., 2001; McLaren, 2003; Oatley and Brinster, 2008; Culty, 2009). Gonocytes resume 
their proliferative activity at 1-4 dpp in rodents or ~8 wk after birth in the male infant (Culty, 2009). 
Throughout the quiescent stage, gonocytes reside at the center of seminiferous cords, where they 
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can be identified as distinctively large round cells, with one or two nucleoli in a prominent nucleus 
(McGuinness and Orth 1992).  
Prior to birth or shortly after, gonocytes (T1-prospermatogonia) migrate to the basement 
membrane, resume mitotic divisions and differentiation into T2-prospermatogonia (Coucouvanis 
et al., 1993; de Rooij, 1998; Jiang and Short, 1998). Prior to their migration, gonocytes undergo 
physical changes through the development of cytoplasmic extensions or pseudopods. These 
features are believed to aid in the amoeboid movement that directs the migration of gonocytes 
(McGuinness and Orth, 1992; Nagano et al., 2000). The population of gonocytes that fail to 
develop these cytoplasmic extensions will remain in the center of the seminiferous cords, 
degenerate, and undergo apoptosis (Roosen-Runge and Leik, 1968; Orwig et al., 2002a). In rats, 
gonocytes with pseudopods were able to drive full donor-derived spermatogenesis after 
transplantation into recipient testes, while most round, smooth gonocytes that lacked the 
cytoplasmic projections underwent apoptosis (Orwig et al., 2002a). Migration of gonocytes 
requires the expression of molecular cues that allow the interaction of gonocytes and somatic cells. 
Gonocytes with pseudopods were shown to express c-kit, blocking of which reduced gonocyte 
numbers in vitro and disrupted their migration to the basement membrane in vivo (Orth et al., 1997; 
Basciani et al., 2008). Suppression of PDGF receptors (PDGFRα and ß) also exerted the same 
effects (Thuillier et al., 2003; Basciani et al., 2008). A role has also been suggested for A-
Disintegrin and A-Metalloprotease domain (ADAM)-Integrin-Tetraspanin complexes 
(Kierszenbaum, 2005; Culty, 2009), due to their timely expression during the relocation and 
interaction with the extracellular matrix components of the basement membrane (Rosselot et al., 
2003; Siu and Cheng, 2004b).  
In rats, approximately 20% of the neonatal gonocytes undergo mitosis between 4 and 5 dpp 
(McGuinness and Orth, 1992). This event has been known to be driven by several molecular cues 
including 17ß-estradiol (E2) and platelet-derived growth factor (PDGF) (Thuillier et al., 2003; 
Wang et al., 2004; Basciani et al., 2008). Administration of E2 to mouse pups for three consecutive 
days after birth doubled the number of gonocytes (Vigueras-Villaseñor et al., 2006), while in the 
absence of estrogen receptors, the number of gonocytes was reduced two fold (Delbès et al., 2004). 
Other factors that have been identified to affect the proliferative activity of gonocytes include RA 
(Livera et al., 2000b; Boulogne et al., 2003; Zhou et al., 2008), leukemia inhibitory factor (LIH) 
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(De Miguel et al., 1996), and glial-derived neurotrophic factor (GDNF) (Braydich-Stolle et al., 
2007). Once settled at the basement membrane, gonocytes are confined in a special 
microenvironment, bounded by the basal lamina at the periphery, embedded between neighboring 
Sertoli cells, and isolated from the adluminal compartment via the blood-testis barrier. This 
microenvironment supports the differentiation of gonocytes to T2-prospermatogonia and future 
SSC, and hence is referred to as the ‘stem cell niche’.  
2.2.3 Spermatogonial Stem Cells  
Gonocytes that successfully migrate to the basement membrane (T2-prospermatogonia) resume 
proliferative activity, and a subset of this population (potentially NANOS3-positive) will 
differentiate and give rise to spermatogonial stem cells (SSC) (Yoshida, 2006; Nakagawa et al., 
2007; Suzuki et al., 2009). In mice, SSC appear at 3-8 dpp (Vergouwen et al., 1991; Drumond et 
al., 2011) and immediately initiate the first wave of spermatogenesis (Yoshida, 2006). In pigs and 
infant boys, SSC can be first detected at 1-2 mo and 3-12 mo, respectively (Hughes and Varley, 
1980; Goel et al., 2007; Chen and Liu, 2015). As precursors to all subsequent generations of germ 
cells, SSC undergo continuous self-renewal and differentiation (spermatogenesis) to produce tens 
of millions of spermatozoa per day throughout the adult life (De Rooij and Russell, 2000; Kubota 
and Brinster, 2006). However, SSC are a rare population among testis cells; in adult rodents, they 
comprise ~0.02-0.2% of testis cells, other estimates put their numbers at ~0.03% of all germ cells 
or 30,000 per testis in mice (Huckins, 1971; Tegelenbosch and de Rooij, 1993; de Rooij, 1998; 
Kanatsu-Shinohara et al., 2005). SSC reside in the stem cell niche, which ensures their survival, 
and regulates their differentiation and self-renewal (Oatley et al., 2009; Oatley and Brinster, 2012). 
Differentiation of gonocytes (T2-prospermatogonia) to SSC in rodents is induced by the RA and 
PDGF signaling pathways (Wang and Culty, 2007; Zhou et al., 2008; Manku et al., 2015). The 
involvement of microRNA (miRNA) in coordinating the differentiation of gonocytes to SSC has 
also been suggested (Tong et al., 2011; McIver et al., 2012). The differentiation to SSC is 
morphologically evident by proliferations to form spermatogonial clusters connected by 
intercellular bridges (Aponte et al., 2005; Kanatsu-Shinohara and Shinohara, 2013).  
Spermatogenesis begins at the basement membrane with mitosis of SSC to produce two daughter 
cells; one maintains its SSC characteristics to preserves the SSC pool to ensure continuity of the 
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process, while the other may continue mitotic divisions to form more advanced stages of 
spermatogonia. More detailed involvement of SSC in spermatogenesis was discussed in Chapter 
2.1.3. This self-renewal capability is essential in ensuring the maintenance of SSC pool (De Rooij 
and Russell, 2000; De Rooij, 2001a). Self-renewal and differentiation of spermatogonia must be 
kept in balance, or it may lead to either germ cell tumor or depletion of SSC (Meng et al., 2000). 
This balance is regulated by both extrinsic and intrinsic factors, including GDNF, as one of the 
most important regulators of SSC self-renewal, produced by Sertoli cells under the influence of 
FSH. GDNF signaling induces expression of specific genes such as Ets variant gene 5 (Etv5) and 
B-cell leukemia/lymphoma 6 (Bcl6b) that are involved in SSC self-renewal (Simon et al., 2007), 
while RA and DAZL are crucial regulators for spermatogonial differentiation (van Pelt and de 
Rooij, 1990; de Rooij et al., 1999). 
2.3 In Vitro Culture and Manipulation of Gonocytes 
2.3.1  Identification, Isolation, and Enrichment of Gonocytes 
Gonocytes have unique attributes that make them a suitable model for MGSC research and use in 
preserving or restoring fertility. However, gonocytes are present at very low numbers in the 
neonatal testis, comprising ~1-2% of total testis cells in rat pups, and ~7% of cells within 
seminiferous cords in piglets (Orwig et al., 2002a; Honaramooz et al., 2005a). The low number of 
gonocytes limits their use in downstream applications and necessitates their efficient identification, 
isolation, enrichment, and propagation in culture. 
Being the only germ cells present in the testis at birth, gonocytes can be identified by their size, 
distribution, and distinct morphology (Orwig et al., 2002a; Goel et al., 2007). In the neonatal testis, 
gonocytes reside at the center of seminiferous cords, and are characterized as large round cells with 
one or more nucleoli in their prominent nucleus (McGuinness and Orth, 1992; Orth et al., 2000). 
Upon digestion of the neonatal testis tissue, freshly isolated gonocytes are comparatively larger in 
size than Sertoli cells (Goel et al., 2007). In culture, gonocytes develop pseudopodia or cytoplasmic 
extensions, an attribute that is believed to be crucial for their migration (McGuinness and Orth, 
1992; van Dissel-Emiliani et al., 1993). Transplanting donor rat gonocytes with or without 
pseudopods into infertile mice showed that only gonocytes with pseudopods are able to produce 
donor-derived spermatogenesis (Orwig et al., 2002a). Although the morphological attributes of 
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gonocytes provide a valuable means for their identification, availability of molecular markers 
exclusively expressed by gonocytes remain crucial for their efficient identification, isolation, and 
enrichment.  
Currently, no biomarker is known to be uniquely expressed by gonocytes; hence, identification of 
gonocytes commonly relies on using other germline- and stem cell-specific markers. Germline-
specific markers such as DAZL and VASA, which are uniquely expressed in the germ cell lineage 
can be used to distinguish gonocytes from somatic cells (Castrillon et al., 2000; Reijo et al., 2000; 
Wu et al., 2009; Fujihara et al., 2011). Gonocytes have also been shown to express specific stem 
cell markers such as Oct3/Oct4, ZBTB16 (also known as PLZF), KIT, SSEA, NANOG and SALL4 
(Ohbo et al., 2003; Hoei-Hansen et al., 2005; Yamaguchi et al., 2005; Rajpert-De Meyts, 2006; 
Goel et al., 2007; Basciani et al., 2008; Fujihara et al., 2011). Gonocytes also have alkaline 
phosphatase activity and express surface markers such as CD9, THY1 (CD90), ubiquitin carboxyl-
terminal hydrolase-L1 (UCHL1, otherwise known as protein gene product 9.5 –PGP9.5) (Richards 
et al., 1999; Han et al., 2009) (Kubota et al., 2003; Kanatsu-Shinohara et al., 2004a; Luo et al., 
2006; Goel et al., 2007; Lee et al., 2013; Zheng et al., 2014a). THY1 has been suggested as a 
reliable surface marker for undifferentiated male germ cells including gonocytes in farm animals 
(i.e., cattle, pig, goat) (Reding et al., 2010; Abbasi et al., 2013; Zheng et al., 2014a). Lectin 
Dolichos biflorus agglutinin (DBA) is also an alternative surface marker for identification and 
purification of gonocytes, especially in pigs (Goel et al., 2007; Yang and Honaramooz, 2010; 
Abbasi et al., 2013). In contrast to the germline-specific markers for which the expression is 
conserved in all cells of the germ cell lineage, the expression of stem cell markers and surface 
markers in gonocytes are stage-dependent and may show different patterns in different populations 
of gonocytes (e.g., mitotic fetal, quiescent, and mitotic postnatal/migratory).  
Ideally, the isolation of gonocytes from testes should be performed using neonatal donors 
(immediately or shortly after birth) to obtain a higher proportion of gonocytes and to exclude SSC. 
This is especially critical in studies involving rodents because the window of gonocyte presence in 
these species is shorter (few days) (Hamra et al., 2008). The protocols for isolating gonocytes vary 
among laboratories, but a commonly used method has been a two-step enzymatic digestion. In the 
first step of this method, the parenchyma of neonatal testis tissue is minced and exposed to 
enzymes, such as collagenase and hyaluronidase, to dissociate the extracellular matrices/interstitial 
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tissue. In the second step, the tissue digestion is followed by treatment with trypsin either alone or 
in combination with other enzymes such as DNase to digest the seminiferous cords and prevent 
aggregation of cells (van Dissel-Emiliani et al., 1993; Orwig et al., 2002a; Goel et al., 2007). The 
main drawback of the two-step method is that it has not been specifically designed for isolation of 
neonatal testis cells, thus results in low gonocyte yields (~10%) in the freshly isolated cells from 
various species (van Dissel-Emiliani et al., 1989; van Dissel-Emiliani et al., 1993; Li et al., 1997; 
Orwig et al., 2002a; Lo et al., 2005; Herrid et al., 2009). In more recent years, the technique for 
isolation of gonocytes from fresh neonatal testis tissue has been improved by the introduction of a 
three-step isolation method, where gentle enzymatic digestion is combined with mechanical 
agitation (by including two rounds of vortexing). This procedure results in obtaining ~40% 
gonocytes among the isolated neonatal pig testis cells (Yang et al., 2010). 
Several strategies have been applied to enrich gonocytes in the populations of isolated testis cells. 
Methods such as velocity sedimentation (STA-PUT) or density gradient centrifugation (e.g., using 
BSA, Percoll, or Nycodenz) have allowed separation of gonocytes from other testis cells based on 
their cell size/density differences (van Dissel-Emiliani et al., 1989; Luo et al., 2006; Goel et al., 
2007; Yang and Honaramooz, 2011; Bryant et al., 2013). For instance, gonocytes were purified to 
70-75% among freshly isolated rat testis cells, using the two-step enzymatic digestion, followed 
by BSA separation (van Dissel-Emiliani et al., 1989). The gonocyte proportion also has been 
increased from an initial 40% in the freshly isolated pig testis cell to ~80% after Nycodenz 
centrifugation (Yang and Honaramooz, 2011). Another commonly used approach to gonocyte 
enrichment is utilizing the differences in adhesion of somatic cells and gonocytes toward 
extracellular matrices (e.g., fibronectin, laminin, or collagen). This strategy is referred to as 
differential plating and can be applied to either freshly isolated testis cells or gonocytes enriched 
using other methods for further purification. Using differential plating can lead to purification of 
gonocytes up to ~90% for testis cells of farm animals (Han et al., 2009; Kuijk et al., 2009; Kim et 
al., 2010a; Yang and Honaramooz, 2011; Zheng et al., 2014a). Alternatively, gonocytes can be 
enriched using cell sorting technologies targeted toward gonocyte surface markers (i.e., 
fluorescent-activated cell sorting –FACS– and magnetic-activated cell sorting –MACS) (Valli et 
al., 2014). Freshly isolated testis cells or cells enriched using other methods can be labelled with 
either single or double markers that can positively or negatively select gonocytes. Although this 
technology can yield highly enriched populations of gonocytes (Kubota et al., 2004a; Abbasi et al., 
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2013; Wu et al., 2013; Kim et al., 2014; McMillan et al., 2014; Zheng et al., 2014a), it also leads 
to a significant gonocyte loss that limits its use for most applications.  
2.3.2 Maintenance and Propagation of Gonocytes in Culture 
The use of gonocytes for certain applications, such as transplantation into recipient testes, requires 
very high numbers that necessitates in vitro propagation of gonocytes. This requires the 
identification of ideal culture conditions that support self-renewal of gonocyte while maintaining 
their pluripotency. For mouse SSC, long-term culture systems (5 mo to 2 yr) have been successfully 
established (Kanatsu-Shinohara et al., 2003; Ryu et al., 2005). Application of either the same or 
modified culture systems for gonocytes using farm animal donors (e.g., goats, cattle, pigs), 
however, has been less successful in maintaining them beyond 2 mo (Luo et al., 2006; Goel et al., 
2007; Kuijk et al., 2009; Bahadorani et al., 2012; Heidari et al., 2012; Zheng et al., 2013; Sahare 
et al., 2015). The reasons are not clear but likely involve a reduction in self-renewal capacity of 
gonocytes in culture, differentiation into SSC, or apoptosis over time (Zheng et al., 2014b). 
However, a few studies have reported successful maintenance of bovine and porcine gonocytes in 
culture for various periods, with the longest being up to 6 mo (Han et al., 2009; Lee et al., 2013; 
Sahare et al., 2016). These two groups each used a different culture system, and to date there is no 
standardized system for maintenance and propagation of gonocytes from farm animal species. 
Variations in culture conditions (i.e., media, temperature, additives, feeder layer), protocols, and 
sources of cells make it difficult to replicate the reported systems for maintenance and propagation 
of gonocytes in different species/laboratory settings.  
Once cultured, gonocytes are believed to require the presence of supporting cells or a feeder layer; 
therefore, at least initially, gonocytes are commonly co-cultured with Sertoli cells (Orth and 
Boehm, 1990; Orth and McGuinness, 1991; van Dissel-Emiliani et al., 1993). Sertoli cells promote 
in vitro survival of gonocytes via the establishment of specific Sertoli-gonocyte contacts, even in 
the presence of other testis somatic cells (van Dissel-Emiliani et al., 1993). However, it has also 
been suggested that various metabolic products or molecular signals released from Sertoli cells 
may potentially inhibit the proliferation of gonocytes, while promoting their differentiation 
(Griswold, 1998; Hasthorpe et al., 2000). Alternative cells for co-culturing with MGSC have 
included mitotically-inactivated cells such as SIM embryo-derived thioguanine and aoubain 
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resistant (STO) or mouse embryonic fibroblasts (MEFs), obtained through mitomycin-C treatment 
or irradiation. The STO cells have been found to be the most effective feeder cells for maintenance 
of MGSC, notably SSC, and have also been used to co-culture with gonocytes of various donor 
species (e.g., rodent, bovine, porcine, human) (van Dissel-Emiliani et al., 1993; Olie et al., 1995; 
Nagano et al., 1998; Hasthorpe et al., 1999; Oatley et al., 2002; Kent Hamra et al., 2004; Kubota 
et al., 2004a; Childs et al., 2008; Wu et al., 2009; Han et al., 2009; Nasiri et al., 2012). The use of 
feeder cells, however, is not without its limitations. Different types of feeder cells have different 
effects on proliferation and self-renewal capability of MGSC, and there is considerable variation 
in the source, treatments applied, and batches among these cells. In addition, some of the same 
concerns remain over the potential adverse effects of their released metabolites/factors on MGSC 
(He et al., 2015). 
Since the establishment of in vitro culture systems for MGSC, the choice of culture media has 
always been an essential component of the culture system. Different types of media have been used 
for culturing gonocytes, ranging from very basic (e.g., DMEM) to enriched/specialized (e.g., 
DMEM/F12, StemPro) (van Dissel-Emiliani et al., 1993; Goel et al., 2007; Aponte et al., 2008; 
Fujihara et al., 2008; Kuijk et al., 2009). The serum has been commonly added as a main 
component to these media to support optimal growth of cells; although its effect on cultured MGSC 
remains poorly understood. The use of serum may in fact have inadvertent influences on the rate 
of proliferation and differentiation of SSC, since higher serum concentrations were found to 
negatively affect the expansion of SSC (Kanatsu-Shinohara et al., 2005; Bahadorani et al., 2012). 
Effects of serum on gonocytes are even less studied, but have been suggested to be similar to SSC. 
Fetal bovine serum (FBS) used at 5% was shown to promote the survival of porcine gonocytes up 
to 9 days when cultured either alone or in the presence of Sertoli cells (Marret and Durand, 2000). 
However, FBS exerted deleterious effects when added at 2-8% to cultured rat gonocytes, where a 
reduction in gonocyte numbers was observed at 5 days onward (van Dissel-Emiliani et al., 1993). 
Using neonatal pig testis cells, a negative correlation was observed between the colony formation 
potential of gonocytes and serum concentrations (i.e., more colonies in 1% than 10% FBS) (Zheng 
et al., 2013). High concentrations of serum in the media may also enhance the growth of somatic 
cells and exert detrimental effects on SSC proliferation (Izadyar et al., 2003a; Bahadorani et al., 
2012; Zheng et al., 2013). These findings collectively suggest that serum should be used cautiously 
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as an additive to the culture of gonocytes. Similar to feeder cells, variations in the sources, 
composition, batches, and manufactures of serum may influence the cell culture outcomes. 
Given the limitations and uncertainty over the effects of feeder cells and serum on MGSC, 
alternative serum-free and feeder-free culture conditions have also been explored. In serum-free 
systems, a variety of specialized media may be used that include minimum essential medium-alpha 
(MEMα), F10, Knockout Serum Replacement (KSR), StemPro-34, B27 supplement, and Iscove’s 
modified Dulbecco’s medium (IMDM) (Kubota et al., 2004a; Kanatsu-Shinohara et al., 2005, 
2011; Aoshima et al., 2013; Kanatsu-Shinohara et al., 2014; Sahare et al., 2016). To replace feeder 
cells, MGSC have been cultured on plates coated with extracellular matrices such as laminin, 
gelatin, or poly-L-lysine (Sadri-Ardekani et al., 2009; Kanatsu-Shinohara et al., 2011; Kanatsu-
Shinohara and Shinohara, 2013; Lee et al., 2013; Sahare et al., 2016). On the other hand, exogenous 
nutrients such as bovine serum albumin (BSA), growth factors, amino acids, and vitamins have 
been added as essential components in serum-free and feeder-free culture systems. As discussed in 
Chapter 2.4, a number of growth factors have been identified to regulate the proliferation and self-
renewal of cultured MGSC/gonocytes including GDNF, PDGF, RA, epidermal growth factor 
(EGF), basic fibroblast growth factor 2 (FGF2), leukemia inhibitory factor (LIH), and stem cell 
factors (SCF). Thus far, serum-free and feeder-free culture systems have been developed for 
culturing gonocytes from rodents (Kanatsu-Shinohara et al., 2011, 2014), cattle (Sahare et al., 
2016), humans (Sadri-Ardekani et al., 2009; Piravar et al., 2013), and pigs (Lee et al., 2013). 
2.3.3 Potential Derivation of Pluripotent Stem Cells  
Pluripotent stem cells (PSC) are undifferentiated cells that have the capacity for self-renewal, 
proliferation, and giving rise to different types of cells and tissues of all three germinal layers (i.e., 
ectoderm, mesoderm, and endoderm). These PSC can be of embryonic origin (i.e., embryonic stem 
-ES- cells) or artificially induced (iPSC) in vitro (Evans and Kaufman, 1981; Thomson et al., 
1998). The ES cells are collected from the inner-mass cells of embryos at the blastocyst stage, 
while iPSC are obtained through reprogramming of somatic cells by enforcing the expression of 
key pluripotency genes (i.e., Oct3/4, Klf4, c-Myc, Sox2) (Takahashi and Yamanaka, 2006; 
Takahashi et al., 2007; Wernig et al., 2007; Yu et al., 2007; Lowry et al., 2008; Park et al., 2008; 
Kim et al., 2016). Once induced, iPSC share many similarities with ES cells (i.e., morphology, 
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karyotype, gene expression) and the resemblance becomes more prominent as iPSC lose their 
epigenetic markers over time, after multiple passages (Wernig et al., 2007; Yu et al., 2007; Kim et 
al., 2010b). Therefore, iPSC offer an alternative to ES cells, where the collection is hampered by 
ethical issues and limited supply (Yamanaka and Blau, 2010). However, given the use of viral 
vectors for the induction of pluripotency genes, the clinical application of iPSC for stem cell 
therapy (i.e., regenerative medicine) carries a risk of carcinogenicity. While iPSC can be used as a 
valuable tool for diseases modelling and drug screening in vitro (Colman and Dreesen, 2009), the 
search continues for alternative sources of pluripotent stem cells whose application is not hampered 
by ethical or carcinogen concerns. 
Male germline stem cells (i.e., PGC, gonocytes, SSC) may have the potential to be induced into 
PSC (Sabour and Schöler, 2012). The original concept was suggested in 1979 (Illmensee and 
Stevens, 1979), a decade before PSC were successfully obtained in vitro from PGC of 8.5-12.5 dpc 
embryos, under the influence of growth factors (i.e., FGF2, SCF, LIF) (Matsui et al., 1992; Resnick 
et al., 1992). These PSC where characterized by the formation of embryoid bodies and 
differentiation into multiple type of cells in long-term culture, development of tumors (i.e., 
teratomas and teratocarcinomas) upon implantation into nude mice, and contribution to germline 
chimeras when microinjected into blastocysts (Matsui et al., 1992; Resnick et al., 1992; Labosky 
et al., 1994; Stewart et al., 1994). It was initially presumed that the capability to transform into 
PSC was restricted to PGC, because an attempt to derive PSC from postnatal spermatogonia using 
the same conditions had failed (Labosky et al., 1994). However, this view changed in 2003, when 
ES-like cells were derived from mouse SSC, which showed PCS characteristics upon culture in a 
newly developed long-term system (Kanatsu-Shinohara et al., 2003, 2004b, 2005). Interestingly, 
the transformation into pluripotency state occurred without the need for ‘reprograming’ and in the 
absence of GDNF, a key factor associated with SSC self-renewal (Kanatsu-Shinohara et al., 
2004b). Unlike iPSC from somatic cells and ES cells (Hayashi et al., 2012; Easley et al., 2014), 
SSC-derived PSC lose their spermatogenic potential (Kanatsu-Shinohara et al., 2004b, 2008b). 
Although SSC-derived PSC have been produced from mice of different ages (Guan et al., 2006; 
Seandel et al., 2007; Ko et al., 2009), a recent study suggested that the capability of SSC to be 
induced pluripotent is age-dependent, where it decreases as the mouse reached adulthood (Azizi et 
al., 2016). In addition to mouse SSC, PSC have also been derived from human, porcine, bovine, 
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and caprine SSC (Conrad et al., 2008; Kossack et al., 2009; Wang et al., 2014, 2016a; Jafarnejad 
et al., 2018). 
ES-like colonies have been produced and characterized mostly in cultures using gonocytes from 
non-rodent models (i.e., pigs, cattle, goats), because relatively large numbers of testis cells can be 
collected from their neonatal testes (Goel et al., 2009; Kuijk et al., 2009; Zheng et al., 2014a). 
More recently, derivation of PSC from mouse and pig gonocytes has also been reported (Tanaka 
et al., 2015; Niu et al., 2016). Mechanisms underlying the formation of ES-like cells from postnatal 
MGSC remain to be elucidated. It was hypothesized that ES-like cells might be the remnants of 
pluripotent cells from the fetal stage (Kubota and Brinster, 2006); however, this possibility has 
been questioned because the direct derivation of ES-like cells from either ES cells or embryonic 
germ cells in culture conditions has been problematic (Labosky et al., 1994; Kanatsu-Shinohara et 
al., 2004b). The frequency of ES-like cells formation by postnatal MGSC is low, but treatment 
with glycogen synthase kinase-3 (GSK3) inhibitors and vitamin C has been found to promote the 
formation of ES-like cells from SSC culture (Moraveji et al., 2012; Wang et al., 2014). A newly-
developed protocol involving depletion of two germ cell tumor candidate genes, Trp53 and Dmrt1 
(double knockout), improved the efficiency of PSC derivation from MGSC (Takashima et al., 
2014; Tanaka et al., 2015).  
2.3.4 In Vitro Spermatogenesis 
In vitro spermatogenesis refers to an ex vivo production of haploid cells from diploid male germ 
cells in an artificial environment, which can be performed by culturing testis organ, tissue, or cells 
in two- (2D) or three-dimensional (3D) systems (Tesarik et al., 1999; Izadyar et al., 2003a; Suzuki 
and Sato, 2003; Stukenborg et al., 2008; Sato et al., 2011a; Abu Elhija et al., 2012; Riboldi et al., 
2012; Yokonishi et al., 2014). Testis organ/tissue culture involves using a whole testis or its small 
fragments, which ensures that the germ cells remain in their niche architecture and 
microenvironment throughout the culture period (Ibtisham et al., 2017). However, the success of 
this technique relies heavily on the ability of the system to keep the tissue viable for a longer period. 
The use of isolated testis cells, on the other hand, involves culturing of germ cells with or without 
somatic or feeder cells to initiate the spermatogenic process (as described in Chapter 2.3.2).  
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Replicating the complex process of spermatogenesis in vitro has many applications that range from 
use as a research model to potential experimental/clinical use as an alternative for infertility 
treatment or conservation/preservation of endogenous spermatogenesis. Therefore, achieving in 
vitro differentiation of germ cells has been a long-standing research objective going back a century 
(Champy, 1920). Since then, substantial improvements have been made especially in cell culture 
protocols and in our understanding of the requirements of in vitro differentiation. The media 
composition and additives may play an important role during this process. Several studies have 
reported positive effects of FBS on in vitro differentiation of germ cells (Haneji et al., 1983; Izadyar 
et al., 2003b), while the effects of serum-free media have been less consistent. When KSR was 
used in cultures of neonatal and adult mouse testis tissues, differentiation potential was greatly 
improved as compared with FBS (Sato et al., 2011a; Riboldi et al., 2012). However, another study 
using fetal mouse testes reported that using KSR prevented the entry of male germ cells into mitotic 
arrest and caused epigenetic instabilities that raised safety concerns (Hogg and Western, 2015). In 
vitro differentiation and fertilization potential of germ cells were improved with the use of FSH 
and testosterone, alone or in combination, in culture systems (Tesarik et al., 1998; Sousa et al., 
2002; Movahedin et al., 2004; Vigier et al., 2004; Hasegawa et al., 2010; Xie et al., 2010). 
Similarly, RA promoted in vitro germ cell differentiation, especially in the early steps; however, 
the effect on later steps requires further investigation, since the production of haploid germ cells 
was found to be less efficient (Wang et al., 2016b).  
Cryopreservation does not seem to hinder the progression of spermatogenesis in vitro, which has 
important clinical implications. Cryopreserved immature mouse testis tissue was shown to have 
comparable differentiation potential (SSC to secondary spermatocytes and spermatids after 2 wk 
of culture), and even slightly higher fertilization rate (78% vs. 74%) than that of fresh adult testis 
tissue (Suzuki and Sato, 2003). Viable offspring have also been produced from spermatids 
produced in vitro from cryopreserved testis tissue, through the use of round spermatid injection 
(ROSI) or intra-cytoplasmic spermatozoa injection (ICSI) (Sato et al., 2011a; Yokonishi et al., 
2014). The differentiation efficiency appears donor age-dependent; fewer fertile haploid cells were 
produced when the tissue was from adult mouse testes than from neonates (Sato et al., 2015).  
There is no consistent or standardized incubation temperature defined for in vitro spermatogenesis 
since the temperatures used vary from 30-39 ˚C (Matte and Sasaki, 1971; Hofmann et al., 1994; 
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Tesarik et al., 1999; Izadyar et al., 2003a; Sato et al., 2011a). Using different incubation 
temperatures in a single study showed that although both germ cell proliferation and differentiation 
occurred steadily at 37 ˚C, conditions were more favorable for proliferation at 39 ˚C and better for 
differentiation at 32 ˚C (Hofmann et al., 1994). In more recent years, 3D culture technology has 
been introduced for in vitro spermatogenesis, in which isolated cells or tissue fragments are 
cultured on/in 3D scaffolds, made from natural or synthetic polymers (e.g., agarose, collagen 
matrix, methylcellulose) or poly lactic-co-glycolic acid (PLGA). The 3D culture system, however, 
seems to be more efficient than the 2D system, because it led to increased occurrence of post-
meiotic cells (haploid germ cells) (Lee et al., 2007a; Abu Elhija et al., 2012; Khajavi et al., 2014; 
Huleihel et al., 2015).  
The results of in vitro spermatogenesis in the literature vary greatly, and different degrees of germ 
cell differentiation have been reported. The results seem to be heavily affected by the source of 
cells/tissues (i.e., prepubertal vs. adult vs. cryptorchid, or nonobstructive- vs. obstructive 
azoospermia), strains (wild-type vs. transgenic), species (mouse, rat, human, non-human primates, 
cattle), culture length (short-term vs. long-term), and culture systems (organ/tissue vs. isolated 
cells, or 2D vs. 3D). Nevertheless, more recently functional spermatozoa have been successfully 
produced in vitro using both organ/tissue and isolated cell cultures, with greater success (75%) 
using organ/tissue cultures (Sato et al., 2011a, b; Abu Elhija et al., 2012; Yokonishi et al., 2014). 
Interestingly, these successful studies were all performed using rodent donors, in the form of tissues 
or cells, and 3D systems. The resultant haploid germ cells (i.e., spermatids and spermatozoa) were 
also functional, examined through the use of ROSI or ICSI, resulting in the production of donor-
derived offspring (Sato et al., 2011a, b; Yokonishi et al., 2014). 
Thus far, there has been no report of studies achieving or specifically testing the differentiation 
potential of neonatal gonocytes all through the production of spermatozoa in vitro. Almost all 
available literature refers to the use of cells or tissues from immature/prepubertal to adult rodents 
(Matte and Sasaki, 1971; Tesarik et al., 1999; Izadyar et al., 2003b; Suzuki and Sato, 2003; 
Movahedin et al., 2004; Stukenborg et al., 2008; Abu Elhija et al., 2012; Riboldi et al., 2012). 
Because in mice, SSC appear as early as 3-8 dpp (Vergouwen et al., 1991; Drumond et al., 2011), 
even in the studies where the source of testes was indicated as neonates, the earliest germ cells 
were SSC, not gonocytes (Sato et al., 2011a; Wang et al., 2016b). Since differentiation of 
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gonocytes to SSC can be induced in vitro such as with RA treatment (Wang and Culty, 2007; Zhou 
et al., 2008), in vitro spermatogenesis from gonocytes is theoretically achievable.  
2.4 Involvement of Growth Factors in Testis Development 
2.4.1 Fibroblast Growth Factors  
Members of the fibroblast growth factor (FGF) family are expressed in various cells throughout 
the male reproductive tract and play an important role in the development of fetal and postnatal 
testes. As described earlier (in Chapter 2.1.1), FGF9 is one of key regulators of sexual 
differentiation, in which the expression is upregulated as a result of Sry-activated SOX9 (Colvin et 
al., 2001; Sekido et al., 2004; Wilhelm et al., 2005). Persistent expression of FGF9 is crucial in 
maintaining SRY and SOX9 to drive the center-to-pole (poleward expansion) of testiculogenic 
programs and testis cords formation in the developing gonad (Kim et al., 2006a; Moniot et al., 
2009). The FGF9 signaling drives the proliferation of mesenchymal stem cells and the migration 
of mesonephric cells into the gonad, leading to formation of the interstitial compartment (Colvin 
et al., 2001). Coordinated expression of SRY, SOX9, and FGF9 maintain the expression of testis 
genes, while deactivating genes involved in the ovarian development (Li et al., 2014). FGF9 alone 
has been shown to exert antagonist effects on WNT4, a crucial factor in promoting the female 
gonad development (Jameson et al., 2012). 
Other members of the FGF family involved in testis development include FGF8, FGF1, FGF2, and 
FGF4. For instance, FGF8 has an important function in maturation of the seminiferous epithelium, 
thus its expression can decrease over time (Valve et al., 1997). FGF2 and FGF4 affect somatic cells 
of the testis by playing an important role in the proliferation and survival of Sertoli cells, 
respectively (van Dissel-Emiliani et al., 1996), while FGF2 and FGF1 have been associated with 
steroidogenesis and the normal function of Leydig cells (Sordoillet et al., 1992; Laslett et al., 1997). 
The potential direct role of the FGF family on germ cells is less clear; however, it has been 
suggested that the proliferation of neonatal gonocytes in vitro can be induced by FGF2 (van Dissel-
Emiliani et al., 1996). FGF2 is also a critical regulator of SSC self-renewal, where it is involved in 
the expression of ETV5 and BCL6B, candidate transcription factors for SSC-self renewal (Ishii et 
al., 2012). The FGF9 signaling is also involved in mitogen-activated protein (MAP) kinase 
activation, which contributes to the proliferation of primitive spermatogonia and spermatogenic 
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meiosis during fetal and postnatal stages, respectively (Sun et al., 1999). Finally, FGF4 and FGF21 
exert anti- and pro-apoptotic effects on germ cells, respectively, as a potential mechanism for 
maintaining the germ cell pool in the testis (Yamamoto et al., 2002; Hirai et al., 2004). 
2.4.2 Glial Cell-Derived Neurotrophic Factor 
The glial cell-derived neurotrophic factor (GDNF), a member of the transforming growth factor-
beta (TGFß), was first identified in the media of glioma cell line cultures (Lin et al., 1993). GDNF 
has been shown to promote the renal and neural development, while in the testis, it is produced by 
Sertoli cells under the influence of FSH, certain growth factors, and cytokines (Tadokoro et al., 
2002; Simon et al., 2007). GDNF exerts its effects via the GFRα-1 and RET receptors, expressed 
by undifferentiated spermatogonia, to affect the establishment of stem cell niche, and to regulate 
SSC self-renewal and differentiation both in vivo and in vitro (Meng et al., 2000; Viglietto et al., 
2000; Tadokoro et al., 2002; Kanatsu-Shinohara et al., 2003; Yomogida et al., 2003; Hofmann et 
al., 2005; Naughton et al., 2006). The GDNF-receptor complex is involved in the intercellular 
communications between Sertoli cells and SSC, development of actin cytoskeleton, and migration 
of gonocytes/SSC to the stem cell niche (Dovere et al., 2013). Disruptions in GDNF signaling, as 
observed in Ets variant gene 5 (Etv5) knockout mice, results in the loss of spermatogonia, due to 
decreased chemoattraction between Sertoli cells and SSC (Simon et al., 2010), while 
overexpression of GDNF promotes the proliferation of spermatogonia (Meng et al., 2000). 
Subsequent germ cell transplantation studies, where SSC from fertile donors were transplanted into 
GDNF knockout mice further validated these findings (Kanatsu-Shinohara et al., 2003; Ogawa et 
al., 2003; Yomogida et al., 2003). In addition to the effects on germ cells, GDNF plays a role in 
the proliferation of Sertoli cells in the developing testis (Wu et al., 2005). 
GDNF was also one of the growth factors used in the establishment of a long-term culture system 
for the maintenance of SSC (Kanatsu-Shinohara et al., 2003). The spermatogonia from neonatal 
mouse testes cultured on mouse embryonic fibroblasts (MEFs) in the presence of GDNF, EGF, 
LIH, and FGF2 supported the formation of germ cell colonies expressing SSC markers for up to 2 
years. Since then, GDNF has been added as an indispensable component in long-term cultures of 
SSC from young and adult mice (Kanatsu-Shinohara et al., 2004b; Kubota et al., 2004a; Ogawa et 
al., 2004; Ryu et al., 2005). The GDNF signaling for self-renewal of SSC occurs via the activation 
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of phosphoinositide 3-kinase (PI3K)/AKT and mitogen-activated protein kinase/ERK1 kinase-1 
(MEK) pathways (Braydich-Stolle et al., 2007; Lee et al., 2007b; Oatley et al., 2007), which are 
responsible for the expression of transcription factors such as ETV5, BCL6B, EGR2 LHX1, 
FOXO1, ID4, POU3F1, and L-GILZ (Oatley et al., 2006, 2011; Wu et al., 2011; Ishii et al., 2012; 
Romero et al., 2012). Some of these factors (e.g., ETV5, BCL6B, FOXO1, L-GILZ) are necessary 
in maintaining the expression of the RET receptor. In addition, the presence of ETV5 upregulates 
the expression of CXCR4, a chemokine receptor involved in the migration of PGC to the 
developing gonad, and SSC to the stem cell niche in the postnatal testes. Thus, the suppression of 
GDNF signaling pathways and their downstream transcription factors result in the failure of SSC 
to proliferate or survive and hence lead to depletion of spermatogenesis (Ara et al., 2003; Kanatsu-
Shinohara et al., 2012; Kanatsu-Shinohara and Shinohara, 2013).  
2.4.3 Stem Cell Factor 
The stem cell factor (SCF) and its receptor, the tyrosine kinase receptor c-kit (SCF/c-kit), have 
been shown to play an important role in the development of functional testis tissue. SCF is 
produced by Sertoli cells, and its expression in the adult testis can be seen at the basement 
membrane of seminiferous tubules and on the surface of Sertoli cells, while c-kit receptors are 
localized to germ cells (i.e., spermatogonia, spermatids) and Leydig cells (Bokemeyer et al., 1996; 
Unni et al., 2009). Therefore, the SCF/c-kit complex provides the microenvironment necessary for 
spermatogenesis by exerting its effect on both the somatic and germ cell components of the testis 
(Bokemeyer et al., 1996). Mutation of the W and Sl loci, which encode c-KIT and SCF, 
respectively, results in aberrations of spermatogenesis (Morrison-Graham and Takahashi, 1993; 
Loveland and Schlatt, 1997; Olaso and Habert, 2000). On somatic cells, the SCF/c-kit complex has 
been found to regulate the formation of Leydig cell populations during testis morphogenesis, 
support their survival, and affect testosterone synthesis during testis development (Yoshinaga et 
al., 1991; Yan et al., 2000a). 
The actions of SCF/c-kit on germ cells persist throughout life; for instance, during gonadal 
development, expression of c-kit regulates the migration, survival, and proliferation of PGC and 
can be traced back to 7-12.5 dpc (Dolci et al., 1991; Matsui et al., 1991; Motro et al., 1991). 
SCF/c-kit also supports the subsequent processes and events in testis development, including the 
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promotion of Sertoli-germ cell adhesion during testis cords formation (Marziali et al., 1993). 
Decreases in SCF at certain stages of testis development have been associated with the mitotic 
arrest of spermatogonia (Mauduit et al., 1999). In the postnatal testis, SCF/c-kit is known to support 
the differentiation of various germ cells, and survival of differentiated spermatogonia, 
spermatocytes, and spermatids (Yan et al., 2000a) (Dolci et al., 1991; Yoshinaga et al., 1991; 
Hakovirta et al., 1999; Schrans-Stassen et al., 1999). This action was further highlighted in a study 
using telomerase-immortalized type A spermatogonia, where in the presence of SCF, these cells 
became capable of undergoing differentiation into haploid spermatids (Feng et al., 2002). 
2.4.4 Leukemia Inhibitory Factor 
The leukemia inhibitory factor (LIF) is a multifunctional polypeptide cytokine/growth factor of the 
interleukin 6 (IL-6) family, first identified for its supporting role in the maintenance of self-renewal 
and totipotency of mouse ES cells (Smith et al., 1988). LIF is produced predominantly by the 
peritubular myoid cells, and in the rat testis can be detected from 13.5 dpc until adulthood (Piquet-
Pellorce et al., 2000). LIF receptors (LIF-R) are expressed by germ cell precursors (i.e., PGC, 
gonocytes, spermatogonia), as well as Sertoli cells and Leydig cells. Therefore, considerable 
amounts of bioactive LIF can be found in both the interstitial and tubular compartments of the testis 
(Jenab and Morris, 1998; Piquet-Pellorce et al., 2000). 
In vitro studies have demonstrated that LIF plays a significant role in the proliferation and survival 
of MGSC (Matsui et al., 1991; Pesce et al., 1993; Cheng et al., 1994; De Miguel et al., 1996; 
Koshimizu et al., 1996). LIF has been found to promote the proliferation of murine PGC in vitro, 
even in the absence of feeder cells, where the blocking of its receptor using LIF-R antiserum results 
in their apoptosis and death (Pesce et al., 1993; Cheng et al., 1994) (Godin et al., 1991; Matsui et 
al., 1991). The addition of LIF initiates the proliferation and survival of rodent gonocyte-Sertoli 
co-cultures (De Miguel et al., 1996), enhances the formation of germ cell colonies, and promotes 
the differentiation of murine and bovine gonocytes to spermatogonia (Kanatsu-Shinohara et al., 
2007; Aponte et al., 2008; Rastegar et al., 2015). On the other hand, the withdrawal of LIF can 
disrupt the development of SSC and their colonies (Rastegar et al., 2015). A role for LIF in the 
proliferation and survival of SSC has been shown by the increased incorporation of 3H-thymidine 
in spermatogonia in the micro-dissected seminiferous tubule cultures (Dorval-Coiffec et al., 2005). 
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For somatic cells, LIF has been found to promote the survival of Sertoli cells when co-cultured 
with gonocytes (De Miguel et al., 1996), and upregulate transcription of the c-fos gene, which is 
important for their differentiation in primary cultures (Jenab and Morris, 1998). LIF may also act 
as a regulator of testosterone production (Jenab and Morris, 1998; Yano et al., 1998). Much less is 
known about the role of LIF in differentiated germ cells; the incubation of spermatozoa with LIF 
promotes their motility and survival in a dose-dependent manner (Attar et al., 2003), while 
overexpression of LIF has been found to have detrimental effects on spermatogenesis (Hilton and 
Gough, 1991; Shen et al., 1994; Yano et al., 1998). 
2.4.5 Vascular Endothelial Growth Factor  
The vascular endothelial growth factor (VEGF) is a very important family of growth factors for 
diverse functions ranging from blood vessel development and permeability to cellular migration 
(Ferrara et al., 1996; Ferrara, 2000). The VEGF proteins are well-conserved and have several 
subtypes encoded in humans by five different genes including, VEGF-A, VEGF-B, VEGF-C, 
VEGF-D, and placental growth factors (PLGF). During embryonic development, the absence of 
even a single VEGF allele halts the development of vasculature, which is lethal for the embryo 
(Carmeliet et al., 1996; Ferrara et al., 1996). The VEGF family exert their actions via receptors 
known as VEGFR1 and VEGFR2, where, for instance, VEGFR1 is responsible for the development 
of endothelial lineage and VEGFR2 for the organization of endothelium (Fong et al., 1995; Shalaby 
et al., 1995). The role of VEGF in the testis is poorly understood because the adult tissue is not an 
active site of angiogenesis. VEGF expression has been detected along the male genital tract, such 
as in Leydig and Sertoli cells, as well as the lining of the epididymis, prostate, and vesicular glands 
(Carmeliet et al., 1996). VEGF-A is produced by Sertoli and Leydig cells during different stages 
of testis development (Liu and Yang, 2004; Bott et al., 2006). VEGFR2 is expressed in the testis 
micro-vasculature and vascular endothelium of the epididymis, while VEGFR1 is expressed in 
human and rodent germ cells (Ergün et al., 1997; Korpelainen et al., 1998; Nalbandian et al., 2003; 
Rudolfsson et al., 2004). Therefore, it is presumed that the role of VEGF in the testis may involve 
vascular permeability and postnatal germ cell development (Korpelainen et al., 1998). 
During the fetal period, VEGF-A is involved in the formation of testis cords, where it promotes 
and coordinates the migration of cells, including endothelial cells from the mesonephros into the 
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developing gonad (Bott et al., 2006; Cool et al., 2011). Blocking the VEGF receptors with VEGF 
antagonists results in disruption of seminiferous cords formation. Testis tissue xenografting and 
testis cell implantation studies demonstrated that VEGF is required for the normal function of germ 
cells, where treating the donor testis tissue and cells with VEGF (i.e., VEGF-A or VEGF-164) prior 
to grafting/implantation promoted the proliferation, survival, and differentiation of germ cells 
(Schmidt et al., 2006a; Dores and Dobrinski, 2014). A protective role for VEGF on germ cells has 
also been suggested using a ‘loss-of-function’ approach; VEGFR2 antagonists caused a reduction 
of germ cell numbers in bovine testis tissue fragments after 5 days in culture, while this number 
increased when VEGF-A was added (Caires et al., 2009). On the other hand, the overexpression 
of VEGF (e.g., VEGF-A120 and VEGF-A165) in transgenic mice increased the size, density, and 
permeability of vasculature in the testis and epididymis, but also caused infertility, likely as a result 
of elevated testis temperature, leading to impaired spermatogenesis (Korpelainen et al., 1998; 
Huminiecki et al., 2001).  
2.4.6 Retinoic Acid  
Retinoic acid (RA) or tretinoin is a bioactive metabolite of retinol (vitamin A). Long known as a 
crucial factor for vision, RA is also involved in the development of cells and organs, and various 
other functions in the immune and reproductive systems (Mark et al.; Wang et al., 1997; Gale et 
al., 1999; White et al., 2000; Doyle et al., 2007; Anderson et al., 2008; Chung et al., 2011; Cassani 
et al., 2012; Valli et al., 2014). Because RA cannot be synthesized in vivo (except in the testis), it 
has to be acquired from the diet and stored in the liver to be delivered to target tissues via binding 
with retinol binding proteins. In the tissue, retinol is converted to all-trans retinal through oxidation 
by retinal dehydrogenase enzymes (Theodosiou et al., 2010; Napoli, 2012). Thus far, several RA 
isomers including all-trans-RA, 9-cis-RA, 13-cis-RA, 11-cis RA and 9, and 13-di-cis-RA have 
been identified (Kunchala et al., 2000). The molecular actions of RA are exerted through binding 
to heterodimers or nuclear RA receptors (RARα, β, γ) and retinoid X receptors (RAXα, β, γ). 
However, amongst all receptors, the expression of RARβ is known to be markedly enhanced by 
RA (Ghyselinck et al., 2006; Cassani et al., 2012; Samarut and Rochette-Egly, 2012).  
The required RA in the testis is synthesized in situ by Sertoli cells and distributed to germ cells 
(Livera et al., 2002), where RA receptors are found in both Sertoli cells and differentiated germ 
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cells (Dufour and Kim, 1999; Chung et al., 2009). A number of important roles are played by RA, 
which include contributing to testosterone production, ensuring the integrity of the stem cell niche 
(e.g., by maintaining the blood-testis barrier and anchoring germ cells to Sertoli cells), and assisting 
in the release of mature spermatozoa into the lumen of seminiferous tubules (Appling and Chytil, 
1981; Huang et al., 1983; Vernet et al., 2006). In the fetal testis, RA appears to stimulate both the 
proliferation and apoptosis of gonocytes (Livera et al., 2001). The expected decrease in gonocyte 
mitotic activity between 11.5 and 13.5 dpc was partly prevented under the influence of RA in organ 
culture (Trautmann et al., 2008), while the number of mitotic 16.5 dpc gonocytes reduced after 6 
days of culture with RA (Boulogne et al., 2003). This dual action of RA is thought to be important 
in maintaining the fetal gonocyte pool and eliminating abnormal gonocytes. In the postnatal testis, 
RA has a critical role in spermatogenesis, where its lack results in impaired spermatogenesis. In 
the vitamin A-deficient (VAD) model, spermatogenesis is arrested at the type A spermatogonia 
stage in mice and at the preloptotene stage in rats, but it can be restored with the systemic 
administration of vitamin A (van Pelt and de Rooij, 1990; Van Pelt and de Rooij, 1991). RA has 
also been identified as the leading promoter of gonocyte differentiation into spermatogonia. In 
vitro-cultured neonatal mouse and rat gonocytes treated with RA show increased Stra8 expression, 
an indicator of gonocyte differentiation to spermatogonia (Wang and Culty, 2007; Zhou et al., 
2008).  
2.4.7 Epidermal Growth Factor 
The epidermal growth factor (EGF) is a cytokine first found in the submandibular salivary gland 
of mice and in human urine (also named urogastrone) (Carpenter and Cohen, 1990). However, EGF 
has been shown to be involved in diverse and important processes such as facilitating cell 
proliferation, tissue differentiation, and organogenesis (Fisher and Lakshmanan, 1990; Adamson, 
1993). The localization of EGF expression in the testis varies in different species; in rodents, it is 
expressed predominantly in Leydig cells (Zhang et al., 1997; Yan et al., 1998), in boars and bulls, 
mainly in germ cells (Caussanel et al., 1996; Kassab et al., 2007), and in adult alpaca, in both germ 
cells and somatic cells (He et al., 2009). EGF exerts its effect via EGF receptor (EGFR) mainly 
found on testis somatic and germ cells in rodents, humans, and non-human primates (Stubbs et al., 
1990; Suarez-Quain and Niklinski, 1990; Haneji et al., 1991; Radhakrishnan et al., 1992; Moore 
and Morris, 1993; Caussanel et al., 1996; Nakazumi et al., 1996). The role of EGF in male 
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reproduction was initially studied using sialoadenectomy–the removal of submandibular glands–
in mice which led to a significant drop in the circulating levels of EGF, and a marked decrease in 
the number of mature spermatozoa in the epididymis. Treating mice with EGF restored the number 
of mature spermatozoa in the epididymis and spermatids in the testis to normal levels (Tsutsumi et 
al., 1986; Liu et al., 1994; Suarez-Quian et al., 1994). The EGF/EGFR complex is involved in the 
proliferation and differentiation of germ cells, as shown by the increased incorporation of 3H-
Thymidine (3H-dT) into rat spermatogonia using cultured seminiferous tubules (Wahab-Wahlgren 
et al., 2003). In vitro incubation of testis fragments from cryptorchid donor mice with EGF induced 
differentiation of spermatogonia type A into type B and primary spermatocytes (Haneji et al., 
1991). Moreover, spermatogenesis is impaired in EGFR knockout mice, although the testes appear 
to be of normal size (Levine et al., 2000). 
2.5 In Vivo Culture Systems for Male Germline Stem Cells  
2.5.1 Male Germ Cell Transplantation 
Male germ cell transplantation (GCT) is a technique introduced in 1994, which involves the 
transfer of germ cells (i.e., containing SSC) isolated from a fertile donor into the seminiferous 
tubules of infertile recipient testes. The transplanted germ cells are capable of migrating from the 
seminiferous tubular lumen, where they are deposited, to the basement membrane, where they 
colonize and undergo complete spermatogenesis; making it possible for the recipient to sire 
progeny using donor-derived spermatozoa (Brinster and Avarbock, 1994; Brinster and 
Zimmermann, 1994). Being initially established in a mouse model, the same principle has been 
extrapolated for using GCT in other rodents (i.e., rats, hamsters), and modified for use in farm 
animals (i.e., pigs, goats, sheep, cattle), monkeys, fish, and chicken (Jiang and Short, 1995; 
Clouthier et al., 1996; Ogawa et al., 1999; Schlatt et al., 2002b; Takeuchi et al., 2003; Zhang et 
al., 2003; Honaramooz et al., 2003a, b; Izadyar et al., 2003b; Joerg et al., 2003; Trefil et al., 2006, 
2010; Stockwell et al., 2009; Herrid et al., 2009; Hermann et al., 2012; Pacchiarini et al., 2014; 
Yoshizaki and Lee, 2018). Cross-species (heterologous) transplantation (xenotransplantation) of 
germ cells is also feasible, but only for closely-related species (e.g., between rodent species) 
(Clouthier et al., 1996; Ogawa et al., 1999; Honaramooz et al., 2002a; Zhang et al., 2003). 
Although the initial stages of colonization can occur when transplanting donor germ cells between 
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phylogenetically-distant species, such as from a non-rodent donor (i.e., pig, dog, cattle, horse, 
baboon, cat, human) into rodent recipients, spermatogenesis fails to advance (Dobrinski et al., 
1999; Nagano et al., 2001, 2002; Kim et al., 2006b). Prior to applying GCT, donor germ cells and 
recipient animals need to be prepared. 
As with any transplantation, the success and efficiency of GCT highly depend on the number and 
developmental potential of donor cells. Increasing the number of transplanted donor germ cells 
and/or increasing the proportion of SSC in donor cells are both directly correlated with the rate of 
colonization by donor cells in the recipient testes (Nagano et al., 1999; Shinohara et al., 1999, 
2001; Jiang, 2001; Buageaw et al., 2005). This can be achieved by propagating and/or 
purifying/enriching isolated donor germ cells before use. Certain donor animals, such as the 
cryptorchid, VAD, and Steel mutant (Sl), can offer high proportions of SSC for transplantation, 
because in all of these animal models, the only type of germ cells remaining in the testis is 
undifferentiated spermatogonia (van Pelt et al., 1996; Ogawa et al., 2000; Shinohara et al., 2000a). 
Another more readily available source of donor germ cells, however, is the neonatal/immature 
animal, which provides proportionally higher populations of MGSC (gonocytes and/or SSC) than 
adults (Honaramooz and Yang, 2010).  
The efficiency of GCT also heavily relies on the proper preparation of the recipient testes; namely, 
the recipient testes must not immunologically reject the donor cells, and should ideally have 
sufficient unoccupied stem cell niches for colonization of donor SSC. For GCT in rodent models, 
immunocompatibility between donors and recipients is typically not a limiting factor, because 
genetically-compatible recipients (congenic) and/or immunodeficient animals are readily available 
(Brinster and Avarbock, 1994; Kanatsu-Shinohara et al., 2003; Zhang et al., 2003). For GCT in 
non-rodent species, although congenic or immunodeficient recipients are not readily available, 
surprisingly no evidence of donor testis cell rejection was observed after GCT between 
immunocompetent goats of different breeds (Honaramooz et al., 2003b), paving way for the 
application of GCT in several farm species (Honaramooz et al., 2002b, 2003a; Rodriguez-Sosa et 
al., 2009; Stockwell et al., 2009). The degree of donor germ cell colonization is also improved 
when the recipient testes contain little or no endogenous germ cells, allowing more stem cell niches 
to be available. Cytoablative methods such as chemotherapy or irradiation are commonly used to 
deplete the endogenous populations of germ cells in the recipients (Brinster and Avarbock, 1994; 
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Izadyar et al., 2003b; Honaramooz et al., 2005a; Oatley et al., 2005; Mikkola et al., 2006). The 
irradiation method was found to be a safer choice for use in farm animals, because chemotherapy 
agents such as busulfan can show unexpectedly high toxicity in certain strains or species, and carry 
various degrees of health risk for the recipients (Ogawa et al., 1999; Brinster et al., 2003; 
Honaramooz et al., 2005a). 
The transplantation protocols used for GCT in large animals are different from those used for 
rodents. In rodents, where the tunica albuginea is translucent, the donor germ cells are suspended 
in a dye solution to be deposited into the visible seminiferous tubules, efferent ductules, or rete 
testis using a glass micropipette system. The dye (e.g., trypan blue) facilitates the immediate 
tracking of the injected solution to ensure the cells are being deposited in the targeted site (Brinster 
and Avarbock, 1994; Brinster and Zimmermann, 1994). In large animal, the technique had to be 
modified to allow transfer without direct visualization in the testes that were also hundreds of fold 
larger than in rodents. This led to the use of ultrasonography to visualize the needle insertion path 
into the centrally located rete testis, followed by tracking the injected solution through the 
introduction of air bubbles or an ultrasound contrast media along with the donor cell suspension 
(Honaramooz et al., 2002b, 2003a; Izadyar et al., 2003a; Joerg et al., 2003; Rodriguez-Sosa and 
Dobrinski, 2009). 
Confirmation of the proper transfer of donor cells into recipient seminiferous tubules and follow 
up analyses of the donor cell development can be performed using several methods. For the 
detection of donor cells after a short interval post-GCT, the donor cells can be labelled prior to 
injection using either a dye or a fluorescent agent (e.g., trypan blue, carboxyfluorescein diacetate 
succinyl diester- CFDA-SE- and/or PKH26) (Honaramooz et al., 2002b; Hill et al., 2005; 
Rodriguez-Sosa et al., 2009). For detection of the transplanted cells over long-term, however, a 
more permanent marker is required which can be provided by using germ cells from donors 
carrying inherent markers such as the lacZ or chloramphenicol acetyltransferase (CAT) that can be 
visualized directly in situ using immunohistochemical detection methods (Iwase et al., 1994; 
Honaramooz et al., 2002b; Orwig et al., 2002b). A more commonly used strategy for long-term 
identification of donor-derived germ cells or resultant spermatozoa is based on nucleic-acid 
techniques to trace a transgene or donor-specific microsatellites (Honaramooz et al., 2002b; 
Stockwell et al., 2009; Hermann et al., 2012). An alternative method, although less commonly 
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used, includes transplanting normal germ cells into the testes of recipients with a genetic aberration 
such as the immotile short-tail spermatozoa syndrome which is based on detection of normal donor-
derived spermatozoa in the recipient ejaculates (Mikkola et al., 2006). Nonetheless, the ultimate 
proof of GCT success is determined by the number of functional donor-derived spermatozoa 
produced, assessed through in vitro or in vivo fertilization, or the capability of the recipients to sire 
donor-derived progeny (Brinster and Avarbock, 1994; Goossens et al., 2003; Honaramooz et al., 
2003a). 
GCT has sparked considerable interest in its use as a unique means for understanding the 
unexplored aspects of the biology of spermatogenesis, particularly related to the stem cell potential 
and stem cell niche. It also offers the only available bioassay for evaluating the in vivo competency 
of putative populations of SSC (Pereira et al., 1998; Nagano et al., 1999; Hill and Dobrinski, 2006; 
Honaramooz and Yang, 2010). In terms of clinical or field applications, GCT can also be used as 
a tool for the conservation, preservation, or restoration of fertility (discussed in Chapter 2.6), as 
well as production of transgenic farm animals, because the current methods are inefficient 
(Brinster, 2002, 2007; Keefer, 2004; Niemann and Kues, 2007). 
2.5.2 Testis Tissue Xenografting  
Historically, grafting of the testis tissue has been performed as early as the mid-18th century, 
although mostly as autologous (same individual) or homologous (same species), and merely to 
understand the biology of testis function (i.e., spermatogenesis, endocrinology) or its role in male 
reproduction (i.e., male secondary characteristics) (Setchell, 1990). Although 
heterologous/xenogeneic (across species) grafting (xenografting) was also attempted, the results 
from the early studies were subjected to controversies, and the tissue rejection was always a 
limiting factor that hindered success (Gunn and Seddon, 1930; Setchell, 1990). The feasibility of 
cross-species testis tissue grafting was highlighted only in the 1970s when a Finnish group reported 
that a testis tissue of human fetal origin and its germ cells (gonocytes) survived 4-8 wk post-grafting 
in the abdominal wall of adult nude mice. Furthermore, they showed that the developmental 
potential of germ cells was maintained after xenografting of rat testis tissue into mice (Povlsen et 
al., 1974; Skakkebaek et al., 1974). These findings also marked for the first time, the potential of 
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testis tissue xenografting (TTX) as a tool for the preservation of male genetic material; however, 
the progress in TTX remained stagnant. 
Complete cross-species spermatogenesis and the production of functional spermatozoa from TTX 
were finally achieved in 2002. In this breakthrough study, small fragment (0.5-1 mm3) of testis 
tissue from neonatal mice, pigs, and goats were ectopically grafted under the back skin of 
immunodeficient mice. The grafts from all three donor species survived and responded to the host 
mouse gonadotropins by initiating testicular development and completing all stages of 
spermatogenesis. At the end of the study, fertilization-competent donor-derived spermatozoa were 
retrieved from the grafts of all donor species, evidenced by pronuclear and polar-body formation 
after ICSI in mouse oocytes. In addition, when the homologous mouse embryos produced using 
this system were transferred into pseudo-pregnant mice, normal fetal development was observed 
(Honaramooz et al., 2002a). As a result, the newly developed TTX system uses the recipient mice 
as a bio-incubator for the grafted testis tissue. The establishment of blood supplies 
(revascularization) from the grafts as well as surrounding tissues (recipient) allowed initiation of 
feedback loops between the pituitary of the mouse and the endocrine cells in grafts (Schlatt et al., 
2002b). The immunodeficient status of the recipients is key, ensuring the survival of the grafts, 
which is particularly critical for grafting from phylogenetically distant species (Paris et al., 2004; 
Dobrinski, 2005).  
Since 2002, this system has been adopted by many research groups and applied to answer various 
biological questions in a range of species. Currently, complete spermatogenesis after TTX from 
immature testis tissues of diverse species has been reported, which includes lab animals (e.g., 
mouse, rat, hamster, rabbit), companion animals (e.g., dog, cat), farm animals (e.g., pig, goat, 
sheep, horse, cattle, alpaca), and wildlife species (e.g., ferret, monkey, deer, bison) (Honaramooz 
et al., 2002a; Schlatt et al., 2002b; Shinohara et al., 2002; Kaproth et al., 2002; Snedaker et al., 
2004; Rathi et al., 2008, 2005, 2006; Kim et al., 2007a; Abbasi and Honaramooz, 2010a, 2012; 
Abrishami et al., 2010a; Gourdon and Travis, 2011; Elzawam, 2013; Parvari et al., 2015). 
Moreover, viable progenies have been produced using the spermatozoa extracted from the grafts 
(i.e., mice, rabbits, pigs) using ICSI and embryo transfer (Schlatt et al., 2002b; Shinohara et al., 
2002; Nakai et al., 2010; Kaneko et al., 2012). Several of these studies found that the maturation 
in the grafted tissue is accelerated, where spermatozoa could be found earlier than in intact testes. 
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This was particularly the case after TTX from donor pigs, monkeys, sheep, and humans 
(Honaramooz et al., 2002b, 2004; Zeng et al., 2006; Sato et al., 2010). Unlike from animal donors, 
the grafts from human donors demonstrated poor survival, and germ cells underwent massive 
degeneration after TTX (Geens et al., 2006; Schlatt et al., 2006; Wyns et al., 2007, 2008, Poels et 
al., 2013, 2014), the reasons for which are described in Chapter 2.5.4. 
2.5.3 Testis Cell Aggregate Implantation 
Following the establishment of GCT and TTX systems, another novel approach was introduced 
which involved the implantation of testis cell-aggregates (Dufour et al., 2002; Gassei et al., 2006; 
Honaramooz et al., 2007; Kita et al., 2007; Arregui et al., 2008b; Zhang et al., 2008; Campos-
Junior et al., 2014). Testis cell implantation (TCI) involves implanting dissociated testis cells from 
diverse donor species, obtained from enzymatic digestion, into immunodeficient recipient mice. 
Similar to TTX, the subcutaneous tissue of the back skin has been used a common site for TCI 
(Gassei et al., 2006; Honaramooz et al., 2007; Kita et al., 2007; Arregui et al., 2008b; Zhang et al., 
2008; Campos-Junior et al., 2014). Upon implantation, dissociated donor cells undergo 
autonomous cellular reorganization, which over time leads to regeneration of a donor-derived 
functional testis tissue capable of supporting spermatogenesis (Honaramooz et al., 2007; Kita et 
al., 2007).  
Compared with TTX, the TCI model is understudied; although it has been performed using 
different rodent and non-rodent mammalian and non-mammalian species (i.e., pig, sheep, cattle, 
marmoset, fish, frog) (Dufour et al., 2002; Gassei et al., 2006; Kawasaki et al., 2006, 2010; 
Honaramooz et al., 2007; Kita et al., 2007; Arregui et al., 2008b; Zhang et al., 2008; Aeckerle et 
al., 2013; Campos-Junior et al., 2014). In all these studies, the ability of the dissociated testis cells 
to reorganize and regenerate testis cords after ectopic implantation was retained. Complete 
spermatogenesis and donor-derived progenies have been reported only after TCI from donor mice 
(Kita et al., 2007). Although, haploid germ cells (i.e., spermatids/spermatozoa) have also been 
obtained after TCI of sheep and pig testis cells, indicating the potential of this in vivo system for 
development of testis cell aggregates from diverse species (Honaramooz et al., 2007; Arregui et 
al., 2008b; Watanabe et al., 2009; Campos-Junior et al., 2014). In a TCI study using bovine cells, 
the formation of seminiferous tubules containing some germ cells was observed; however, the 
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spermatogenic potential was not further evaluated since the study only lasted 3 mo (Zhang et al., 
2008). 
When compared with TTX, the onset of germ cell differentiation and spermatogenesis is delayed 
after TCI (Gassei et al., 2006; Honaramooz et al., 2007; Arregui et al., 2008b; Campos-Junior et 
al., 2014). For example, while using sheep donor testis tissue for TTX resulted in the completion 
of spermatogenesis at 12 wk, comparable with the timing in situ, it took ~40 wk for the same event 
to occur after TCI (Arregui et al., 2008a). In a side-by-side comparison using peccary (Tayassu 
tajacu) donors, spermatogenesis was observed at 6 mo and 8 mo, in TTX and TCI, respectively 
(Campos-Junior et al., 2014). Although the dissociated donor cells are fully capable of rearranging 
and developing into testicular cords and structures that have remarkable morphological and 
physiological similarity to normal testis tissue, the newly developed seminiferous cords/tubules are 
typically void of germ cells (Gassei et al., 2006; Honaramooz et al., 2007; Kita et al., 2007; Arregui 
et al., 2008a). The lack of germ cells in the regenerated cords/tubules was believed to result from 
the very low initial number of donor germ cells used for TCI and/or a progressive degeneration of 
germ cells after implantation (Rathi et al., 2006; Arregui et al., 2008a). These differences resulted 
in relatively lower spermatogenic efficiency of TCI, depicted by lower production of haploid 
spermatids (Watanabe et al., 2009; Campos-Junior et al., 2014). 
Since most initial TCI studies merely adopted components of the well-established GCT and TTX 
systems, modifications of the employed protocols (e.g., cell preparation, donor species, recipient 
strain, implantation technique, incubation period) are expected to improve the outcomes of TCI. 
When the population of donor testis cells used in TCI was almost entirely comprised of somatic 
cells (~93% Sertoli and 2% myoid cells), de novo formation of testis cords still occurred, suggesting 
that this event is independent of germ cells (Dufour et al., 2002). Since there has been no 
standardized protocol for the preparation of donor cells for TCI, different research groups have 
used different protocols for isolation of testis cells. This can lead to differences in somatic-germ 
cell ratios, and has likely contributed to the discrepancy in findings of many TCI studies (van der 
Wee and Hofmann, 1999; Gassei et al., 2006; Honaramooz et al., 2007; Arregui et al., 2008a; 
Watanabe et al., 2009). There has also been a lack of consistency in the number of implanted cells, 
especially when the procedure was performed using the conventional surgical approach (creating 
a small pocket in the subcutaneous fascia to be filled with donor cells) (Honaramooz et al., 2007). 
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However, this issue can be resolved by subcutaneous injection of cells to reduce the potential 
leakage of cells out of the implantation site. Adding commercially-available extracellular matrices 
such as Matrigel, to act as a carrier for injected cell suspensions, has also been tested with varying 
results (Gassei et al., 2006; Watanabe et al., 2009; Aeckerle et al., 2013; Dores and Dobrinski, 
2014). 
Therefore, TCI provides a unique in vivo culture system that is also easily accessible for the study 
and manipulation of potential molecular cues and cellular interactions during testis morphogenesis. 
Using TCI, the recipient milieu can also be controlled to better elucidate various factors involved 
in the regulation of spermatogenesis; thereby, using it as a previously-unavailable model to 
examine biological questions that are otherwise difficult to study in situ. 
2.5.4 Factors Affecting the Outcome of Testis Tissue Xenografting and Testis Cell 
Implantation 
Since the introduction of TTX and TCI, many studies have used these models to examine the 
developmental potential of testis tissues and cells from various donors. A few of these studies 
directly or indirectly investigated several factors that affect the outcomes of these models, which 
included the effects of donor, recipient, tissue/cell preparation, and technique used.  
The outcomes of TTX and TCI expectedly vary to a great extent based on factors related to the 
donor. Following TTX and TCI, the testis tissue and cells from all examined donor species have 
survived, developed, and initiated spermatogenesis in the recipient mouse, and given enough time, 
most have also shown completion of spermatogenesis (Honaramooz et al., 2002a; Schlatt et al., 
2002b; Shinohara et al., 2002; Snedaker et al., 2004; Kawasaki et al., 2006; Zeng et al., 2006; 
Honaramooz et al., 2007; Arregui et al., 2008a; Watanabe et al., 2009; Abrishami et al., 2010a; 
Kawasaki et al., 2010; Campos-Junior et al., 2014). However, the extent of post-TTX/TCI 
development in the grafts/implants from certain donor species has been limited. In particular, TTX 
using human testes, regardless of the developmental stage of the donor tissue (i.e., fetal, infantile, 
prepubertal, adult), has resulted in limited development of germ cells beyond the spermatogonial 
stage or even in degeneration of the tissue (Schlatt et al., 2006; Yu et al., 2006; Geens et al., 2008; 
Goossens et al., 2008; Wyns et al., 2008; Van Saen et al., 2011). Nevertheless, occasionally, 
generation of spermatocytes has been observed in infant testis grafts 9-12 mo post-TTX (Sato et 
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al., 2010; Van Saen et al., 2011). The grafts from high spermatozoa producing species (e.g., pig, 
goat, sheep) show a higher percentage of seminiferous tubules with fully-formed spermatozoa than 
in some others (e.g., horse, bull) (Honaramooz et al., 2002a; Zeng et al., 2006), (Oatley et al., 2004, 
2005, Rathi et al., 2005, 2006; Huang et al., 2008). In the former examples, the number of 
spermatozoa produced (per gram of tissue) in the grafts was also comparable to that in intact tissues 
(Honaramooz et al., 2002a). The underlying reasons for differences in spermatogenic efficiency 
among various species remain to be elucidated. However, the development potential of testis grafts 
naturally relies on the compatibility and interactions between the graft and host hypothalamic-
pituitary axis of the host, and this may explain some of the observed differences in spermatogenic 
efficiency after TTX (Arregui and Dobrinski, 2014).  
Aside from the effect of donor species, TTX and TCI outcomes are known also to be donor-age 
dependent, where grafts from neonatal/immature donors demonstrate superior developmental 
potential compared with the adult/mature. In the original report and almost all subsequent TTX 
studies, when neonatal/immature sources were used as tissue donors, full testicular development 
and complete spermatogenesis were observed in the grafts (Honaramooz et al., 2002a) (Schlatt et 
al., 2002a; Shinohara et al., 2002; Snedaker et al., 2004; Rathi et al., 2005; Kim et al., 2007; Abbasi 
and Honaramooz, 2011, 2012; Reddy et al., 2012; Elzawam, 2013). In contrast, tissues from mature 
sources are typically unable to survive or develop after TTX, and frequently degenerate (Schlatt et 
al., 2006; Arregui et al., 2008b; Turner et al., 2010). This degeneration was found to be especially 
more evident in species/tissues with more intense spermatogenesis (high daily spermatozoa output 
per gram of testis tissue, i.e., pigs and goats) or more advanced pre-grafting spermatogenesis than 
those with less intense/advanced spermatogenesis (i.e., bulls and monkeys) (Arregui et al., 2008b). 
This phenomenon has been associated with the vulnerability of differentiated germ cells to hypoxic 
conditions after grafting, as well as the poor angiogenic ability of the adult testis tissue (Rathi et 
al., 2006; Kim et al., 2007). In addition, Sertoli cells in the adult testes have reached maturity and 
have lost their proliferative potential (Meachem et al., 2005), leading to the lack of compensatory 
regeneration following TTX.  
Effect of donor age or the developmental status of the testis tissues used in TTX, on the progression 
of spermatogenesis in grafts has been examined using different donor species. The results varied, 
but a general theme can be inferred from these studies. For instance, optimal TTX results were 
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obtained if the donor cats and dogs were neonatal or were used at some time prior to the onset of 
puberty at ~4 mo and ~6 mo, respectively (Kim et al., 2007; Abrishami et al., 2010a). Using fetal 
testes for TTX from humans, cattle, and Cuzier’s gazelle, it was concluded that the developmental 
potential and spermatogenic capacity are probably conserved in the fetal tissue; however, no 
haploid germ cells have so far been produced in the grafts (Povlsen et al., 1974; Skakkebaek et al., 
1974; Yu et al., 2006; Rodriguez-Sosa et al., 2011; Arregui et al., 2014). Variations observed in 
the developmental potential of testis grafts have been associated with differences in gene 
expression and cues at different ages/developmental stages (Schmidt et al., 2007). The efficiency 
of spermatogenesis was suggested to be higher with TTX using young and immature bovine or 
feline tissues, compared with the neonatal (Oatley et al., 2005; Kim et al., 2007). The increased 
number of SSC prior to puberty (Orwig and Schlatt, 2005), may provide the grafts with more 
readily available SSC to initiate differentiation shortly after TTX (Rathi et al., 2006; Kim et al., 
2007). Hypoxic conditions that grafts are expected to undergo in the first few hours or days post-
TTX, before revascularization occurs, are thought to be responsible for the massive losses of 
(especially differentiated) germ cells. Therefore, having a relatively higher number of SSC prior to 
grafting can be advantageous to spermatogenic efficiency (Schlatt et al., 2002a, b; Yu et al., 2006; 
Arregui et al., 2008b, 2012). 
Although the tissue/cells to be used in TTX/TCI are ideally collected fresh, in real-world 
applications, they cannot always be used immediately after the collection, and may need to be 
stored either short-term or long-term for later use. Short-term storage of testis tissue, in the form 
of refrigeration for up to three days, was shown to result in comparable development after TTX 
using pig, cat, or rhesus monkey donor tissues. Interestingly, the percentage of tubules with 
differentiated germ cells was unexpectedly higher in the grafts from refrigerated than fresh tissue. 
Therefore, cold storage of donor tissue/cells prior to TTX at low temperatures, may in fact lead to 
decreased hypoxic damages by reducing the metabolism of tissue/cells (Honaramooz et al., 2002a; 
Jahnukainen et al., 2007; Zeng et al., 2009; Abrishami et al., 2010b; Abbasi and Honaramooz, 
2011; Mota et al., 2012). For long-term storage of testis tissue, different approaches (i.e., 
slow/programed freezing or vitrification) have been introduced, although the protocols had to be 
modified/adjusted according to the donor species and tissue maturity (Abrishami et al., 2010b; 
Mota et al., 2012; Arregui et al., 2014). Overall, cryopreserved tissue demonstrated satisfactory 
cellular survivability and differentiation potential, and at times similar graft recovery rates as with 
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fresh tissue (Honaramooz et al., 2002a; Shinohara et al., 2002; Jahnukainen et al., 2007; Wyns et 
al., 2008; Zeng et al., 2009; Abrishami et al., 2010b; Van Saen et al., 2011; Poels et al., 2012; 
Arregui et al., 2014). However, similarities in viability between the fresh and frozen testis tissue 
should not be taken as equal developmental potential, because tissues might develop differently 
after grafting (Arregui et al., 2014). The cryoprotectant used for cryopreservation (e.g., DMSO), 
for instance, might have a more severe adverse effect on germ cells than somatic cells and result in 
delayed onset of spermatogenesis (Jahnukainen et al., 2007; Zeng et al., 2009; Mota et al., 2012). 
The type of recipient mice may also affect the outcomes of TTX. So far, two strains of 
immunodeficient mice have been used as recipients in the majority of TTX/TCI studies. The nude 
mouse (nu/nu), which was used in the initial development of both TTX and TCI models 
(Honaramooz et al., 2002a, 2007) is a popular choice, while the severe combined immunodeficient 
(SCID) mice have also been used as an alternative to the nude mice (Snedaker et al., 2004; Rathi 
et al., 2006; Kim et al., 2007; Campos-Junior et al., 2014). Both strains of recipients were reported 
to produce comparable TTX outcomes (Snedaker et al., 2004; Rathi et al., 2005, 2006; Geens et 
al., 2006; Schlatt et al., 2006); however, SCID mice might have an advantage over nude mice, 
because their immune system is more compromised. The loss of human testis tissue grafts was less 
likely to happen in SCID than in nude mice (Schlatt et al., 2006). On the other hand, the 
spermatogenic potential of porcine grafts implanted in SCID mice was reported to be significantly 
higher than in nude mice (Abbasi and Honaramooz, 2010b). In a study designed to compare the 
efficiency of TTX and TCI techniques, no significant effect of strain was found (i.e., nude vs. SCID 
vs. NOD/Shi-SCID, IL-2Rγcnull-NOG), although SCID mice appeared to promote better 
reconstitution of the testis tissue (morphogenesis) and restoration of spermatogenesis (Watanabe 
et al., 2009). 
The castration of recipient mice is generally presumed to have a beneficial effect on TTX outcomes. 
The removal of testes from recipient mice prior to grafting results in the elimination of the androgen 
negative feedback on gonadotropins, causing a surge in the release of LH and FSH from the 
pituitary (Schlatt et al., 2002b). Both FSH and LH promote graft development by initiating the 
proliferation of Sertoli cells and maturation of Leydig cells, which later produce testosterone to 
support spermatogenesis. Removing the recipient testes also terminates the growth promoting 
effects of mouse testosterone on its vesicular glands, where the development is androgen-
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dependent (Gosden and Aubard, 1996). Thus, in castrated recipients, the physical and histological 
properties of the vesicular glands can be used as a bioassay for monitoring the androgenic 
competence of testis grafts. The effect of recipient gonadal status (castrated vs. intact) on TTX 
outcomes seems to be species-specific. While the development of immature testis tissue of horses 
and rhesus monkeys was compromised upon TTX into intact recipients (Honaramooz et al., 2004; 
Rathi et al., 2006), using immature tissue from rabbits, cattle, pigs, hamsters, and buffalos led to 
the development and production of functional spermatozoa in similarly intact recipient mice 
(Shinohara et al., 2002; Huang et al., 2008; Abbasi and Honaramooz, 2010b; Schlatt et al., 2010; 
Reddy et al., 2012). A side-by-side comparison of castrated and intact recipients showed no 
differences in the development of grafts between recipient types (Huang et al., 2008; Abbasi and 
Honaramooz, 2010a; Schlatt et al., 2010). The sex and age of the recipient mice were also examined 
for their potential effects on TTX outcomes. Although even female recipient mice with intact 
ovaries were fully capable of supporting the development of porcine testis grafts, the grafts in male 
recipients were larger in size, with higher graft recovery rate, and higher occurrence of fully 
developed seminiferous tubules (Abbasi and Honaramooz, 2010b). The use of mature recipients 
(1-year-old at grafting) led to better development of hamster testis xenografts, speculated to be due 
to the immunosenescence of recipients, because the grafts recovered from young recipients (1-wk-
old at grafting) showed more spermatogenic loss with a high prevalence of Sertoli-cell-only tubules 
(Ehmcke et al., 2008).  
Conventionally, grafting eight fragments of testis tissue per recipient (4 on each side of the back 
skin) has been a common practice in TTX; however, having more grafts/implants per recipient 
would be advantageous because potentially more spermatozoa could be recovered from the 
developed grafts. When 2, 4, 8, or 16 tissue grafts were used per mouse, the recipient mice were 
fully capable of supporting the development of even 16 grafts. More importantly, in mice with 16 
grafts, in addition to generating a greater total mass of grafted tissue, even the individual graft sizes 
and development observed per graft were higher when compared with mice with only 2 grafts 
(Abbasi and Honaramooz, 2010a).  
The mouse is a social species by nature and may prefer to be housed in a group, rather than 
individually (Würbel, 2001; Van Loo et al., 2003; Latham and Mason, 2004; Fitchett et al., 2006). 
Grouping male mice in a single cage, on the other hand, might negatively affect the androgen levels 
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and other reproductive parameters (Machida et al., 1981; Koyama and Kamimura, 1998). This 
potential effect on graft development, however, was ruled out in a study where the recipients of 
TTX were housed either individually or in a group; housing choice had no significant effect on the 
graft recovery rate, weight, microscopic development, or serum levels of androgens (Arregui et al., 
2008b).  
The ability of grafts to establish neovascularization has also been proposed to have an impact on 
the graft survival and development, and hence TTX outcomes (Schmidt et al., 2006b; Caires et al., 
2009). Treating the grafted tissue with VEGF was found to promote angiogenesis and increase the 
graft size and number of tubules with elongated spermatids (Schmidt et al., 2006b). 
As discussed earlier (Chapter 2.5.3), different outcomes might be expected from testis tissue grafts 
than cell implants, as exemplified by the delayed spermatogenesis and higher prevalence of tubules 
with no germ cells in implants from TCI (Gassei et al., 2006; Honaramooz et al., 2007; Arregui et 
al., 2008b; Watanabe et al., 2009; Campos-Junior et al., 2014). Therefore, the effects of recipient 
and donor factors on the survival and development of implants would need to be examined for TCI 
as well, in order to improve the outcomes. 
2.6 Application of Male Germline Stem Cells in Fertility and Conservation 
As shown by the evidence presented thus far in this chapter, MGSC can be maintained using in 
vitro and in vivo culture systems, and induced to proliferate and differentiate into haploid germ 
cells. The self-renewal, proliferation, and differentiation properties of MGSC ensure that a stem 
cell pool remains to provide a continuous supply of spermatozoa throughout adulthood. In addition, 
advances in the field of MGSC and assisted reproductive technologies (ART; e.g., GCT and IVF) 
in recent years have allowed a better understanding of MGSC biology and opened many windows 
of potential application in genetic conservation and male reproductive health.  
At least theoretically, a combination of the aforementioned technologies can be applied to 
overcome fertility challenges that only two decades ago would have seemed impossible to resolve. 
For instance, it is now conceivable to preserve the fertility potential of prepubertal boys undergoing 
gonadotoxic treatments (i.e., chemotherapy or total body radiotherapy), which frequently result in 
the depletion of germ cells. Unlike in adult men, the collection of spermatozoa for cryopreservation 
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is not an option for pre-pubertal males. However, cryopreservation of testis biopsies obtained prior 
to the onset of cytoablative cancer treatments can offer an option if decades later the donor decides 
to seek treatment for infertility (Wyns et al., 2008, 2011; Honaramooz, 2012). Cryopreserved 
biopsies from immature testes that are void of haploid germ cells can then undergo maturation 
using the aforementioned in vitro or in vivo systems to produce spermatozoa, elongated spermatids, 
or even round spermatids for use in ICSI or ROSI to achieve donor-derived progeny (Schrader et 
al., 2001). In the adult male, MGSC technologies also offer a therapeutic potential for infertility 
treatment, particularly those conditions that hinder the development and differentiation of SSC into 
advanced germ cells. Examples include chromosomal abnormalities or genetic disorders, where 
oligozoospermia or azoospermia is caused by the lack of certain factors or signaling pathways. 
Using in vitro systems, the missing factors or signals can be introduced, either in a pure or 
recombinant form, to induce in vitro spermatogenesis. This possibility was substantiated using the 
Steel (Sl) mouse model, a condition caused by c-kit ligand (KITL) mutation, which results in 
underdeveloped testis, low and abnormally distributed SSC, and total absence of spermatozoa 
(non-obstructive azoospermia). The number of SSC in the mutant testis tissue fragments was 
increased in a dose-dependent manner after culturing with recombinant KITL, which eventually 
led to successful induction of in vitro spermatogenesis (Sato et al., 2012). It goes without saying 
that despite the promising perspectives and recent progress in lab animal models, the clinical 
application of MGSC technologies for humans is not yet feasible; aside from the ethical and safety 
concerns, the efficiency remains very low at the present time. Various questions, particularly 
related to understanding the requirements of every step involved in these technologies (e.g., 
cryopreservation, culturing, transplantation, IVF), need to be addressed.  
In recent decades, species are becoming extinct at a faster rate, mostly due to the impact of human 
activities. The loss of genetic diversity due to infertility and premature death of neonatal/young 
males adds to conservation challenges. The declining number of animals in an endangered species 
populations means that the genetic material of every existing individual is immensely valuable, and 
the ability to obtain offspring from a single male could have a significant impact on the preservation 
of genetic diversity within a population. Hence, MGSC can be potentially applied in genetic 
conservation of endangered wildlife or valuable rare breeds of livestock. When such a prized male 
dies, and the collection of semen or even testicular/epidydimal spermatozoa is not an option, such 
as when the individual is neonatal/immature, then testis tissue collected even shortly after death 
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can be prepared for cryopreservation for future use in similar advanced reproductive technologies. 
This concept has also been supported, through the use of testis tissue cryopreservation and TTX 
using domestic mammals (e.g., the sheep, goat, cattle, horse, pig, alpaca, cat, dog) as a model for 
endangered counterparts (e.g., ungulate herbivores, equid, suid, camelid, felid, canid) (Snedaker et 
al., 2004; Oatley et al., 2005; Rathi et al., 2006; Abrishami et al., 2010a; Elzawam, 2013). 
Promising results and even donor-derived spermatozoa have also been obtained through TTX from 
donors of some of the target wildlife species, such as the Javan banteng, Iberian lynx, Cuvier 
gazelle, Mohor gazelle, white-tailed deer, and bison (Honaramooz et al., 2005b; Abbasi and 
Honaramooz, 2011, 2012; Arregui et al., 2014). 
2.7 Conclusions  
The testis plays a central role in male reproduction by providing male gametes and androgens; both 
of which occur via complex processes that extend continuously throughout the male adult life. 
These involve highly coordinated signaling between the autocrine, paracrine, and endocrine 
components, including the hypothalamic-pituitary-gonadal axis. Any disruption during the 
development or normal function of the testis may impact the male reproductive health and fertility. 
Despite the tremendous advances in the study of testis function, many questions pertaining to the 
regulation of testicular development and spermatogenesis remain unanswered and require further 
investigation. 
MGSC form the foundation of spermatogenesis, where their capacity for self-renewal and 
differentiation ensure the continuity of the male germ cell lineage. Understanding the mechanisms 
controlling self-renewal and differentiation, provide a basis for the maintenance and manipulation 
of MGSC both in vitro and in vivo. Most of our knowledge about MGSC has come from the 
extensive studies performed using SSC. Not until recent years had gonocytes been given proper 
attention in MGSC studies. Being the only germ cell type present in the neonatal testis, gonocytes 
offer great advantage and practicality as the source of MGSC over the other types. Our knowledge 
of MGSC in general and gonocytes, in particular, is very limited when it comes to farm animals, 
especially in the pig as an important biomedical model. 
The efficacy of using MGSC in clinical or biomedical research relies on our ability to prepare large 
numbers of enriched populations. New developments in technology and the introduction of novel 
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biomarkers continue to improve the identification, isolation, enrichment, and manipulation of 
MGSC. In vitro culture systems have been successful in supporting the self-renewal and 
differentiation of MGSC. Incorporation of growth factors that have the potential to play a part in 
testis culture systems either in vitro or in vivo, will also lead to a better understanding of their roles 
for testis development in situ. Using laboratory animal models, MGSC have been propagated, 
maintained long-term, and allowed to differentiate into even functional spermatozoa. However, the 
application of these culture conditions is still limited due to species differences and lack of 
standardized protocols. Therefore, the search for optimal culture conditions for MGSC, especially 
from nonrodent species demand ongoing efforts.  
In vivo culture systems for testis tissue and cells offer an alternative for culturing MGSC that is 
more readily applicable to diverse donor species. GCT provides a unique bioassay to assess the 
competency of MGSC for establishing new colonies of spermatogenesis, and allow examination 
of their stem cell niche. The capability of testis tissue fragments or dissociated cells (through TTX 
and TCI) from distant species to develop into functional tissue and give rise to donor-derived 
spermatozoa in mice, has introduced new solutions to genetic and fertility preservation challenges. 
The autonomous reorganization and de novo formation of testis tissue after TCI can be used to 
understand the mechanisms behind testicular morphogenesis. The developmental potential and 
spermatogenic efficiency of TTX/TCI relies on various factors; the investigation for which will 
also give new insights on spermatogenesis and testis function. 
Recent developments in the field of MGSC technologies have greatly impacted the fields of 
regenerative medicine and advanced reproductive technologies. The limitless self-renewal and 
proliferation potential of MGSC can be exploited as an alternative source for the generation of 
pluripotent stem cells for use in cell-based therapy and drug delivery studies. However, the most 
significant application of MGSC technology at least in the near future will be the preservation, 
conservation, and restoration of fertility, especially when recovery of spermatozoa is not possible. 
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2.8 Objectives and Hypotheses  
The overarching hypothesis of this thesis was that in vitro and in vivo culture systems can be used 
to study the development of porcine testis cells and tissue. The general objectives of this thesis 
were to identify, examine, and manipulate potential factors associated with the development of 
testis cells and tissue using in vitro and in vivo culture systems. Experiments were designed to test 
the following specific objectives and hypotheses:  
A. Optimization of Culture Conditions for Short-Term Maintenance, Proliferation, and Colony 
Formation of Porcine Gonocytes (Chapter 3) 
The objective of this study was to: 
1. Optimize culture conditions (gonocyte proportion, cell seeding density, temperature, and 
medium changing regimen) to improve maintenance, proliferation, and colony formation of 
porcine gonocytes. 
It was hypothesized that: 
1. Optimizing culture conditions (cell seeding density and gonocyte proportion, incubation 
temperature, and medium changing regimen) will improve maintenance, proliferation, or 
colony formation of porcine gonocytes. 
B. Live-Cell Imaging and Ultrastructural Study of Cultured Porcine Gonocytes (Chapter 4) 
The objective of this study was to: 
1. Study cellular organization, movement pattern, and ultrastructure of neonatal porcine 
gonocytes in a prolonged culture. 
It was hypothesized that: 
1. Organization, movement pattern, or ultrastructure of neonatal porcine gonocytes will change 
over time in culture.   
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C. Effect of Multiple Factors on Regeneration of Testis Tissue After Ectopic Implantation of 
Porcine Testis Cell Aggregates in Mice: Improved Outcomes Consistency and in Situ Monitoring 
(Chapter 5)  
The objectives of this study were to: 
1. Establish an efficient method for implantation of neonatal porcine testis cell aggregates in 
mice.  
2. Evaluate the potential of ultrasound biomicroscopy for in situ assessment of the 
development of testis cell aggregates after implantation in mice.  
It was hypothesized that: 
1. The optimized method will be more efficient than the conventional method for implantation 
of neonatal porcine testis cell aggregates in mice.  
2. Ultrasound biomicroscopy will be utilized for assessing the development of neonatal 
porcine testis cell implants in mice.  
D. Effects of Growth Factors on De Novo Regeneration of Porcine Testis Tissue After Ectopic 
Implantation of Testis Cells in Mice (Chapter 6) 
The objective of this study was to: 
1. Evaluate the effects of growth factors (EGF, RA, VEGF, FGF2, FGF9, GDNF, SCF, or 
LIF) on de novo formation of porcine testis tissue after implantation of testis cell 
aggregates in mice. 
It was hypothesized that: 
1. The addition of growth factors (EGF, RA, VEGF, FGF2, FGF9, GDNF, SCF, or LIF) to 
testis cell aggregates will improve de novo formation of porcine testis tissue after 
implantation in mice.  
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CHAPTER 3  
OPTIMIZATION OF CULTURE CONDITIONS FOR SHORT-TERM MAINTENANCE, 
PROLIFERATION, AND COLONY FORMATION OF PORCINE GONOCYTES 1, 2 
3.1 Abstract 
Gonocytes give rise to spermatogonial stem cells, and thereby play an essential role in establishing 
spermatogenesis. Optimized culture conditions for gonocytes provide an opportunity for their study 
and in vitro manipulation for potential application in reproductive technologies. Using six 
experiments in a step-wise design, we examined the effects of several culture conditions on the 
maintenance, proliferation, and colony formation of porcine gonocytes. Testis cells from neonatal 
piglets were cultured for 7 d in DMEM supplemented with 10% fetal bovine serum. The examined 
culture conditions included using different cell seeding densities, gonocyte proportions, incubation 
temperatures, sampling strategies, and medium changing regimens. Confluency of cells was 
optimal (>90% by ~6 d) when 3.0 × 104 testis cells/cm2 containing ~40% gonocytes were used. 
Incubating the cells at 35 °C or 37 °C resulted in similar cell number and viability at confluency, 
but incubation at 35 °C resulted in a delayed confluency. In the first 2 d of culture, gonocytes 
remained mostly floating in the medium and gradually settled over the next 5 d. Consequently, not 
changing the medium for 7 d (as opposed to changing it every 2 d) led to a significant increase in 
the number of gonocyte colonies by reducing the loss of “floating gonocytes”. We found that 
gonocytes require the presence of a critical minimum number of somatic cells for settlement, and 
can proliferate and form growing colonies even in a basic medium. Large numbers of viable 
gonocytes remain floating in the medium for several days. The optimized culture conditions in the 
                                                        
1 This study has been published. Awang-Junaidi AH and Honaramooz A (2018). J. Anim. Sc. 
Biotechnol. 9:8. Portions of this study were also presented at the 41st American Society of 
Andrology Annual Meeting. The document has been reformatted from the original version for 
inclusion in the thesis.  
 
2 AHAJ contributed to the conceiving and designing of the study, performed the experiments and 
wrote the first draft of the manuscript. 
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present study included seeding with 3.0 × 104 testis cells/cm2 containing ~40% gonocytes, 
incubating at 37 °C, and without changing the medium in the first week, which can result in 
improved colony formation of porcine gonocytes.  
3.2 Introduction 
Testis stem cells are a unique population of stem cells in an adult body, because in addition to their 
dual ability to self-renew and give rise to differentiating germ cells, they can pass the genetic 
information to the offspring. Among the many types of male germ cells present from the fetal 
period to adulthood, primordial germ cells (PGC), gonocytes, and particularly spermatogonial stem 
cells (SSC) are believed to possess stem cell potential and hence are referred to as male germline 
stem cells (MGSC) (Lehmann, 2012). An in vivo functional assay for confirming the stem cell 
potential of MGSC was provided when SSC were deposited in the lumen of seminiferous tubules 
of recipient testes using germ cell transplantation technique. The transplanted SSC were capable 
of homing to the tubule basement membrane, forming new colonies of developing germ cells, and 
initiating donor-derived spermatogenesis (Brinster and Avarbock, 1994; Jiang and Short, 1998; 
Honaramooz et al., 2002b, 2003b, a; Izadyar et al., 2003b). In breeding trials, some of the germ 
cell recipient animals of various species were capable of siring donor-derived progeny (Brinster 
and Avarbock, 1994; Honaramooz et al., 2003a; Herrid et al., 2009). There are also a few reports 
of using gonocytes and PGC as donor cells in germ cell transplantation leading to the establishment 
of spermatogenesis in the recipient testis (Jiang and Short, 1998; Chuma et al., 2005; Kim et al., 
2014). 
The choice of donor MGSC is a critical factor for the outcome of germ cell transplantation. Using 
PGC as donor cells has been less practical because their isolation requires collection from embryos 
and there are only a limited number of PGC per embryo (Jiang and Short, 1998; Ohta et al., 2004). 
Spermatogonia can be collected from mature donor individuals and enriched for SSC at relatively 
high numbers. However, spermatogonia are inherently a heterogeneous population of cells and the 
lack of biomarkers has made unequivocal isolation of pure SSC populations difficult (De Rooij, 
2001b; Orwig et al., 2002c; Grisanti et al., 2009). Compared with PGC and SSC, gonocytes offer 
a potentially more practical option. Gonocytes are transitory germ cells (between PGC and SSC) 
that have a distinct morphology (large round cells with large nucleus to cytoplasm ratio), and are 
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present during both fetal and early postnatal period for several days, months or even years, 
depending on the species (De Rooij and Russell, 2000; Oatley and Brinster, 2008; Culty, 2009). 
Perhaps more importantly, gonocytes are the only germ cells present in the testes of neonates; thus, 
they can be detected using most germ cell markers (e.g., VASA, DAZL), pluripotency markers 
(e.g., NANOG, OCT4), and certain surface protein markers (e.g., DBA, UCHL1). These 
characteristics provide an opportunity for enrichment and in vitro manipulation of gonocytes (Goel 
et al., 2007; Culty, 2009; Han et al., 2009; Yang and Honaramooz, 2012; Zogbi et al., 2012).  
Gonocytes are relatively limited in numbers since they comprise only ~1.4% of cells in the testes 
of neonatal rats (Orwig et al., 2002a) and ~7% of seminiferous cord cells in piglets (Honaramooz 
et al., 2005a). The efficiency of colonization by the donor germ cells in the seminiferous tubules 
of recipients is directly proportional to the number of transplanted MGSC. Therefore, to increase 
the efficiency of germ cell transplantation, gonocytes must be enriched and/or propagated in vitro 
prior to transplantation, as suggested for SSC (Dobrinski et al., 1999; Shinohara et al., 2000b). 
Various strategies have been introduced to optimize the isolation, enrichment, or purification of 
gonocytes with differing outcomes, depending on the species (van den Ham et al., 1997; Goel et 
al., 2007; Han et al., 2009; Borjigin et al., 2011). Using conventional cell separation methods, no 
more than ~10% of isolated neonatal testis cells were gonocytes (van Dissel-Emiliani et al., 1989; 
Li et al., 1997; Orwig et al., 2002a; Honaramooz et al., 2005a). However, development of a three-
step enzymatic digestion in our laboratory has allowed the collection of populations of cells 
containing ~40% gonocytes from neonatal porcine testes (Yang et al., 2010). The resultant 
population of gonocytes can also be enriched further to ~90% using a combination of Nycodenz 
centrifugation and differential plating (Yang and Honaramooz, 2011). 
While the pig is an important biomedical animal model, purification of porcine MGSC is still 
limited. The ability to obtain highly enriched populations of gonocytes from neonatal piglets (Yang 
et al., 2010; Yang and Honaramooz, 2011), however, has provided new opportunities for using 
gonocytes as a model for in vitro propagation and manipulation of MGSC. This calls for further 
research on culture systems that can allow efficient large-scale propagation of gonocytes. No 
systematic study has examined the effects of different culture conditions on colony formation of 
porcine gonocytes. Therefore, given the importance of cell culture in MGSC research, the present 
study was designed to examine a number of culture conditions for maintenance, proliferation, and 
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colony formation of neonatal porcine gonocytes as a model. The objectives of the present study 
were to examine several aspects of porcine gonocyte culture through multiple experiments in a 
stepwise design. The examined factors included the gonocyte proportion and seeding density, 
incubation conditions, sampling, medium changing regimens, and effects of applying those optimal 
conditions on gonocyte colony formation. 
3.3 Materials and Methods 
3.3.1 Testis Collection and Preparation 
Testes from Yorkshire-cross piglets (Camborough-22 × Line 65; PIC Canada, Winnipeg, MB, 
Canada) less than 1 wk of age were used in this study. The testes were collected weekly (5-15 pairs 
per wk) through aseptic castration at the Prairie Swine Center (a university–affiliated facility). All 
experimental procedures involving animals were reviewed and approved by the University of 
Saskatchewan’s Institutional Animal Care and Use Committee (Animal Use Protocol# 20080042). 
The testes were kept in ice-cold Dulbecco’s phosphate-buffered saline (DPBS; catalogue no. 20-
031-CV; Mediatech, Manassas, VA, USA), containing 1% w/v antibiotics solution (penicillin and 
streptomycin; catalogue no. 30-002-CI, Mediatech), and were transported within 1 h of collection 
to the laboratory. The testes were thoroughly rinsed three times with DPBS prior to processing. 
The parenchyma was separated from the tunica albuginea and excess connective tissues, and used 
for isolation of testicular cells.  
3.3.2 Isolation of Testis Cells and Enrichment for Gonocytes 
Isolation of testis cells and enrichment of gonocytes were performed using methods that were 
established in our laboratory (three-step enzymatic digestion, Nycodenz density gradient 
centrifugation and extracellular matrix (ECM) differential plating; (Han et al., 2009; Yang and 
Honaramooz, 2011). Briefly, for each batch of the three-step enzymatic digestion, ~600 mg of testis 
parenchyma was thoroughly minced with fine scissors for 5 min, suspended in 5 mL of DPBS, 
vortexed for 30 sec in a test tube shaker (Reax Top; catalogue no. 541-10000; Heidolph Instrument, 
Essex, UK) and digested with 1 mL of 0.2% w/v collagenase IV (catalogue no. C-153; Sigma-
Aldrich, Oakville, ON, Canada), 0.1% w/v hyaluronidase (catalogue no. H-3884; Sigma-Aldrich), 
and 0.01% DNase (catalogue no. DN25; Sigma-Aldrich) in Dulbecco’s modified Eagle’s medium 
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(DMEM; catalogue no. 10-013-CM; Mediatech) supplemented with 1% w/v antibiotics (as above) 
at 37 °C for 10 min. Fetal bovine serum (FBS; catalogue no. A15-701; PAA Laboratories, 
Etobicoke, ON, Canada) was added to stop the digestion and the suspension was vortexed for 
another 30 sec and filtered through a 40 µm filter (catalogue no. 3522340; BD Biosciences, San 
Jose, CA, USA). The filtrate suspension was centrifuged at 500×g at 16 °C for 5 min and 
resuspended in 5 mL of DPBS supplemented with 1% w/v antibiotics. A large number of red blood 
cells were observed among the isolated testis cells. Therefore, erythrocyte depletion was performed 
by mixing the cells with 20 mL of the lysis buffer, composed of 156 mmol/L ammonium chloride 
(NH4CL; catalogue no. A9434; Sigma-Aldrich), 10 mmol/L potassium bicarbonate (KHCO3; 
catalogue no. 237205; Sigma-Aldrich), and 0.1 mmol/L disodium ethylenediaminetetraacetate 
(Na2EDTA; catalogue no. E6635; Sigma-Aldrich) in sterile distilled water prior to another cycle 
of centrifugation (500×g at 16 °C for 5 min). Finally, the cell pellet was resuspended in 5 mL of 
DMEM supplemented with 10% v/v FBS and 1% antibiotics (designated as DMEM++) and 
underwent gentle pipetting to obtain a single cell suspension.  
For enrichment of gonocytes among the cells obtained from the three-step enzymatic digestion, 3 
mL of 17% Nycodenz in DPBS (Histodenz; catalogue no. D2158; Sigma-Aldrich) was placed at 
the bottom of a 15-mL graduated conical tube. This was followed by gentle addition of 2 mL of 
cell suspension on top and the tube was centrifuged at 500×g at 4 °C for 15 min. The supernatant 
was discarded, and the pellet was harvested and resuspended as a single cell suspension. This was 
immediately followed by ECM differential plating, for which 6-well culture plates (catalogue no. 
353046; BD Biosciences) were coated with 1 mL of 50 µg/mL poly-D-lysine (catalogue no. 47743-
736; VWR International, Mississauga, ON, Canada) and 10 µg/mL fibronectin (catalogue no. 
477743-728; VWR) in an incubator with 5% CO2 at 37 °C for 1 h, and dried in a biosafety cabinet 
for another 1 h. The poly-D-lysine pre-coated wells were rinsed twice with DPBS before seeding 
the cells obtained from Nycodenz gradient density centrifugation. The cells were seeded onto the 
plates at a concentration of 2.5 × 105 cells/cm2 in DMEM++, and cultured in an incubator with 5% 
CO2 at 37 °C. After 2 to 3 h, the floating cells were harvested, centrifuged at 500×g at 16 °C for 5 
min and the pellets were collected and resuspended as a single cell suspension. These procedures 
lead to obtaining isolated testis cells highly enriched in gonocytes. We performed a side-by-side 
quantitative comparison of the cell yield, viability and loss after each progressive step. Samples 
were prepared from single cell suspensions obtained from each step. The suspension was smeared 
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onto poly-L-lysine pre-coated glass coverslips, dried overnight in a biosafety cabinet and kept at -
20 °C for use in fluorescent labeling.  
3.3.3 Simultaneous Cell Quantification and Viability Assessment  
The number of resultant cells after each isolation and enrichment step as well as after culturing was 
quantified, and the cell viability was assessed using the trypan blue exclusion technique. For 
evaluation of cells collected after isolation and enrichment, single cell suspensions were prepared 
as described above. For cultured cells, detachment of the adherent cells was performed by adding 
1 mL of 0.25% (w/v) trypsin in Hank’s balanced salt solution (HBSS) and 2.21 mmol/L EDTA 
(catalogue no. 25-053-CI; Mediatech) at 37 °C for 1-2 min (depending on confluency) with gentle 
agitation. The enzymatic digestion was stopped by adding 1 mL of undiluted FBS, and the mixture 
was centrifuged at 500×g at 16 °C for 5 min. The pellets were collected and subjected to 
resuspension into a single cell suspension prior to viability assessment. Trypan blue (100 µl of a 
0.4% solution in saline, catalogue no. T8154; Sigma-Aldrich) was mixed (1:1 ratio) gently with 
the cell suspension, and 20 µl of the mixture was transferred to each hemocytometer chamber and 
live/dead cells were identified with the aid of a light microscope. For each replicate, two counts of 
live/dead cells were performed and averaged to calculate the yield and viability of cells (given as 
a percentage). As explained in more detail in Chapter 3.3.6, fluorescent labeling of lectin DBA was 
performed to confirm and quantify gonocytes, as they are the only type of germ cells present in 
neonatal pig testes; hence the remaining cells were categorized as somatic cells. For this staining, 
a minimum of 600 cells in randomly selected fields were counted in each cell smear, and the 
proportion (%) of gonocytes/somatic cells was calculated.  
3.3.4 Cell Culture 
Different cell culture conditions were evaluated using a stepwise approach. The same medium 
(DMEM++), culture plates (6-well plates), and incubator conditions (5% CO2 and 95% humidity) 
were used in all experiments in order to evaluate the effects of changing other variables (i.e., 
gonocyte proportion, incubation temperature, cell seeding density, and medium changing regimen). 
For all experiments, pH of the medium was adjusted to 7.4 immediately prior to using it in cell 
cultures. The pH of the medium was measured using a digital pH meter (catalogue no. 11288-368; 
model Symphony SB70P; VWR). Cell growth was monitored at least once daily using an inverted 
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phase contrast microscope (Nikon, Eclipse TS100). For each experiment, multiple replications 
were performed where cells obtained from each batch of testis tissue digestion were considered 
one replication. We have previously shown that the characteristics of cells obtained from 1-wk old 
piglets from this source remain consistent over time, both within and among litters (Yang et al., 
2010). 
Effects of several factors on the behavior and the morphology of cultured testis cells were examined 
using cytology and fluorescent labeling. The examined factors included different gonocyte 
proportions obtained before or after each step of enrichment (40% vs. 80% vs. 86%), incubation 
temperature (35 °C vs. 37 °C), cell seeding density (1.0 × 105 vs. 3.0 × 105 vs. 5.0 × 105 cells/well; 
each well in a 6-well plate has ~10 cm2 cell growth area) and medium changing regimen (every 2 
d vs. modified regimen vs. no changing of medium for up to 7 d). Confluency assessment was 
defined as the relative coverage of the plate surface by the mixture of testis cells, and a gonocyte 
colony was defined as a group of more than three gonocytes in close contact. 
3.3.5 Cell Sampling  
For sampling of cultured cells, glass coverslips coated with 0.1% w/v poly-L-lysine were used. 
Glass coverslips sized 22 × 22 mm (catalogue no. 12-540B; Fisher Scientific, USA) were arranged 
in a sterile metal coverslip rack and immersed in 1% HCL in 70% alcohol for 10 min, followed by 
rinsing with sterile distilled water for 5 sec and allowed to dry for 20 min. The rack was transferred 
into a 0.1% w/v poly-L-lysine (catalogue no. P8920; Sigma-Aldrich) solution for 10 min and 
allowed to dry overnight. Finally, the glass coverslips were placed at the bottom of each well in 6-
well plates. These procedures were conducted under a biosafety cabinet. 
3.3.6 DBA Fluorescent Labeling 
Gonocytes were identified using Dolichos biflorus agglutinin (DBA) according to previously 
described protocols (Yang et al., 2010; Yang and Honaramooz, 2011), with minor modifications. 
Briefly, the dried coverslips (with cell smears or with cells grown directly on them) were fixed in 
Bouin’s solution (catalogue no. 1120-31; Richa Chemical Company, Pocomoke City, MD, USA) 
for 2-3 min. The samples were then rinsed three times with 70% alcohol to remove excess Bouin’s 
solution followed by three rinses with DPBS. The samples were blocked with 5% bovine serum 
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albumin (BSA; catalogue no. 0332, Amresco, Solon, OH, USA) at 37 °C for 30 min in a humidified 
chamber. The blocking agent was removed and the samples were incubated with fluorescein 
isothiocyanate (FITC)-conjugated lectin DBA (1:100, catalogue no. FL-1031, Vector Labs, 
Burlington, ON, Canada) overnight at 4 °C in a humidified chamber. The samples underwent 
another cycle of rinsing, followed by incubation with 0.3% Sudan Black B w/v (catalogue no. 
S2380; Sigma-Aldrich) in 70% alcohol for 15 min, at 37 °C in a humidified chamber. The samples 
were rinsed with DPBS and stained with 4’6’-diamidino-2-phenyilindole (DAPI; catalogue no. 
D9542; Sigma-Aldrich) and observed under a fluorescence microscope. FITC-conjugated lectin 
DBA specifically labels gonocytes which appear green under the fluorescence microscope while 
DAPI stains the nuclei of all cells which appear blue (Fig. 3.1). 
3.3.7 Statistical Analyses 
Unless stated otherwise, all data are presented as means ± standard error of mean (SEM) and 
analyzed using either one-way or two-way analysis of variance (ANOVA), as appropriate, followed 
by Tukey’s HSD post-hoc test. For percentages, the data were transformed using Arcsine function 
prior to analysis using ANOVA. The level of significance was set at P < 0.05. Data were analyzed 
using the Statistical Package for Social Science (SPSS; Version 20.0, SPSS Inc., Chicago, IL, 
USA).  
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Fig. 3.1. Dolichos biflorus agglutinin (DBA) fluorescent labeling of neonatal gonocytes. (A-C) 
Gonocyte labeling with DBA was performed on testis cell smears collected immediately following 
cell isolation. (D-F) Multiple gonocytes form a colony on a somatic-cell monolayer observed at 1 
wk of culture. (G-I) Floating gonocytes in the removed medium observed 4 d after incubation. 
(A,D,G) DAPI-stained nuclei of the cells appear blue (B,E,H). Fluorescein-conjugated DBA-
labeled gonocytes appear green under the fluorescence microscope. (C,F,I) Merged images.  
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3.4 Results 
As summarized in Table 3.1, enzymatic digestion of testis tissues yielded a population of testis 
cells containing ~41% germ cells (Fig. 3.1A-C), which at this developmental stage (~1 wk of age) 
are exclusively gonocytes. Gradient centrifugation by Nycodenz, followed by ECM differential 
plating resulted in enrichment of gonocytes to ~80% and ~86%, respectively. However, the 
enrichment procedures also caused significant reductions (P < 0.05) in cell counts after each step, 
resulting in ~73% and ~92% total testis cell loss and ~47% and ~83% gonocyte loss, respectively. 
The relatively lower gonocyte loss at each step, compared with the total cell loss, resulted in 
significant enrichment of gonocytes. The viability of cells was also reduced after each enrichment 
step (from ~93% to 84% and 82%, respectively, P < 0.05). When the cells were cultured (3.0 × 105 
cells/well at 37ºC with 5% CO2 and the medium was changed every 2 d), only the cells used 
immediately after the three-step enzymatic digestion (i.e., without enrichment) demonstrated 
growth by reaching ~90% confluency in ~6 d.  
3.4.1 Experiment 1: Effect of Cell Seeding Density and Gonocyte Proportion  
One of the objectives of this experiment was to determine the optimal seeding density for culturing 
testis cells. A comparison was made by randomly assigning cells into 6-well plates at 1.0 × 105, 
3.0 × 105, or 5.0 × 105 cells/well (i.e., 1.0 × 104, 3.0 × 104, or 5.0 × 104 cells/cm2 since each well 
was ~10 cm2, n = 12 replications), in 3 mL of medium to determine the time required for the cells 
to reach 90% confluency. Cells were used fresh (immediately after enzymatic digestion and without 
enrichment, hence containing ~40% gonocytes) and cultured under similar conditions at 37 °C, and 
the medium was changed every 2 d.  
As shown in Table 3.2, cells in the highest seeding density group (5.0 × 105) became confluent 
earlier than other groups (P < 0.05), reaching >90% confluency in ~4 d, while the 3.0 × 105 seeding 
density group of cells were >90% confluent by ~Day 6. Cells cultured at 1.0 × 105 seeding density 
had slow growth and only reached ~30% confluency after 7 d in culture.  
In a separate experiment, testis cells enriched for gonocytes (undergoing both Nycodenz 
centrifugation and ECM plating, hence containing ~86% gonocytes) were used as the source of 
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cells for culturing, using the same incubation conditions. Cells did not grow in plates seeded with 
1.0 × 105 or 3.0 × 105 cells/well and only had limited growth in the 5.0 × 105 seeding density group 
after 7 d in culture (5-15% confluency, data not shown). Therefore, for the remaining experiments 
in this study we used testis cells without enrichment (i.e., containing ~40% gonocytes), and since 
the 3.0 × 105 seeding density resulted in confluency of cells in ~6 d (without the need for passaging 
the cells within 1 wk), we used this seeding density in the subsequent experiments. 
3.4.2 Experiment 2 : Effect of Incubation Temperature  
The objective of this experiment was to evaluate the growth of cultured testis cells using incubation 
temperatures of either 35 °C or 37 °C for 1 wk (n = 12 replications), while other culture conditions 
remained the same (e.g., medium, cell seeding density, and CO2 levels). As shown in Table 3.3, 
the viability and number of cells at confluency did not differ between the two incubation 
temperatures (P > 0.05). However, the cells cultured at 35 °C reached confluency later than those 
at 37 °C (P < 0.05); therefore, for practical reasons we chose to culture the cells at 37 °C for 
subsequent experiments.   
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Table 3.1. The population of testis cells obtained after enzymatic digestion and subsequent enrichment. 
 
Method 
Proportion (%) Cell count (× 106) * Cell loss (%) **  
Viability (%) 
 
Growth Gonocytes  Somatic cells Total Gonocytes Total Gonocytes 
Enzymatic 
digestion 
40.60 ± 1.21a 59.40 ± 1.21a 37.84 ± 2.44a 15.38 ± 1.09a - - 92.62 ± 0.59a Yes 
Nycodenz 
centrifugation 
80.40 ± 1.46b 19.60 ± 1.46b 10.00 ± 0.41b 8.00 ± 0.21b 73.18 ± 1.76a 
 
46.72 ± 4.69a 84.20 ± 1.06b Limited 
ECM differential 
plating 
86.40 ± 1.03c 13.6 0 ± 1.03c 3.02 ± 0.19c 2.60 ± 0.2c 91.62 ± 0.79b 82.61 ± 1.71b 81.66 ± 0.71c Limited 
 
The results are mean ± SEM.  
* Each replicate was based on the digestion of ~600 mg of testis tissue.  
One-way ANOVA (or t test **) was used for statistical analyses, and P < 0.05 was considered as significant.  
abc Within each column, data with different superscripts differ significantly (P < 0.05). n = 5 replications.
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Table 3.2. The effect of seeding density on the growth of testis cells in culture. 
 
Seeding density 
Maximum confluency 
Confluency at days Cell count Viability (%) 
1.0 × 105 (*~30% at 7) (*2.98 × 105 ± 0.01) (*88.4 ± 1.02) 
3.0 × 105 >90% at 6.0 ± 0.17a 8.10 × 105 ± 0.01 91.21 ± 0.58 
5.0 × 105 >90% at 4.0 ± 0.15b 8.16 × 105 ± 0.01 91.62 ± 0.56 
 
The results are mean ± SEM.  
*The results from 1.0 × 105 seeding density group were excluded from statistical analysis as the cells did 
not reach 90% confluency.  
Independent sample t test was used for statistical analyses.  
ab Within each column, if data differed significantly (P < 0.05), they are denoted by different superscripts. 
n = 12 replications. 
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Table 3.3. The effect of incubation temperature on the growth of testis cells in culture. 
 
Temperature 
>90% confluency 
Days Cell count Viability (%) 
35 ºC 6.42 ± 0.15a 7.98 × 105 ± 0.01 89.98 ± 0.49 
37 ºC 5.83 ± 0.17b 8.27 × 105 ± 0.01 90.04 ± 0.49 
 
The results are mean ± SEM.  
Independent sample t test was used for statistical analyses.  
ab Within each column, if data differed significantly (P < 0.05), they are denoted by different superscripts. 
n = 12 replications.
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3.4.3 Experiment 3: Sampling of Cultured Testis cells for Analysis 
Various methods can be used to sample cultured cells for analysis. When sampling for applications  
such as immunocytochemistry, coverslips are commonly pre-coated with certain matrices to 
enhance adherence of cells. It is not clear whether the presence of the pre-coated coverslips in testis 
cell culture would affect cell growth. Furthermore, in situations where multiple samplings from 
each replicate are required, it would be more efficient to use all available cultured cells, including 
those grown on areas of the culture well not covered by the coverslip. The objectives of this 
experiment were to determine 1) whether the rate or pattern of testis cell growth in culture would 
change in the presence of glass coverslips (22 × 22 mm) coated with 0.01% poly-L-lysine, and 2) 
whether the growth of testis cells on the coverslips differs from those on the peripheral areas of the 
wells, not covered by the coverslips (Fig. 3.2). 
When plates with and without poly-L-lysine-coated coverslips were compared, the number or 
viability of the resultant cultured cells did not differ between plates (8.18 ± 0.01 × 105 vs. 8.22 ± 
0.02 × 105 cells per plate, with 91.0 ± 0.57% vs. 91.3 ± 0.87% cell viability, plates with coverslips 
vs. plates with no coverslips, respectively, n = 12 replications, P > 0.05). When non-coated 
coverslips were used, little or no cell growth was observed. Furthermore, within the plates with 
poly-L-lysine-coated coverslips, the viability of cells grown on coverslips did not differ from those 
grown on the peripheral areas of the well, not covered by coverslips (92.0 ± 0.33% vs. 92.4 ± 
0.51%, coverslips vs. periphery, respectively, P > 0.05). However, the number of cells obtained 
from the peripheral areas was higher than that from the coverslips (4.59 ± 0.14 × 105 vs. 2.99 ± 
0.06 × 105, respectively, P < 0.05), even though both encompassed a similar cell growth area (~4.8 
cm2 each).   
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Fig. 3.2. Schematic representation of the areas within culture plates used for sampling in 
Experiment 3. The numbers and viability of cells grown on poly-L-lysine-coated coverslips (A) 
were compared with those grown on the peripheral areas of the wells, not covered by the coverslip 
(B).   
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3.4.4 Experiment 4: Short-Term Culture of Neonatal Porcine Testis Cells  
Morphological changes of neonatal porcine testis cells in culture were evaluated for 1 wk under 
the above-mentioned culture conditions (3.0 × 105 seeding density, DMEM++, 37 °C, n = 6 
replications). The medium was changed every 2 d. Within the first 12 h of incubation, most of the 
cells and cell particles were still floating in the medium (Fig. 3.3A). By 24 h after incubation, small 
numbers of cells settled and appeared to have adhered to the plate. The early settling cells were 
mostly somatic cells and began to form cytoplasmic projections, creating irregularly shaped cell 
boundaries (Fig. 3.3B), while more cells continued to settle. After 2 d of incubation, the cells started 
to appear in clumps (Fig. 3.3C), and over time these groups of cells spread further and combined 
to create a large somatic-cell monolayer. At the same time, round cells with large nuclei, appearing 
bright or with a halo under phase-contrast microscopy, were seen attached onto the somatic-cell 
monolayer (Fig. 3.3D-E). These rounds cells were confirmed to be gonocytes using fluorescent 
labeling (Fig. 3.1D-F). It was also observed that while initially gonocytes were present as singles 
or pairs, starting at Day 5, colonies (grape-like clumps) of more than 3 cells could also be observed 
(Fig. 3.3D). It was noticed that gonocytes were only loosely attached to the somatic-cell monolayer, 
since some would detach due to slight movements of the plate. By the end of the experiment (Day 
7), the number of these round cell colonies were still considerably less than expected, given that 
the population of testis cells at seeding contained ~41% gonocytes. The somatic cells continued to 
multiply and once reaching 70-80% confluency (at ~4 to 5 d), many appeared as spindle-shaped 
fibroblast-like cells (Fig. 3.3E). 
3.4.5 Experiment 5: Floating Cells in the Culture Medium 
Based on the findings of Experiments 1 and 4, it was clear that gonocytes require sufficient ratios 
of somatic cells or feeder cells, to which they formed a loose attachment for growth in culture. We 
speculated that the very low number of gonocyte colonies observed by Day 7 during short-term 
culture (Fig. 3.3E) might be due to their loss through routine medium changes, which apparently 
eliminated the floating and loosely adherent gonocytes. Therefore, this experiment was designed 
to examine the medium removed from the plates. The results showed that indeed high numbers of 
round cells were present in the medium removed routinely every other day. The number of these 
cells was greatest in the medium removed on Day 2 (6.81 ± 0.63 × 104), compared with Days 4 and 
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6 (1.02 ± 0.09 × 104 and 0.4 ± 0.07 × 104 cells/well, P < 0.05, n = 5 replications, Fig. 3.4). On the 
other hand, if the medium was not changed, greater numbers of floating gonocytes remained in the 
medium examined on Days 4 and 6 (4.2 ± 0.10 × 104 and 1.92 ± 0.05 × 104 cells/well, respectively), 
compared with the numbers obtained on the same days when the medium was changed every other 
day (P < 0.05, n = 5 replications, Fig. 3.4). Based on the morphology, it was presumed that these 
cells were gonocytes; they were large and round in shape with prominent nuclei (large nucleus to 
cytoplasm ratio). The viability of these round cells remained high in all examined days (~85-97%, 
data not shown). Using fluorescent labeling, these round cells were later confirmed to be gonocytes 
(Fig. 3.1G-I).  
3.4.6 Experiment 6: Effect of Medium Changing Regimens on Attached Gonocytes 
This experiment was designed to assess the effects of different medium changing regimens on the 
number and viability of attached gonocytes. The cells were cultured using the selected culture 
conditions (3.0 × 105 testis cells/well containing ~40% gonocytes, DMEM++, 37 °C) for 1 wk, and 
medium changing regimens were assigned to groups of plates as follows: 1) To serve as a control 
group, the cells were seeded with 3 mL of medium, and the medium was changed routinely, every 
2 d (routine group, 3 changes in 1 wk); 2) the cells were seeded with 2 mL of medium, followed 
by the addition of another 1 mL after 24 h, and then every 2 d 1 mL of medium was removed from 
the well and replaced with 1 mL of fresh medium (modified group); or 3) the cells were seeded 
with 3 mL of medium but the medium was not changed (unchanged group). On Days 2, 4, 6, and 
7, the cultured cells were observed under an inverted microscope and the number of gonocyte 
colonies in four randomly selected fields at 400× was recorded and cells were collected for 
evaluation of viability (n = 5 replications per group).  
As shown in Fig. 3.5, alterations in medium changing regimens affected the number of attached 
gonocytes or gonocyte colonies present on the somatic-cell monolayers. Overall, the number of 
gonocyte colonies increased (P < 0.05) from Day 2 to Day 4 of culture in all medium changing 
regimens. However, among the medium changing regimens, the unchanged group had greater (P 
< 0.05) number of gonocyte colonies on Days 6 and 7 compared with the routine medium changing 
group (control).  
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The viability of cells in different medium changing regimens is shown in Fig. 3.6. Compared with 
the cell viability at seeding (~90%), there was a reduction in viability of cells at Days 4, 6, and 7 
in all groups (P < 0.05). The cell viability was reduced further in the unchanged group on Days 6 
and 7 (P < 0.05). Between the regimens, the viability of cells in the unchanged groups was lower 
(P < 0.05) than the routine group on Days 6 and 7 of culture.   
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Fig. 3.3. Morphology of testis cells in short-term cell culture. (A) Morphology of floating cells 12 
h after seeding. (B) Some somatic cells settled to the bottom of the plate within 24 h of incubation. 
(C) These somatic cells extended cytoplasmic projections toward one another. (C-F) Cells 
presumed to be gonocytes are seen attached to somatic cells (black arrows). The same gonocytes 
are also shown at a higher magnification (insets). (D) Gonocytes appeared as singles (black arrow), 
pairs (yellow arrow), or small colonies (red arrow). (E) Spindle-shaped fibroblast-like cells were 
more prominent when confluency reached >70%. Only a small number of gonocyte colonies were 
observed by Day 7 when routine medium changing regimen was applied. (F) Increased number of 
gonocyte colonies were observed when the medium was not changed for 7 d. (Scale bar: 50 µm).  
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Fig. 3.4. Number of gonocytes upon analysis of the floating cells from the removed medium. The 
initial number of cells at seeding was set at 3.0 × 105 cells/well containing ~40% gonocytes and 
the viability was 89 ± 0.5%. The medium removed from the plates was examined and large numbers 
of gonocytes were seen floating in the medium on Day 2. Most of the floating gonocytes were 
eliminated by routine (every 2 d) medium changes (Routine), while some were present on Days 4 
and 6, if the medium was not changed (Unchanged). The data are mean ± SEM. ab Data with 
different letters within each day differ significantly (P < 0.05). xyz Data with different letters within 
each treatment over time differ significantly (P < 0.05). n = 5 replications.  
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Fig. 3.5. Number of gonocytes or gonocyte colonies observed after applying different medium 
changing regimens. The cultured cells underwent one of the following medium changing regimens: 
1) Seeded with 3 mL of medium and the medium was routinely changed every 2 d (Routine); 2) 
Seeded with 2 mL of medium, followed by the addition of another 1 mL after 24 h, and then every 
2 d, 1 mL of medium was removed from the well and replaced with 1 mL of fresh medium 
(Modified); 3) Seeded with 3 mL of medium but the medium was not changed for 7 d (Unchanged). 
The data are mean ± SEM. ab Data with different letters within each day differ significantly (P < 
0.05). xy Data with different letters within each treatment over time differ significantly (P < 0.05). 
n = 5 replications.   
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Fig. 3.6. Viability of cells at seeding and after applying different medium changing regimens. The 
cultured cells underwent one of the following medium changing regimens: 1) Seeded with 3 mL 
of medium and the medium was routinely changed every 2 d (Routine); 2) Seeded with 2 mL of 
medium, followed by the addition of another 1 mL after 24 h, and then every 2 d, 1 mL of medium 
was removed from the well and replaced with 1 mL of fresh medium (Modified); 3) Seeded with 
3 mL of medium but the medium was not changed for 7 d (Unchanged). Viability on Day 0 
represents the initial viability at seeding. The data are mean ± SEM. ab Data with different letters 
within each day differ significantly (P < 0.05). xyz Data with different letters within each treatment 
over time differ significantly (P < 0.05). n = 5 replications.  
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3.5 Discussion 
In the neonatal testis, gonocytes represent MGSC, which have great potential applications in male 
reproduction research (reviewed in (Honaramooz and Yang, 2010; Honaramooz, 2012). Various 
methods have been established to culture MGSC to facilitate their study and manipulation or to 
harness their potential for downstream applications such as genetic conservation, transgenesis, or 
infertility treatments (Honaramooz et al., 2002b, 2003b, 2008; Zeng et al., 2013; Mankidy et al., 
2014). However, depending on the donor species, age, or developmental status, optimized culturing 
or enrichment of MGSC can be challenging (Yang and Honaramooz, 2010; Yang et al., 2010). 
Cell isolation is a critical step in preparing testis cells for culture. The number and proportion of 
the resultant populations of cells also vary greatly depending on the methods used to isolate the 
cells. As a first step in the present study, we performed a side-by-side comparison of the total testis 
cell yield and gonocyte proportions from three protocols (Yang et al., 2010; Yang and 
Honaramooz, 2011). Although as expected the enrichment process resulted in highly purified 
populations of gonocytes (~86%), it also led to losing up to 90% of the initial number of testis cells. 
These findings provide a basis upon which an appropriate approach could be adopted for gonocyte 
isolation/enrichment in order to meet the objectives and needs of specific experiments. For 
example, the highly enriched populations of gonocytes could be used in studies that focus mainly 
on gonocytes per se, while the heterogeneous populations of testis cells obtained immediately after 
enzymatic digestion may be more suitable for longer-term culture or for the study of interactions 
between gonocytes and somatic cells.  
One of the advantages of using neonatal testes as the source of germ cells is that gonocytes are the 
only type of germ cells present during the early postnatal stage. Gonocytes possess a distinct 
morphology and a unique pattern of distribution in the seminiferous cords of neonatal testes, which 
facilitate their identification in situ (Orwig et al., 2002a; Goel et al., 2007). Once the cells are 
enzymatically dissociated; however, accurate identification of gonocytes requires 
immunocytochemistry/fluorescent labeling. There are several biomarkers that could be used for 
identification of gonocytes including germ cell markers (e.g., VASA and DAZL, (Reijo et al., 
1996; Castrillon et al., 2000) and stem cell markers (e.g., Nanog, SSE-A1, and OCT4, (Anderson 
et al., 2007; Goel et al., 2007; Fujihara et al., 2011; Zogbi et al., 2012). Two of the most commonly 
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used markers for neonatal porcine gonocytes are DBA (Goel et al., 2007; Kim et al., 2010a; Yang 
and Honaramooz, 2012) and ubiquitin C-terminal hydrolase L1 (UCHL1; previously known as 
PGP9.5) (Han et al., 2009; Kim et al., 2010a). DBA has a specific affinity to bind to α-D-N-acetyl-
galactosamine, which is localized on the surface of porcine gonocytes (i.e., primitive germ cells) 
(Goel et al., 2007), while UCHL1 can identify both primitive and more advanced germ cells. 
In the present study, the identification of gonocytes was initially hampered by autofluorescence, 
which was partly overcome by using a quenching protocol (Yang and Honaramooz, 2012); 
however, some autofluorescence remained. Autofluorescence in the tissue/cells can be due to 
endogenous sources (e.g., lipofuscin or lipofuscin-like pigments), or acquired during processing 
(e.g., certain fixatives). In any case, autofluorescence can interfere with specific signals by 
fluorescent labeling and lead to false positive results. In the present study, the autofluorescence 
was eliminated through modification of the quenching protocol (Yang and Honaramooz, 2012). 
The use of Sudan black B (SBB) has been reported to be efficient in masking autofluorescence of 
lipofuscins, triglycerides, and lipoproteins origin (Schnell et al., 1999; Baschong et al., 2001) and 
is a major component of the quenching protocol for testis cells (Yang and Honaramooz, 2012). In 
this study, as a first step in modifying the original quenching protocol, the length of incubation 
with SBB was extended, which led to a further reduction of the autofluorescence of testis cells, but 
not to its complete elimination. We then speculated that the remaining autofluorescence might have 
a fixative origin. The picric acid component of Bouin’s solution used for fixing testis tissue has 
also been cited as a potential cause of autofluorescence (Hess and Moore, 1993; Howroyd et al., 
2005). Therefore, we applied further control measures to refine the use of fixatives in the quenching 
protocol. We found that the inclusion of three thorough and gentle rinses with 70% alcohol after 
the Bouin’s fixation completely eliminated the autofluorescence problem in Bouin’s fixed testis 
cell samples. As an alternative, we also found that to avoid the autofluorescence caused by Bouin’s, 
cell smears or cells grown on coverslips can be fixed using methanol at -20 °C for 10 min.  
Cell seeding density influences the performance of cultured cells, presumably by affecting the 
contact and interactions among cells (Xia et al., 2011). Optimization of the cell seeding density 
prior to culturing cells ensures normal cell growth and allows estimation of the time to reach certain 
confluency levels. In the present study, the cell seeding density of 3.0 × 105/well (i.e., in ~10 cm2) 
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was found to be more practical because it allowed sampling within 1 wk without a need for 
passaging the cells.  
Temperature may play an important role in the efficiency of testis cell culture, but the effect of 
incubation temperature on the proliferation of neonatal porcine testis cells has not been well 
studied. In Experiment 2, testis cells were cultured at either 35 or 37 °C to mimic the testis 
temperature in situ, which is normally lower than the core body temperature, ranging 38–40 °C in 
pigs (Ingram and Legge, 1970; Lohse et al., 2010). Testis cells cultured at either 35 or 37 °C 
proliferated and reached a 90% confluency within 1 wk; however, those cultured at 35 °C became 
90% confluent later (5.8 vs. 6.4 d, respectively, P < 0.05). Earlier studies using human or mouse 
testis cells concluded that DNA synthesis and steroidogenesis were increased when cells were 
cultured at 31/32 °C, compared with 37 °C, which is the core body temperature in these species 
(Nakamura et al., 1987; Zhou et al., 2008). Although these latter studies also point to the beneficial 
effects of culturing testis cells at lower than core body temperature, they each examined only one 
such temperature, making it difficult to compare the results. Results from the present study suggest 
that further studies will be required to determine the optimal temperature for culturing testis cells 
for a given species.  
The use of poly-L-lysine-coated coverslips is recommended when sampling cultured testis cells. 
Opposing ionic charges among the cells (polyanionic) and poly-L-lysine-coated coverslip surface 
(polycationic) enhance efficient attachment of cells onto the coverslips. In the present study, we 
showed that 1) the presence of poly-L-lysine-coated coverslips had no adverse effects on the 
growth of cultured testis cells; 2) cells did not grow on non-coated coverslips; and 3) there was no 
difference in cell viability between the cells growing on coverslips and the peripheral areas of the 
well. Therefore, while coverslips placed at the bottom of round plate wells provide a convenient 
method of sampling for analyses such as immunocytochemistry, the cells at the peripheral areas 
could also be used for other evaluations such as monitoring of the cell viability or use in other 
assays. Using coverslips also offers the advantage of allowing multiple samplings from the culture 
dish with minimal disturbance to other cells in the same dish/plate.  
In vivo proliferation of gonocytes is influenced by their contact or interaction with the basement 
membrane of the seminiferous tubule (McGuinness and Orth, 1992). It has also been suggested 
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that gonocytes require the presence of feeder cells in order to settle and form colonies in vitro (Orth 
and McGuinness, 1991; Hasthorpe et al., 1999; Kanatsu-Shinohara et al., 2003; Nagano et al., 
2003; Borjigin et al., 2011). In the present study, testis somatic cells formed a monolayer, which 
provided a platform for subsequent gonocyte attachments. It also appeared that the survival and 
propagation of gonocytes depended on the proper ratio of gonocytes to somatic cells. This was 
exemplified in Experiment 1, where we used highly enriched gonocytes (~86%) for seeding and 
observed no or slow cell proliferation, even when the enriched gonocytes were used at the same 
seeding density (3.0 × 105/well) as heterogeneous populations of testis cells. This is in agreement 
with a previous study by van Dissel-Emiliani et al., (1993) showing that when gonocytes were 
cultured alone, they failed to adhere to the culture plate and instead formed gonocyte aggregates, 
which were subsequently lost. 
In fetal and neonatal testes, gonocytes are larger than most testis cells and one would expect that 
among testis cells in the suspension, gonocytes would be one of the first cells to settle. This was 
indeed the case for mouse fetal gonocytes showing the highest sedimentation velocity of all testis 
cells (van Dissel-Emiliani et al., 1989). In the present study, however, gonocytes settled much later 
than other testis cells, and could be seen floating even after several days of culture. Goel et al., 
(2008) examined the population of floating cells after 4 h of culturing neonatal pig testis cells and 
concluded that they were mostly viable (~95%) and composed of mostly germ cells (91%). In the 
present study, although the number of floating gonocytes decreased over time, their viability 
remained high (78-86%) up to 6 d after culture. The extended presence of floating gonocytes may 
be an advantageous characteristic if they are collected to be used for gonocyte enrichment; 
however, it can also be disadvantageous and lead to the loss of gonocytes during medium changes, 
if done without due care.  
Changing of medium is important to furnish nutrients and remove waste from a culture system; 
however, the frequency of medium-changing may affect culture conditions. Most studies on testis 
cell culture use a daily, every-other-day, or twice-weekly approach to medium changing (Joffre 
and Roche, 1988; van Dissel-Emiliani et al., 1993; Majumdar et al., 1995; Goel et al., 2007; Han 
et al., 2009). In the present study, routine changing of medium (every 2 d) reduced the number of 
attached gonocytes, prompting us to design Experiment 6 for optimizing the medium changing 
regimen to increase the number of gonocyte colonies. Given our observations of the floating 
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gonocytes, we compared gonocyte colony formation following the routine medium changing 
regimen (every 2 d) with the group in which the medium was not changed for 1 wk, or with the 
modified medium changing regimen, where a smaller volume of medium was exchanged at a time. 
Compared with Day 2 (~5.0 × 103), the number of gonocytes and gonocyte colonies increased in 
all regimens in subsequent days (Days 4, 6, and 7; Fig. 3.5). The increased number of gonocyte 
colonies on Day 4 in all groups (ranging from ~10.0 × 103 to ~13.5 × 103, Fig. 3.5) could be taken 
as evidence of gonocyte proliferation in these early days of culture. This conclusion is especially 
based on the plates in the routine medium changing regimen which had undergone a complete 
medium change. As a result, this group of plates presumably should have lost all or most of its 
floating gonocytes, yet there was a 2-fold increase in the number of gonocyte colonies. On the other 
hand, the number of gonocyte colonies in subsequent days (6 and 7) were ~50% greater in the 
unchanged group, compared with the routine medium changing regimen (~18.0 × 103 vs. ~12 × 
103, respectively, Fig. 3.5). This can be seen as evidence of continued settlement of gonocytes. The 
number of gonocyte colonies also increased over time in all groups; this increase was ~3.3 fold for 
the unchanged medium group (from ~5.4 × 103 on Day 2 to ~18.0 × 103 on Day 7, Fig. 3.5). This 
fold-increase in the total number of gonocyte colonies does not take into account that the number 
of gonocytes within each colony also increased over time (Fig. 3.3D). Therefore, these results 
collectively indicate that the optimized culture conditions developed in the present study improved 
gonocyte colony formation. 
In the present study, we systematically examined the effects of several culture conditions on testis 
cells of the neonatal pig, as a non-rodent animal model. After each experiment, we built upon the 
newly obtained results and designed subsequent experiments to make successive advances in the 
survival, propagation, and colony formation of gonocytes. Our results are expected to facilitate 
further studies aiming at, for instance, investigation of specialized media for large-scale 
propagation of gonocytes, as a source of MGSC. Applications for MGSC range from basic to 
applied research, including germ cell transplantation studies in farm animals for the purpose of 
animal transgenesis, genetic conservation, or infertility treatment models (Honaramooz et al., 
2002b, 2003b, 2008; Zeng et al., 2013; Mankidy et al., 2014). Germ cell transplantation can also 
be used as a functional assay to assess the relative abundance or confirm the developmental 
potential of MGSC within a given population of testis cells, including cultured gonocytes (reviewed 
in Honaramooz, 2012).   
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3.6 Conclusions 
In conclusion, the optimized culture conditions developed in the present study included seeding 
neonatal porcine testis cells at 3.0 × 104 testis cells/cm2 containing ~40% gonocytes in DMEM++ 
at 37 °C, and without changing the medium in the first week. These results can be used to improve 
in vitro maintenance, proliferation, and formation of gonocyte colonies and thereby as a basis for 
the development of more specialized culture systems for MGSC.  
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TRANSITION  
The optimized culture conditions established in Chapter 3 efficiently maintained and supported the 
proliferation and formation of gonocyte colonies in a short-term culture. Therefore, these optimized 
conditions were utilized in Chapter 4 as a basis to study the organization, behavior, and 
ultrastructure of neonatal porcine gonocytes in a prolonged culture.  
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CHAPTER 4 
LIVE-CELL IMAGING AND ULTRASTRUCTURAL STUDY OF CULTURED 
PORCINE GONOCYTES 3, 4 
4.1 Abstract 
Gonocytes in the neonatal testis have male germline stem cell potential. The objective of the present 
study was to examine the behavior and ultrastructure of gonocytes in culture. Neonatal porcine 
testis cells were cultured for 4 wk and underwent live-cell imaging to explore real-time interactions 
among cultured cells. This included imaging every 1 h from Day 0 to Day 3, every 2 h from Day 4 
to Day 7, and every 1 h for 24 h at Days 14, 21, and 28. Samples also underwent scanning electron 
microscopy, transmission electron microscopy, morphometric evaluations, immunostaining, and 
RT-PCR. Live-cell imaging revealed an active amoeboid-like movement of gonocytes, assisted by 
the formation of extensive cytoplasmic projections, which under scanning electron microscopy 
were categorized as spike-like filopodia, leaf-like lamellipodia, membrane ruffles, and cytoplasmic 
blebs. In the first wk of culture, gonocytes formed loose attachments on top of a somatic-cell 
monolayer and in Week 2 formed grape-like clusters, which over time grew in cell number. Starting 
at Week 3 of culture, some of the gonocyte clusters transformed into large multinucleated embryoid 
body-like colonies (EBLC) that expressed both gonocyte- and pluripotent-specific markers. The 
number and diameter of individual gonocytes, the number and density of organelles within 
gonocytes, as well as the number and diameter of the EBLC increased over time (P < 0.05). In 
conclusion, cultured porcine gonocytes displayed extensive migratory behavior facilitated by their 
                                                        
3 The manuscript for this study has been submitted for publication in the Journal of Cell & Tissue 
Research under joint co-authorship with Eiko Kawamura, LaRhonda Sobchishin, and Ali 
Honaramooz. 
 
4 AHAJ contributed to the conceiving and designing of the study, performed the experiments, and 
wrote the first draft of the manuscript. 
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various cytoplasmic projections, propagated, and transformed into colonies that increased in size 
and complexity over time.  
4.2 Introduction 
Gonocytes are a transient population of germ cells that are intermediary between the primordial 
germ cells (PGC) and spermatogonial stem cells (SSC) (Orwig et al., 2002). Gonocytes are formed 
during the fetal period as a morphologically-distinct group of actively proliferating large cells (also 
referred to as M-gonocytes) which reside at the center of seminiferous cords. Gonocytes remain 
largely quiescent throughout the fetal and early postnatal periods (also referred to T1-
prospermatogonia), and are the only type of germ cells present during these periods (Shinohara et 
al., 2000). At a certain species-specific developmental stage after birth, gonocytes resume 
proliferation and migrate to the basal membrane of the seminiferous cords, where they become 
known as (T2)-prospermatogonia (McGuinness and Orth 1992). Prospermatogonia later develop 
into undifferentiated spermatogonia which can either commit to differentiation to initiate 
spermatogenesis, or to self-renewal to maintain the SSC population and ensure the continuity of 
the germline (Oatley and Brinster 2008; De Rooij 1998). PGC, gonocytes and especially SSC 
possess stem cell potential and are hence referred to as male germline stem cells (MGSC) (De Rooij 
and Russell 2000). The distinct morphology and unique spatial and temporal distribution of 
gonocytes in the neonatal testis make them more accessible for identification, isolation, and 
manipulation, compared with their predecessors (PGC) and successors (SSC).  
Studies using gonocytes have important implications for various basic and applied settings 
including animal conservation, experimental and/or clinical reproductive medicine (e.g., fertility 
preservation and restoration), as well as stem cell research and therapy. For instance, testes can be 
collected postmortem for genetic preservation of newborn or immature males of rare/endangered 
species that die prior to reaching maturity. Gonocytes within the cryopreserved testis tissues can 
be then used as a source of MGSC to initiate spermatogenesis and produce spermatozoa using the 
emerging in vitro and in vivo reproductive technologies (Honaramooz 2012; 2014). Similarly, 
gonocytes in cryopreserved biopsies of testis tissue can be potentially used for future restoration of 
fertility of prepubertal boys undergoing gonadotoxic chemotherapy or irradiation (Honaramooz 
2012; 2014). The study of porcine gonocytes can also provide insights for the ongoing research on 
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MGSC and even as a source of multipotent stem cells (Goel et al., 2009; Niu et al., 2016).  
Gonocytes comprise a relatively small percentage of cells in the neonatal testes (e.g., ~1.4% in rats) 
and using conventional enzymatic digestion of the neonatal pig testis tissue only ~5-10% of freshly 
isolated cells were gonocytes (Honaramooz et al., 2003; Herrid et al., 2009; Yang and Honaramooz 
2011). Therefore, the number of gonocytes would need to be increased prior to their potential use 
in downstream applications. We have introduced a novel three-step enzymatic digestion method 
that results in the isolation of neonatal porcine testis cells containing ~40% gonocytes (Yang et al., 
2010). We have also developed efficient methods for enrichment of neonatal porcine gonocytes to 
~90%, using Nycodenz gradient density centrifugation and/or extracellular matrix differential 
plating techniques (Yang and Honaramooz 2011). Enrichment of gonocytes in different species has 
also been made possible using fluorescent or magnetic cell sorting technologies (i.e., FACS and 
MACS) (Kubota et al., 2004; Shinohara et al., 2000; Shinohara et al., 1999). Gonocytes possess 
several known surface markers (e.g., DBA, UCHL1, THY1) (Zheng et al., 2014; Yang et al., 2010; 
Goel et al., 2007) as well as markers that are common with both germ cells (e.g., DAZL, VASA) 
(Castrillon et al., 2000; Reijo et al., 2000), and stem cells (e.g., POU5F1, NANOG, SOX2, SSEA) 
(Wang et al., 2015; Fujihara et al., 2011; Goel et al., 2008; Perrett et al., 2008; Ohmura et al., 
2004; Ohbo et al., 2003).  
Maintenance and propagation of gonocytes have been achieved in various short-term and long-
term culture systems (Lee et al., 2013; Borjigin et al., 2011; Goel et al., 2007; Kanatsu-Shinohara 
et al., 2003; Nagano et al., 2003; Larsen et al., 2002). But these culture systems vary greatly 
depending on the species and laboratories (Sahare et al., 2016; Kubota et al., 2011; Hamra et al., 
2005; Ryu et al., 2005). For instance, the type of media used in different studies varies from basic 
to enriched (Sahare et al., 2016; Tu et al., 2007), and the media may be supplemented with serum 
or serum-replacements (Aponte et al., 2006; Izadyar et al., 2003). The addition of certain growth 
factors and hormones were also found to be beneficial, especially for long-term maintenance of 
gonocytes (Tu et al., 2007; Chuma et al., 2005; Kubota et al., 2004; Kanatsu-Shinohara et al., 
2003; Larsen et al., 2002). Since gonocytes show limited growth when cultured alone (van Dissel-
Emiliani et al., 1993), they are commonly co-cultured with other testis cells (De Miguel et al., 
1996; van Dissel-Emiliani et al., 1996; Orth and Jester, 1995; van Dissel-Emiliani et al., 1993), 
feeder cells (Kubota et al., 2004), or in the presence of extracellular matrices (e.g., gelatin, collagen, 
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laminin) (Sahare et al., 2016; Yu et al., 2005; Kanatsu-Shinohara et al., 2003; Hadley et al.,1985). 
Alternative serum-free or feeder-free culture systems have also been examined (Kanatsu-Shinohara 
et al., 2014; Aoshima et al., 2013; Kanatsu-Shinohara et al., 2011; Ryu et al., 2005; Kubota et al., 
2004). Gonocytes are believed to retain their self-renewal potential in long-term cultures, and are 
known to form various characteristic colonies, which increase in size and density over time (Lee 
et al., 2013; Borjigin et al., 2011; Goel et al., 2007; Kuijk et al., 2009; Hasthorpe et al., 1999; van 
Dissel-Emiliani et al.,1993). 
Studies on gonocytes have predominantly used rodent models (Orwig et al., 2002; van den Ham et 
al., 1997; van Dissel-Emiliani et al., 1993; McGuinness and Orth, 1992); however, the growing 
evidence for the potential application of gonocytes in the preservation of male fertility from young 
individuals has promoted further studies using large animal models (Kim et al., 2014; Borjigin et 
al., 2011) and humans (Tu et al., 2007; Wu et al., 2009; Altman et al., 2014). Despite recent 
advances in the study of gonocytes, there is a lack of efficient and reproducible systems to culture 
and propagate gonocytes from non-rodent animal models. Development of such models is critical 
for understanding the cellular and molecular signature of gonocytes and for using their potential. 
The pig is an important non-rodent animal model for biomedical research. Recently, we studied a 
number of factors affecting testis cell cultures and introduced an optimized system for short-term 
maintenance and propagation of neonatal porcine gonocytes (Awang-Junaidi and Honaramooz, 
2018). This culture system allowed the optimal growth of neonatal porcine gonocytes and resulted 
in significant increases in the number of gonocyte colonies after 7 days of culture. The objective 
of the present study was to investigate the behavior and ultrastructure of neonatal porcine gonocytes 
in a prolonged culture using various imaging modalities. This is an important step in enhancing our 
understanding of the biology of porcine gonocytes and our ability to harness their potential in a 
large animal model.  
4.3 Materials and Methods 
4.3.1 Testis Collection and Preparation 
Testes were collected from ~one-wk-old Yorkshire-cross piglets (n = 40) via aseptic castration, as 
described in more details in Chapter 3.3.1.  
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4.3.2 Isolation of Testicular Cells  
Isolation of testicular cells was performed using a three-step enzymatic digestion method that has 
been established in our laboratory to yield testicular cells of ~40% gonocytes proportion (Yang et 
al., 2010). A more detailed description of the cell isolation procedures was provided in Chapter 
3.3.2.  
4.3.3 Cell Culture 
The resultant piglet testis cells were cultured using the optimized settings and conditions that we 
have recently reported (Awang-Junaidi and Honaramooz, 2018) and described in Chapter 3.3.4. 
Briefly, the cells were cultured in 6 well-plates, at a cell seeding density of 3.0 ´ 105 cells/well in 
3 ml DMEM, supplemented with 10% FBS and 1% antibiotics. The cells were incubated at 37 °C 
with 5% CO2 and 95% humidity (n = 6 replications). The cell culture was monitored twice daily 
using an inverted microscope (Nikon, Eclipse TS100), the media was changed once a week, and 
the cells were maintained for up to 4 wk. To facilitate sampling for fluorescent labeling, a sterile 
coverslip (sized 22×22 mm; catalogue no. 12-540B; Fisher Scientific) coated with 0.1% poly-L-
lysine was placed at the bottom of each well in 6-well plates prior to cell seeding. 
4.3.4 Live-Cell Imaging  
Real-time interactions of the cultured testis cells were periodically assessed throughout the 4-wk 
period using live-cell imaging. For this purpose, the cells were cultured in glass-bottom tissue 
culture dishes (FluoroDish, catalogue no: FD35-100, World Precision Instruments Inc., Sarasota, 
FL, USA) using the same culture conditions as described above. Throughout the study, differential 
interference contrast (DIC) images were taken from ten randomly-selected fields using an inverted 
microscope (IX83, Olympus, Tokyo, Japan), equipped with a 20× objective (Numerical 
Aperture/N.A. = 0.75) and a DP73 camera, every 1 h from Day 0 to Day 3, every 2 h from Day 4 
to Day 7, and every 1 h for 24 h at Days 14, 21, and 28. Live-cell imaging of shorter intervals 
(every 2.5 s) was also performed at a higher magnification using a 100× objective (N.A. = 1.4) at 
three randomly-selected fields for 5 min after completion of each imaging session (i.e., every day 
from Day 1 to Day 7 and after a full day imaging at Days 14, 21, and 28). Throughout live-cell 
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imaging, the cells were maintained at 37 ºC and 5% CO2 in a humidified incubator fitted on the 
microscope stage.  
4.3.5 Fluorescent Labeling 
Fluorescent labeling was performed using a fluorescein isothiocyanate (FITC)-labelled lectin 
Dolichos biflorus agglutinin (DBA; catalogue no. FL1031; Vector Labs, Burlington, ON, Canada) 
to identify gonocytes, anti-UCHL1 (also known as PGP9.5) antibody (mouse monoclonal to 
PGP9.5; catalogue no. ab 8189; Abcam, Toronto, ON, Canada) to validate their germ cell status, 
anti-POU5F1 (also known as OCT4) antibody (rabbit polyclonal to POU5F1; catalogue no. 
ab18976; Abcam, Toronto, ON, Canada) to evaluate their pluripotency, and phalloidin-FITC 
(catalogue no. P5252; Sigma-Aldrich) to visualize actin filaments. Briefly, the coverslips with cell 
smears (fresh after isolation) or with cultured cells (samples retrieved at Days 7, 14, 21, and 28) 
were fixed for 2-3 min in Bouin’s solution (for DBA) or 4% paraformaldehyde solution (for 
POU5F1 and phalloidin). For DBA staining, the samples were rinsed three times with 70% alcohol 
to remove excess Bouin’s, followed by three rinses with DPBS. For POU5F1, UCHL1, and 
phalloidin fluorescent labeling, the samples were permeabilized three times with 0.1% Triton X-
100 (Omnipur; catalogue no. 9400; EMD Chemical Inc, Gibbstown, NJ, USA) in DPBS for 3 min. 
All samples were blocked with 5% bovine serum albumin (BSA; catalogue no. 2452C055; 
Amresco, Solon, OH, USA) at 37 °C for 30 min in a humidified chamber, incubated with primary 
antibodies (1:100 for both DBA, UCHL1, and POU5F1 at 4 °C overnight, and 1:250 for phalloidin 
at room temperature for 45 min), and washed three times with DPBS. The UCHL1 and POU5F1 
immunostaining were further continued by incubation for 1 h at room temperature with Alexa Fluor 
488-conjugated donkey anti-mouse IgG (1:200, catalogue number ab150109; Abcam) and Alexa 
Fluor 594-conjugated goat anti-rabbit IgG (1:500; catalogue no. ab150088; Abcam). All samples 
were rinsed again with DPBS and mounted using hard-set antifade mounting media containing 
DAPI (Vectashield; catalogue no. H-1500; Vector Labs) prior to microscopic evaluation. DAPI, 
FITC, and Alexa 594 were imaged sequentially using an inverted microscope with 20 and 40× 
(N.A. = 0.95) objectives, with a DAPI filter set (catalogue no. 49000; Chroma, Bellows Falls, VT, 
USA; excitation 350 nm/50 nm and emission 460 nm/50 nm), a FITC filter set (catalogue no. 
49002; Chroma, excitation 470 nm/40 nm and emission 525 nm/50 nm), and a Texas Red filter set 
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(catalogue no. 49008; Chroma, excitation 560 nm/40 nm and emission 630 nm/75 nm), 
respectively. 
4.3.6 RNA Extraction and Reverse Transcription Polymerase Chain Reaction (RT-PCR) 
Total RNA was extracted and cDNA synthesized from neonatal pig testis cells as freshly-isolated 
and as cultured cells at Days 7, 14, 21, and 28 using the Invitrogen TM RNAqueous Micro Total 
Isolation Kit (catalogue no. AM1931; Fisher Scientific, Vilnius, Lithuania) and qScript TM XLT 
cDNA Supermix (catalogue no. CA10142-784; Quanta Biosciences, Gaithersburg, MD, USA) 
according to the manufacturer instructions. Nucleotides 719 to 918 of the POU5F1 (OCT4) coding 
region were amplified using Phusion® High-Fidelity DNA polymerase (catalogue no. M0530S; 
New England Biolabs Inc, Ipswich, MA, USA). The forward and reverse primers for the 
amplification were 5’-AGA GAA AGC GGA CAA GTA-3’ and 5’-ATC CTC TCG TTG CGA 
ATA-3’, respectively. The amplified PCR products were confirmed by sequencing and running 
through agarose gel electrophoresis for visualization. The freshly isolated cells were used as a 
reference, cultured porcine mesenchymal stem cells as the positive control, and no template as the 
negative control. 
4.3.7 Scanning Electron Microscopy  
Scanning electron microscopy (SEM) was performed on the cultured cells at Days 7, 14, 21, and 
28. The cells were fixed by immersion in 3% glutaraldehyde (catalogue no. 014; Canemco, Gore, 
QC, Canada) in 0.1 M sodium cacodylate buffer, pH 7.2 (NaCAC; catalogue no. C0215; Sigma-
Aldrich) for 1.5 h, followed by three rinses with the same buffer. The samples were kept at 4 °C 
until further processing. The samples were post-fixed with 1% osmium tetroxide (catalogue no. 
19110; Electron Microscopy Sciences, Hatfield, PA, USA) for 10 min followed by three rinses 
with distilled water. Dehydration was performed in a series of gradient ethanol (once in 30, 50, 70, 
80, 90, 95%, and twice in 100%) for 10-15 min in each step. Later, the samples underwent 
substitution process by immersion in gradually increasing concentrations of amyl acetate 
(catalogue no. 3-9094; J.T Baker Chemical Co., Philipsburg, NJ, USA) (once in 25, 50, 75%, and 
twice in 100% amyl acetate) for 15 min in each solution. The samples then underwent critical point 
drying (Polaron E3000, Quorum Technologies, Lewes, UK), sputter-coating with gold (Edwards 
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S150B; BOC Edwards, UK), and observation under a scanning electron microscope (SU8010; 
Hitachi, Tokyo, Japan). 
4.3.8 Transmission Electron Microscopy 
For transmission electron microscopy (TEM), the cultured cells were fixed at Days 7, 14, 21, and 
28 with cold (4 °C) 2% glutaraldehyde in 0.1 M sodium cacodylate buffer (pH 7.2) for 3 h, 
immersed in 0.1 M sodium cacodylate buffer, and stored at 4 °C overnight. Post-fixation was 
carried out by immersion in 1% osmium tetroxide for 1 h at room temperature, followed by a rinse 
with distilled water. The cells were then dehydrated in a series of gradient ethanol (50, 70, 95, and 
100%, 15 min at each step), immersed in two changes of absolute ethanol, and LR White resin mix 
(1:1 and 1:2) for 1 h, respectively, and finally in 100% resin for 2 h. The samples were sealed and 
polymerized at 65 °C overnight. The polymerized samples were broken down into small pieces, 
blocked and sectioned at 100 nm using a Leica Ultracut UCT, and viewed under a transmission 
electron microscope (HT7700; Hitachi) at accelerating voltage of 80Kv.  
4.3.9 Morphometric Evaluations  
Morphometric analyses were performed on samples taken at Days 7, 14, 21, and 28 (n = 4 
replications). For each replicate, ten randomly-selected fields were imaged at 100, 200, and 400´ 
and evaluated using the cellSens imaging software (Olympus, Pittsburgh, PA, USA). 
Quantification of gonocytes was performed by counting the number of gonocytes at 200´ in five 
randomly-selected fields. The average diameters (X and Y axes) of at least 150 gonocytes were 
assessed at 400´ in each of four randomly-selected fields (i.e., n = >600 gonocytes). The number 
of EBLC and their average diameters were assessed at 100´ in ten randomly-selected fields. The 
number of gonocytes and EBLC were expressed per cm2.  
4.3.10 Statistical Analyses 
All numerical data were analyzed using one-way analysis of variance (ANOVA), followed by 
Tukey’s HSD as the post-hoc test. The data are presented as mean ± standard error of mean (SEM) 
and the level of significance was set at P < 0.05. Data were analyzed using the SPSS (Version 22.0, 
SPSS Inc., Armonk, NY, USA). 
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4.4 Results 
4.4.1 Organization of Neonatal Porcine Testis Cells in Culture 
Neonatal porcine testis cells were monitored during culture using live-cell imaging and 
conventional phase-contrast microscopy. Based on the morphology and organization, we 
categorized the growth and development of the cultured cells into three main stages, (a) formation 
of a somatic-cell monolayer, (b) establishment of gonocyte colonies, (c) and development of 
embryoid body-like colonies (EBLC).  
4.4.1.1 Formation of Somatic-cell Monolayer 
At seeding, the cells were composed of ~60% somatic cells. Within the first 7 days of culture, 
somatic cells contributed to the formation of a somatic-cell monolayer. Briefly, in the first 12 h 
after seeding, all cells appeared rounded and remained floating in the media (Fig. 4.1A and Video 
1, Appendix A). Shortly after 24 h of incubation, small numbers of cells began to settle and adhere 
to the bottom of the plate. These settling somatic cells (identified based on morphology and later 
by DBA staining exclusion) flatten down and established cytoplasmic projections, forming 
irregular-shaped cells (Fig. 4.1B). Over time, more somatic cells settled, expanded, and formed 
contacts with other cells, leading to the formation of clumps within 48-52 h of incubation (Fig. 
4.1C). These somatic cell clumps later spread further, formed a large somatic-cell monolayer, and 
reached 70-80% confluency at ~4-5 days post-seeding. Upon confluency, the morphology of 
somatic cells transformed from irregular with multiple cytoplasmic projections to fibroblast-like 
spindle-shaped (Fig. 4.1D). In addition, starting as early as Day 5 of culture, some somatic cells 
formed circular arrangements (Fig. 4.1D-E). Over time, these circular arrangements became more 
prominent, increased in diameter, and appeared to be a preferred site for gonocytes and their 
colonies (Fig. 4.1G-I).  
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Fig. 4.1. Representative images showing the organization of neonatal porcine testis cells in culture 
over time. (A) A single-cell suspension of testis cells immediately after seeding. (B-D) Somatic 
cells quickly settled and adhered to the plate and then gradually expanded their cytoplasmic 
projections, forming a somatic-cell monolayer and becoming confluent. (E) Gonocytes (white 
arrows) settled on top of the somatic-cell monolayer, and (E-I) their numbers increased over time 
to form gonocyte colonies. (D-F) Note the organization of somatic cells into circular arrangements 
(CAs, some denoted by dotted circles). (F-I) The CAs appeared to be preferred sites for gonocyte 
cluster- and colony formations. (G) As the number of gonocytes in the culture increased, morula-
like colonies were formed (m). (H) A morula-like colony has transformed into an embryoid body-
like colony (EBLC, black arrow). (I) Multiple EBLC, each within a CA, are seen surrounded by 
many migrating gonocytes. (Scale bar: 50 µm (A-H) and 100 µm (I))  
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 4.4.1.2 Establishment of Gonocyte Colonies 
While the population of somatic cells started settling as early as 24 h post-seeding, gonocytes 
continued to float and settled down after the somatic-cell clumps or monolayer had been 
established. Over time, as more gonocytes settled on the somatic-cell monolayer, the number of 
floating gonocytes in the media decreased (P < 0.001; Day 2: 6.94 ± 0.3 ´ 104 gonocytes/well with 
84.1% ± 1.2 viability; Day 3: 3.75 ± 0.4 104 gonocytes/well with 72.5% ± 2.0 viability; Day 6: 1.9 
± 0.1 ´ 104 gonocytes/well with 69.3% ± 1.5 viability; n = 5 replications). When live cell imaging 
was performed, an active amoeboid-like movement of gonocytes assisted by their extensive 
cytoplasm projections was evident (Fig. 4.2 and Video 2, Appendix A).  
Once gonocytes started settling down within 48 h post-seeding, they formed loose attachments to 
the somatic-cell clumps and later to the somatic-cell monolayer. Morphology of the settled 
gonocytes changed over time. Gonocytes began losing their distinctive round shape (seen after 
isolation and for several hours after seeding) and started forming pseudopod-like cytoplasmic 
extensions. Some gonocytes, especially those that remained floating and/or failed to attach to 
somatic cells maintained their round morphology. Shortly after settling, gonocytes were present as 
singles or pairs (Fig. 4.3A), and after ~5-7 days started to also form grape-like clusters (Fig. 4.3B). 
During Wk 2 of culture, the grape-like clusters became more prevalent, and beginning at Wk 3, the 
number and diameter of grape-like clusters increased, and some clusters transformed into large 
morula-like colonies (Fig. 4.3C), and gradually into larger dome-shaped masses, which we termed 
embryoid body-like colonies (EBLC) (Fig. 4.3D). Using live-cell imaging, we documented the 
active process of gonocyte colony formation in real-time (Video 3, Appendix A). We observed that 
some gonocytes migrated toward others, forming a cluster of gonocytes, which gradually grew in 
size and led to the formation of larger colonies. There seemed to be a tendency for gonocytes to 
migrate to the center of circular arrangements formed by the somatic-cell monolayer, where they 
formed gonocyte clusters and colonies.  
4.4.1.3 Development of Embryoid Body-Like Colonies 
The transformation from morula-like colonies to EBLC was more noticeable beginning at 3 wk of 
culture. EBLC were characterized as large round colonies with a dome-shaped appearance and 
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extensive cytoplasmic projections (Fig. 4.3D-F). Under phase-contrast microscopy, EBLC 
exhibited a light brown appearance, which was different from the bright appearance of the earlier 
stage colonies and clusters. Migration of the surrounding single gonocytes towards the EBLC 
resulted in their joining the colony to form a multinucleated core in the EBLC (Fig. 4.3D-F). These 
large colonies also possessed extensive cytoplasmic projections with pulsatile outward and inward 
movements. The real-time live-cell observations suggested that the formation of EBLC occurs via 
a cell fusion process, where the migrating gonocytes approach the margin of EBLC and either 
anchor their cytoplasmic projections to EBLC or become entrapped by the extensive EBLC 
cytoplasmic projections (Fig. 4.3E).   
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Fig. 4.2. Representative serial images, taken every 30 seconds (sec), from a single porcine gonocyte 
in culture. Sequential images depict the active movement of the cytoplasmic extensions and the 
changes in shape of the gonocyte over time. (Scale bar: 2 µm).  
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Fig. 4.3. Higher magnification images of neonatal porcine gonocytes in culture showing the 
transition to form an embryoid body-like colony (EBLC). (A) Gonocytes settled on the somatic-
cell monolayer as singles (s) or pairs (p). (B) Gonocytes later formed grape-like clusters. (C) The 
number of gonocytes within a cluster increased over time and some formed morula-like colonies 
(m). (D) After ~14 d of culture, EBCLs (eblc) started to be formed. Note the presence of extensive 
cytoplasmic projections (black arrows) out of the EBLC which seemed to assist with their 
movement and attachment of migrating gonocytes. (E) Cytoplasmic fusion (*) of adjacent 
gonocytes seemed to transform a morula-like colony into an EBLC. (F) Continued fusion of 
additional migrating gonocytes (mg) increased the mass of the EBLC. (Scale bar: 20 µm).  
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4.4.2 Morphometric Evaluations 
The data on the number and diameter of individual gonocytes throughout the study are summarized 
in Figure 4. The number of gonocytes increased over time in culture (P < 0.001, n = 4 replications) 
(Fig. 4.4A). Compared with Day 7 after incubation (1.38 ± 0.22 ´ 104 gonocytes/cm2), the number 
of gonocytes increased 5.3 fold at Day 14 (7.32 ± 0.55 ´ 104 gonocytes/cm2), 7.9 fold at Day 21 
(10.99 ± 0.93 ´ 104 gonocytes/cm2), and 8.5 fold at Day 28 (11.74 ± 0.64 ´ 104 gonocytes/cm2). 
The size of individual gonocytes also increased over time in culture (P < 0.001, Fig. 4.4B). The 
average diameter of gonocytes was 13.37 ± 0.11 µm at Day 7 (ranged 10.19-19.08 µm), 14.10 ± 
0.13 µm at Day 14 (ranged 10.29-24.05 µm), 14.36 ± 0.89 µm at Day 21 (ranged 10.88-20.27 µm), 
and 14.53 ± 0.80 µm at Day 28 (ranged 11.41-18.17 µm) (Fig. 4B).  
The data on the number and diameter of EBLC are summarized in Table 4.1. No EBLC were yet 
formed at Day 7 of culture, while both the number and diameter of EBLC increased (P < 0.001, n 
= 4 replications) from Day 14 to Day 21 (P < 0.05), and remained unchanged to Day 28 (end of 
study). Overall, the majority of the EBLC observed at Day 14 were <100 µm in diameter, while 
~70% of the EBLC at Day 21, and ~75% of the EBLC at Day 28 were >100 µm in diameter (Table 
4.1).  
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Fig. 4.4. Changes in the number (A) and diameter (B) of cultured porcine gonocytes over time. 
The data are presented as mean ± SEM. In each graph, columns with different letters differ 
significantly over time (P < 0.05).  
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Table 4.1. Changes in the number and diameter of embryoid body-like colonies (EBLC) over time.  
 
Time 
Number of 
EBLC/cm2 
Diameter 
(µm) 
Diameter 
range (µm) 
Percentage of EBLC in each diameter category (%) 
≤ 99 100 –149 150 –199 ≥ 200 
Day 14 273 ± 13.6a 96 ± 1.7a 59 – 167 58 ± 5.6 41 ± 5.4 0.1 ± 0.0 – 
Day 21 403 ± 10.1b 127 ± 2.4b 53 – 237 31 ± 3.5 41 ± 3.3 21 ± 2.6 7 ± 2.2 
Day 28 413 ± 9.2b 131 ± 2.5b 58 – 236 26 ± 2.7 43 ± 1.7 25 ± 1.1 6 ± 0.6 
 
Data are mean ± SEM.  
EBLC had not yet been formed at 7 d post-seeding; therefore, no data are shown for Day 7.  
ab Within the columns for number of EBLC and diameter, values with different superscripts differ 
significantly (P < 0.05). n = 4 replications.   
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4.4.3 Fluorescent Labeling 
Gonocytes were identified using FITC-conjugated DBA staining as shown in Figure 5A-D. DBA-
labeled gonocytes were consistently observed for the duration of the study (4 wk). DBA stained 
the surface and to some degree the cytoplasm of gonocytes. Expression of POU5F1 (OCT4) as a 
pluripotency marker was also detected for the duration of the study in both nuclear and cytoplasmic 
compartments of gonocytes (Fig. 4.5E-H). Gonocytes and EBLC also stained positive with 
phalloidin fluorescent labeling, localized in the cytoplasm (cytoplasmic projections), indicating the 
presence of actin filaments (F-actin) cytoskeleton (Fig. 4.5I-L). 
4.4.4 PCR Analysis  
The expression of POU5F1 was observed in the porcine neonatal testis cells cultured at Days 7, 14, 
21, and 28, but was absent in the freshly isolated cells (Fig. 4.6). The amplified region of POU5F1 
also showed expression in the cultured porcine mesenchymal stem cells (as a positive control). In 
addition to the analysis by gel electrophoresis, amplicons were confirmed by sequencing.   
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Fig. 4.5. Fluorescent labeling of embryoid body-like colonies (EBLC) formed in the cultures of 
neonatal porcine testis cells. (A-D) Fluorescent labeling using Dolichos biflorus agglutinin (DBA), 
as a gonocyte marker. (E-H) Fluorescent labeling using UCHL1, as a germline stem cell marker. 
(I-L) Fluorescent labeling using POU5F1, as a pluripotency marker. (M-P) Identification of actin 
filaments (F-actin) in cytoplasmic projections (lamellipodia) of an EBLC using phalloidin 
fluorescent labeling. (A, E, I, M) Differential interference contrast (DIC) images. (B, F, J, N) DAPI-
stained nuclei of the cells appear blue under the fluorescence microscope. (C, G, K, O) Fluorescein-
conjugated DBA-positive gonocytes and fluorescein-conjugated phalloidin-positive F-actin appear 
green. (D, H, L) Merged images (Scale bar: 20 µm).  
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Fig. 4.6. Expression of the pluripotency marker POU5F1 (OCT-4) in cultured porcine testis cells. 
M: 100 bp molecular-weight marker; Lane 1: DNA samples from cultured porcine mesenchymal 
stem cells (positive control); Lane 2: DNA samples from freshly isolated porcine neonatal testis 
cells obtained after a 3-step enzymatic digestion (containing ~40% gonocytes); Lane 3 to 6; DNA 
samples from porcine neonatal testis cells cultured for 7, 14, 21, and 28 days, respectively; 7 no 
template control (negative control). 
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4.4.5 Ultrastructure of Gonocyte Colonies 
SEM and TEM of cultured cells were performed on samples taken at weekly intervals and the 
results were as follows:  
4.4.5.1 SEM 
Figure 6 contains representative SEM images that show in more detail the circular arrangements 
formed by somatic cells and provides visualization of the 3-dimensional (3-D) structure of different 
formations of gonocyte clusters and colonies. Individual gonocytes varied in shape from rounded 
to flattened (Fig. 4.7B). Round gonocytes that lacked cytoplasmic projections under live-cell 
imaging had a smooth surface under SEM. More importantly, SEM images showed the various 
forms of cytoplasmic projections of individual gonocytes, clusters, morula-like colonies, and 
EBLC. These cytoplasmic projections could be categorized into spike-like filopodia, leaf-like 
lamellipodia, membrane ruffles, and cytoplasmic blebs (Fig. 4.7B). However, as the colonies 
turned into EBLC, lamellipodia appeared as the most prevalent cytoplasmic projection (Fig. 4.7E). 
Higher magnification of the marginal areas where single gonocytes were closely attached to the 
EBLC showed extensive finger-like projections (Fig. 4.7G-H).  
4.4.5.2 TEM 
Representative TEM images of the cultured testis cells are shown in Figure 4.8. Gonocytes 
contained a prominent nucleus with euchromatin and heterochromatin; the latter mainly 
concentrated near the nuclear membrane. While the spongy-like nucleolus showed no defined 
membranes, the nuclear membrane was prominent with its double-layered structure (inner and 
outer membranes, separated by the perinuclear space) and nuclear pores (Fig. 4.8B). The nuclei of 
gonocytes were frequently observed in close proximity to their attachment to the somatic-cell 
monolayer. Where gonocytes were apposed to the somatic-cell monolayer, a certain gap was 
maintained (Fig. 4.8F). Closer examination of the cytoplasmic projections showed no evidence of 
microtubules. The organelle complexity of gonocytes seemed to increase over time. In Wk 1 
samples, where gonocytes were mostly present as single cells, the organelles consisted mainly of 
mitochondria and rough endoplasmic reticulum (Fig. 4.8A). In samples from the following weeks 
when gonocytes established contacts with each other, increasing numbers of the Golgi apparatus 
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with vesicles, vacuole-like structures, and secretory granules were also observed, creating a dense 
cytoplasm (Fig. 4.8C-D). TEM examination of the EBLC cross-sections also validated the 
multinucleated nature of EBLC, presumed from live-cell imaging and immunostaining (Fig. 4.8E).  
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Fig. 4.7. Representative scanning electron microscopy (SEM) images of neonatal porcine 
gonocytes in culture showing the formation of embryoid body-like colonies (EBLC). (A) 
Gonocytes (few highlighted in a dotted circle) seen on top of the somatic-cell monolayer. (B) 
Within the first week after cell seeding, gonocytes were present as singles (s) or pairs (p) on the 
somatic-cell monolayer (sm). At this magnification, gonocyte cytoplasmic projections could be 
differentiated into spike-like filopodia (fp), leaf-like lamellipodia (lp), membrane ruffles (rf), and 
cytoplasmic blebs (bl). (C) Some migrating gonocytes (mg) formed a cluster and (D) their 
continued increase in numbers formed a morula-like colony (m). (E) Over time, the morula-like 
colonies transformed into EBLC (eblc). (C-F) Gonocytes and their colonies were primarily seen 
within circular arrangements (white arrows) formed by the somatic-cell monolayer. (F) A few 
individual gonocytes with various types of cytoplasmic projections are shown next to an EBLC 
with only lamellipodia. (G-H) Higher magnification images of the interface where individual 
gonocytes are fused with an EBLC show numerous and extensive finger-like projections (Scale 
bar: 100 µm (A) and 10µm (B-H)).  
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Fig. 4.8. Representative transmission electron microscopy (TEM) images of neonatal porcine 
gonocytes in culture. (A) Cross-section of a gonocyte (g) shown on top of a somatic-cell monolayer 
(sm). (B) A gonocyte at a higher magnification with extensive cytoplasmic projections (cp) and 
lysosomes (arrows). Also note the euchromatic and heterochromatic zones of the nucleus (N). 
(A,B) Organelles such as mitochondria (mt) and rough endoplasmic reticulum (ReR) are evident. 
(C) After 2 wk of culture, the number and density of cytoplasmic organelles in gonocytes were 
increased. The spongy appearance of the nucleolus (nu) is also shown. (D) Also shown are the 
cross-section of two adjacent gonocytes in a morula-like colony, and (E) cross-section of an 
embryoid body-like colony showing multiple nuclei (N) and the absence of a distinct border 
separating gonocytes. Numerous secretory granules (sg) are also observed. (F) Higher 
magnification of the interface between a gonocyte and the somatic-cell monolayer (thick arrows) 
shows a constant gap is maintained (Scale bar: 2 µm).  
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4.5 Discussion 
Porcine testis cells have been cultured using various short-term and long-term systems that have 
mainly focused on their maintenance and propagation (Goel et al., 2007; Han et al., 2009; Lee et 
al., 2013; Zheng et al., 2014; Awang-Junaidi and Honaramooz 2018). To our knowledge, the 
present study is the first report on the behavior of cultured porcine testis cells using live-cell 
imaging. This is also the first study reporting on the ultrastructure of porcine gonocytes and their 
colonies. Previous studies on the ultrastructure of testis cells were conducted on tissue samples 
(Baillie 1964; Gondos and Hobel 1971; Tiptanavattana et al., 2015). In a recent study, we examined 
a number of factors that could affect the maintenance, proliferation, and colony formation of 
porcine gonocytes in a short-term culture (i.e., 7 days). The examined factors included the effects 
of using different cell densities, gonocyte proportions, incubation temperatures, sampling effects, 
and media changing regimens. We concluded that seeding of 3.0 × 104/cm2 of neonatal porcine 
testis cells, containing ~40% gonocytes, culturing at 37 °C, and without changing the media in the 
first week, can result in improved colony formation of porcine gonocytes (Awang-Junaidi and 
Honaramooz 2018). Therefore, these optimized culture conditions for short-term culture were also 
used in the present study for a prolonged culture.  
In the present study, gonocytes proliferated and formed clusters and colonies, including EBLC; the 
number of gonocytes increased ~8.5 fold between Days 7 and 28. This fold increase, in fact, 
underestimates the total increases in gonocyte numbers because our counting was based on a fixed 
focal plane immediately above the somatic-cell monolayer and, therefore, excluded gonocytes that 
formed the bulk of EBLC and gonocytes floating in different focal planes. The importance of 
gonocyte proliferation and EBLC formation in the present study is highlighted when considering 
that the culture media was basic; comprising only of DMEM+10% FBS, without additional growth 
factors or hormones. FBS-enriched media alone was deemed sufficient in allowing rat gonocytes 
to initiate growth (Hasthorpe et al., 1999; Hasthorpe et al., 2000). However, the formation of ES-
like cells and/or colonies from the neonatal and/or adult testes of mice, humans, and pigs required 
stem cell-specific media or supplementation with various growth factors (e.g., LIF, GDNF), which 
carry safety concerns over their use in potential cell replacement therapies (reviewed in Goel and 
Imai 2011; Hermann and Orwig 2011). 
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Gonocytes are considered non-adherent to glass or plastic, making their culture as a pure population 
a challenge (van Dissel-Emiliani et al., 1993), requiring co-culture with supporting/feeder cells to 
improve survival and proliferation (De Miguel et al., 1996; McGuinness and Orth 1992; van Dissel-
Emiliani et al., 1993). In the present study, the population of testis cells at seeding contained ~60% 
somatic cells, which led to the establishment of a somatic-cell monolayer acting as feeder cells to 
support proliferation and colony formation of gonocytes. Our results, therefore, differ from studies 
using the rat model that concluded the somatic-cell underlay had no enhancing effects or even had 
inhibitory effects on gonocyte colony formation (Hasthorpe et al., 2000; Hasthorpe 2003; Orth and 
Boehm 1990).  
Sertoli cells promote in vitro survival of gonocytes by establishing specific contacts with 
gonocytes, even in the presence of other testis somatic cells (van Dissel-Emiliani et al., 1993). Rat 
Sertoli cells were reported to became senescent after 20-24 days in culture (Buzzard et al., 2002). 
In the present study, the cultured testis cells were not passaged, and somatic cells were allowed to 
continue growing, forming a monolayer which became confluent in about a week, after which time 
their growth slowed. Not having to passage the cells was convenient and avoided disruption of 
gonocyte colony formation or their potential loss during passaging. Co-culturing gonocytes with 
their somatic cell counterparts (from the same donor) can be advantageous in preventing cross-
contamination with xenogeneic cells, pathogens, or metabolites, which may arise from the use of 
established feeder cell lines (frequently originating from other species such as mice; Llames et al., 
2015). 
We observed the formation of circular arrangements by the somatic-cell monolayer, which 
commonly coincided with gonocyte colony formations. A similar arrangement has been described 
when enriched populations of rat Sertoli cells were cultured on extracellular matrix-containing gels, 
indicating that it was driven by interactions amongst Sertoli cells (Hadley et al., 1985). However, 
to our knowledge, Sertoli cell circular arrangements becoming a preferred site for gonocytes 
colonies in vitro has not been described. We have previously reported that when neonatal testis cell 
suspensions were implanted under the back skin of immunodeficient mice, they showed an 
unexpected ability to regenerate functional testis tissue de novo. Within a few days after 
implantation, extensive cellular rearrangements were evident, and by the second week post- 
implantation, seminiferous cords were fully formed and housed gonocytes in their center. 
  109 
Continued development of the implanted cells eventually led to the formation of a regenerated 
testis tissue capable of producing androgens, differentiating germ cells, and even spermatozoa 
(Arregui et al., 2008; Honaramooz et al., 2007). Therefore, it may be postulated that the observed 
somatic cell circular arrangements in the present study were formed as a result of an innate 
tendency of testis somatic cells to organize themselves in such a way to enclose gonocytes. While 
an in vivo culture system allows the implanted cells to move more freely to form 3-D seminiferous 
cords, the in vitro culture system is understandably more limited to 2-D formations.  
In the present study, in addition to gonocytes typically showing cytoplasmic projections 
(pseudopodia), we observed a smaller population of gonocytes that lacked cytoplasmic projections 
and displayed a round shape with a smooth surface. The morphology of gonocytes has been related 
to their potential fate in the spermatogenic lineage. When rat gonocytes with or without 
pseudopodia were transplanted into the testes of infertile recipient mice, only the gonocytes with 
pseudopodia had the competency to initiate donor-derived colonies of spermatogenesis (Orwig et 
al., 2002). In the developing testis, gonocytes migrate from the center to the periphery of the 
seminiferous cords, via amoeboid movements and this migratory event is believed to be crucial for 
gonocyte survival, since their failure to move to the periphery results in apoptosis (McGuinness 
and Orth 1992; Nagano et al., 2000; Orwig et al., 2002). Therefore, in the present study, gonocytes 
with pseudopodia that were observed to be motile and later developed other cytoplasmic 
projections may represent the functional population of gonocytes, while those lacking pseudopodia 
likely represent the apoptotic or dead gonocytes. This conclusion also highlights the importance of 
the present study in examining gonocyte cytoplasmic projections and migratory behavior. 
In the present study, we also documented that cytoplasmic projections assisted gonocytes in their 
movement/migration, and later contributed to their formation of colonies. Our phalloidin 
fluorescent labeling confirmed that these cytoplasmic projections were composed of a dense and 
dynamic actin meshwork. Polymerization (via ATP hydrolysis) of the actin meshwork has been 
shown to induce protrusions (continuous growth of actin filaments) towards the leading edge, 
which along with retraction of the rear end, results in cell movement (Korn et al., 1987; 
Lauffenburger and Horwitz 1996). Our TEM observations revealed the presence of a constant gap 
at the interface between the basolateral membrane of gonocytes and the somatic-cell monolayer. 
The continuous movement of gonocytes on top of the somatic-cell monolayer, documented by our 
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real-time imaging of live cultured cells, may explain the need for such a constant gap between 
gonocytes and somatic cells.  
In the present study, gonocytes proliferated to form clusters, morulae-like colonies, and EBLC. 
The formation of germ cell colonies by cultured testis cells has been reported for different species 
(Goel et al., 2007; Kuijk et al., 2009; Hasthorpe et al., 1999; van Dissel-Emiliani et al., 1993; Lee 
et al., 2013), which at times formed 3-D structures that resembled embryoid bodies typical of those 
made by pluripotent embryonic stem (ES) cells when cultured in vitro (Sahare et al 2016; Bratt-
Leal et al., 2009). Given the great therapeutic potential of pluripotent stem cells, extensive research 
is underway mainly using either ES cells or induced pluripotent stem cells (iPSC); although 
significant ethical concerns and carcinogenic risks have limited their clinical application. This 
further highlights the importance of research on MGSC, including gonocytes, as a potential 
alternative source of multipotent stem cells. 
Using fluorescent labeling and RT-PCR, we confirmed that EBLC maintained both their primitive 
germ cell status (positive for DBA and UCHL1, a gonocyte marker) and stem cell characteristics 
(expressed POU5F/OCT4, a pluripotency marker). This is an important finding because unlike in 
all previous studies, the EBLC in our study were spontaneously formed in a simple media. 
Therefore, our results are also of interest for the field of therapeutic potential of pluripotent stem 
cells. This is because the use of additional growth factors in culture of these cells can carry 
carcinogenic risks which would limit their clinical application. The exact mechanism of EBLC 
formation in the present study is not clear. The formation of embryoid bodies has been shown to 
occur via cell-to-cell adhesion receptors, involving hemophilic binding of E-cadherin, which is 
highly expressed in undifferentiated embryonic stem cells (Dang et al., 2004; Dasgupta et al., 2005; 
Fok and Zandstra 2005; Kurosawa 2007; Park et al., 2003). This mechanism may explain our live-
cell observations in which gonocytes established contacts with each other, leading to their 
aggregation and creating a center for attraction of more gonocytes to form larger colonies and 
ultimately EBLC.  
In the present study, POU5F1 (OCT4) expression was observed in all weekly samples of cultured 
cells, but was absent in the freshly isolated cells, consistent with a previous report using neonatal 
pig testis cells (Goel et al., 2008). In humans, downregulation of POU5F1 during the fetal to 
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neonatal transition has been associated with differentiation of gonocytes into more advanced germ 
cell stages (Rajpert-De Meyts et al., 2004). On the other hands, POU5F1 expression in PGP9.5-
positive cultured neonatal porcine gonocytes (from 5-day old donors) and in more advanced 
spermatogonia (from 10 wk old donors) suggested that POU5F1 is upregulated in the culture 
environment (Lee et al., 2013; Luo et al., 2006). The expression of POU5F1 is deemed crucial for 
the survival, self-renewal, and pluripotency of male germline stem cells in vitro, as shown in studies 
involving mouse spermatogonia (Pesce et al., 1993; Dann et al., 2008). Transplantation of cultured 
porcine gonocytes expressing POU5F1, as well as other stem cell markers such as NANOG, PLZF, 
and THY1 into the testes of immunodeficient recipient mice has been shown to result in successful 
colonization at the basement membrane of the seminiferous tubules (Lee et al., 2013). The ability 
to induce functional pluripotent male germline stem cells in vitro would have important cell-based 
therapy applications.  
In the present study, using live-cell imaging and TEM, we also found that gonocyte-derived EBLC 
are multinucleated structures, where multiple gonocytes share a cytoplasm. There are no closely 
related comparable observations to compare with our results. In human testis tissue, the presence 
of multinucleated germ cells (e.g., spermatogonia and spermatocytes), occurring via cell-to-cell 
fusion has been associated with senescent of seminiferous tubule epithelium or pathological 
conditions (Miething 1993; 1995). These multinucleated germ cells usually degenerate, in contrast 
to EBLC in our culture which demonstrated increased diameters to 4 wk (end of study).  
In the present study, we also found that over time gonocytes increased in size and underwent 
complex transformations at the subcellular levels. There are no published reports on the size of 
gonocytes in culture to compare with our observations. Increases in cell volume and size in vitro 
have been associated with aging (Cristofalo and Kritchevsky 1969; Schneider and Fowlkes 1976; 
Schneider and Mitsui 1976; Yang et al., 2011). Aging cells have a low proliferative capability, and 
large size cells have been shown to have a shorter lifespan (Bowman et al., 1975; Zadrag-Tecza et 
al., 2009). However, all of these conclusions are derived from studies involving mammalian 
somatic cells, mostly fibroblasts. Stem cells are known to be capable of long-term and sustained 
self-renewal. Gonocytes have been successfully maintained and propagated in long-term culture 
(3-5 months) in an enriched system (Kanatsu-Shinohara et al., 2003; Jeong et al., 2003). 
Considering that gonocytes in the present study were kept for only 4 wk and were mitotically active, 
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these morphological transformations are unlikely to be indicative of aging or degenerative changes. 
We also speculate that the increased size of gonocytes was likely due to their tendency to elongate, 
flatten, and spread their cytoplasm during migration. 
4.6 Conclusions 
In conclusion, live-cell imaging allowed non-invasive monitoring of neonatal porcine testis cells 
in vitro. Gonocytes migrated freely atop the somatic-cell monolayer, assisted by the presence of 
various cytoplasmic projection, delineated through SEM imaging. Gonocytes gradually established 
clusters and colonies, which increased in size and complexity over time, and some transformed into 
EBLC where a number of gonocytes shared a cytoplasm. These observations demonstrated 
remarkable migratory behavior and colony formation of neonatal porcine gonocytes in culture.  
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TRANSITION 
The results of live-cell imaging and electron microscopy in Chapter 4 allowed detailed study of 
neonatal porcine gonocytes and their colony-formation patterns in an in vitro culture system. 
Having addressed our primary objectives related to the study of testis cells in vitro in Chapters 3 
and 4, we designed the experiments in Chapter 5 to expand our study of testis cells by examining 
their potential for de novo formation of testis tissue after implantation in recipient mice, as an in 
vivo culture system.  
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CHAPTER 5 
EFFECTS OF MULTIPLE FACTORS ON REGENERATION OF TESTIS TISSUE 
AFTER ECTOPIC IMPLANTATION OF PORCINE TESTIS CELL AGGREGATES IN 
MICE: IMPROVED OUTCOMES CONSISTENCY AND IN SITU MONITORING 5, 6 
5.1 Abstract 
Ectopic implantation of donor testis cell aggregates in recipient mice results in de novo 
formation/regeneration of testis tissue, and as such provides a unique in vivo model for the study 
of testis development. However, the results are inconsistent, and the efficiency of the model 
remains low. This study was designed to 1) examine several factors that can potentially improve 
the consistency and efficiency of this model, and 2) explore the use of ultrasound biomicroscopy 
(UBM) for the non-invasive in vivo evaluation of implants. Testis cell aggregates, containing ~40% 
gonocytes from 1-wk old donor piglet, were implanted under the back skin of immunodeficient 
mice through skin incisions and using gel matrices or through subcutaneous injections and without 
using gel matrices. The addition of gel matrices led to inconsistent tissue development, where the 
outcomes were dependent on the gel type; gelatin had the greatest development, followed by 
collagen, and agarose resulted in poor development. The results also depended on the implanted 
cell numbers, where implants with 100 × 106 cells were larger than those with 50 × 106 cells. The 
injection approach for cell implantation was less invasive and resulted in more consistent and 
efficient testis tissue development. UBM provided promising results as a means for non-invasive 
monitoring of implants and prediction of the outcomes, and hence improved the implantation model 
further.  
                                                        
5 The manuscript for this study has been submitted for publication in the Journal of Reproduction, 
Fertility and Development under joint co-authorship with Jaswant Singh and Ali Honaramooz. 
 
6 AHAJ contributed to the conceiving and designing of the study, performed the experiments, and 
wrote the first draft of the manuscript. 
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5.2 Introduction 
Implantation of dissociated neonatal porcine testis cells into immunodeficient mice led to de novo 
formation/regeneration of testis tissue (Honaramooz et al., 2007). The testis cell implantation (TCI) 
procedure involved enzymatic digestion of the neonatal pig testis tissue to obtain single-cell 
suspensions, followed by centrifugation to obtain concentrated cell aggregates for ectopic 
implantation under the back skin of immunodeficient mice. Within 4 d post-TCI, some cells 
displayed organized alignments, which by 7 d formed extensive cellular rearrangements leading to 
the formation of cord-like structures. By 2 wk, the newly formed testis cords resembled the 
seminiferous cords typical of those seen in neonatal pig testes. The extensive rearrangements of 
cells and structures in the regenerated tissue included the usual polarization of Sertoli cells (with 
their nuclei facing the basal membrane of the cords), localization of gonocytes in the center of 
cords, and formation of the interstitial tissue in the intertubular areas. When given enough time, 
the de novo formed testis tissues underwent complete development to result in morphologically 
normal spermatogenesis, at times indistinguishable from age-matched pig testis tissue in situ. These 
regenerated xenogeneic porcine testis tissues were also capable of releasing sufficient androgens 
to restore the vesicular gland weights of the castrated recipient mice to the range of values seen in 
intact mice (Honaramooz et al., 2007).  
The unexpected morphogenic capacity of isolated cells from a postnatal donor to undergo 
autonomous rearrangements to form a structurally- and functionally-complex tissue such as the 
testis tissue is remarkable. Testicular morphogenesis has also been shown to occur using 
dissociated cells from other donor species such as the mouse, sheep, and cattle (Kita et al., 2007, 
Arregui et al., 2008b, Zhang et al., 2008). This unique in vivo culture system provides an ideal 
microenvironment, and an accessible model for the study and manipulation of testis morphogenesis 
and spermatogonial stem cell niche formation (Honaramooz et al., 2007; Dores and Dobrinski 
2014). The TCI model may also be viewed as a unique approach to allow preservation of fertility 
potential of prepubertal boys undergoing gonadotoxic cancer treatments. This, for instance, would 
involve cell sorting to exclude cancerous cells out of isolated testis cells obtained from testis tissue 
biopsies of prepubertal cancer patients, followed by formation of the tissue using in vitro or in vivo 
culture systems.  
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Despites its great potential, the application of TCI model for de novo tissue formation has been 
somewhat limited due to the lack of an optimized protocol to provide more efficient and consistent 
outcomes (Dores and Dobrinski, 2014). For instance, the commonly used testis cell isolation 
techniques (e.g., conventional two-step enzymatic digestion) yield testis cell suspensions of low 
germ cell numbers (e.g., ~7%), resulting in a lack of germ cells in many regenerated seminiferous 
cords/tubules, and hence leading to low spermatogenic efficiency (Honaramooz et al., 2007; Kita 
et al., 2007). In these previous studies, the implantation of dissociated testis cells under the back 
skin of recipient mice required transferring loose cell aggregates/pellets into pockets of 
subcutaneous fascia and closing the incisions with sutures or metal wound clips. The drawbacks of 
this approach included the lack of control over the number of transferred implanted cells (since 
cells could remain attached to the holding vials or transferring probes) and also a tendency of the 
cells to leak out of the skin incisions prior to or after wound closure. The inflammation due to skin 
incisions could also affect the fate of implanted cells and the formation of tissue. Thus, a 
comparison of alternative methods for implantation of cell aggregates was needed to provide more 
consistent and efficient strategies to overcome the aforementioned problems. 
To address some of the limitations associated with low germ cell numbers in the donor cell 
populations, we have introduced improvements in the isolation of neonatal testis cells to allow 
obtaining donor cell populations with a high proportion of gonocytes (~40%, using a new 3-step 
enzymatic digestion method; Yang and Honaramooz 2010), which could be further enriched (to 
~90%, using a combination of Nycodenz centrifugation and differential plating) (Yang et al., 
2011).  
Our findings in another implantation model, testis tissue xenografting (TTX), have also provided 
a better understanding of various factors affecting the efficiency of implantation/grafting. For 
instance, TTX studies indicate that using testis tissue from immature donors results in higher graft 
survival and better support of spermatogenesis than tissue from more mature donors (Schlatt et al., 
2002b; Honaramooz et al., 2007; Arregui et al., 2008b; Rathi et al., 2008). The efficiency of 
spermatogenesis in xenografts is also dependent on the donor species. Studies in various species 
demonstrated variations in the response of graft development. Although complete spermatogenesis 
has been observed in grafts from the pig, goat (Honaramooz et al., 2002b, 2003b), cattle (Oatley et 
al., 2005; Schmidt et al., 2006), sheep (Arregui et al., 2008a), cats (Kim et al., 2007), rhesus 
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monkeys (Honaramooz et al., 2004), and horses (Rathi et al., 2006), the spermatogenic efficiency 
has been inconsistent among donor species. In term of recipients, there are indications of 
considerable differences among immunodeficient mice used as a recipient choice (Paris et al., 
2004; Honaramooz et al., 2007). The use of SCID mice for TTX was found to be more 
advantageous than nude mice (Abbasi and Honaramooz, 2010b), thus suggesting the strain of 
immunodeficient mice used as recipients for TCI may also affect the outcomes. The effect of 
recipient mouse sex on TTX outcomes was also examined, in which and males (regardless of the 
strain) gave rise to significantly higher graft development when compared with female recipients 
(Abbasi and Honaramooz, 2010b). The effect of gonadectomy on graft development, however, 
remains less clear. While some studies suggested that castration of recipients prior to TTX led to a 
higher development of grafts over intact recipients (Schlatt et al., 2002a; Rathi et al., 2006), these 
findings contradicted the observations in earlier studies (Shinohara et al., 2002; Abbasi and 
Honaramooz, 2010a). The results from our laboratory showed no beneficial effect of gonadectomy 
(orchidectomy or ovariectomy) for TTX (Abbasi and Honaramooz, 2010a). In addition to recipient 
factors, the number of transplanted grafts, their size, as well as their implantation site have also 
been shown to affect TTX outcomes and therefore these same factors may also influence tissue 
formation in the TCI model (Schlatt et al., 2002b; Shinohara et al., 2002; Rathi et al., 2006; Abbasi 
and Honaramooz, 2010b). 
Gel matrices have been widely used as binders or scaffolds in cell delivery systems, mostly in 
tissue engineering and regenerative medicine applications (Fan et al., 2008; Nicodemus and 
Bryant, 2008; Park et al., 2009). The biocompatible properties of these materials (i.e., being inert 
and absorbable) reduce the risk of rejection when applied as the carrier for drugs and cells. The use 
of Matrigel (a gelatinous protein mixture obtained from a mouse sarcoma cell line), as a 
binder/scaffold for TCI has been reported (Dores and Dobrinski, 2014). However, the presence of 
a host of known and unknown growth factors and other proteins in Matrigel makes its use less 
suitable for cell implantation studies aimed at investigating the effects of different factors on the 
TCI outcome. To date, basic gel-based matrices (without additives) have not been tested as 
potential carriers or scaffolds for TCI.  
Moreover, evaluation of TCI and TTX outcomes have thus far been limited to the post-
mortem/post-retrieval examination of implants/grafts. Therefore, in the present study, we also 
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tested the feasibility of using ultrasound biomicroscopy (UBM), as a non-invasive tool to monitor 
the development of testis cell aggregates prior to their retrieval. UBM is a high-resolution 
ultrasound imaging tool allowing real-time in vivo assessment of structures, tissues, and organs and 
hence has been used in a range of clinical and research applications. However, UBM has not been 
previously used in the assessment of TTX or TCI models. Therefore, the objectives of the present 
study were to examine various factors related to the TCI model, and to test UBM for non-invasive 
evaluation of the implants prior to their retrieval. 
5.3 Materials and Methods 
5.3.1 Study Design 
The present study consisted of two experiments, the design of which is schematically illustrated in 
Fig. 5.1. In Experiment 1, we studied the effects of using different basic gel matrices (gelatin, 
agarose, or collagen, without additives) and different cell numbers (50 × 106 or 100 × 106 cells) on 
de novo formation of testis tissue after TCI of neonatal porcine cell aggregates under the back skin 
of immunodeficient mice. The implantation was performed using a previously described surgical 
approach involving the transfer of cell aggregates through skin incisions (Honaramooz et al., 2007). 
At 2 wk post-TCI, the mice were euthanized and the implants retrieved for gross and microscopic 
analyses. In Experiment 2, a less-invasive method of implantation through subcutaneous injection 
of testis cell aggregates was evaluated. We also examined the effects of gonadal status (intact vs. 
castrated) and implantation site under the back skin on the TCI outcomes. For both experiments, 
the implants were imaged in vivo using UBM, before their retrieval.  
5.3.2 Testis Collection and Preparation 
Neonatal testes were collected through aseptic castration of Yorkshire-cross piglets (Camborough-
22 × Line 65) aged <1 wk (n = 160), as described in more details in Chapter 3.3.1.   
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Fig. 5.1. Schematic overview of the study design for Experiments 1 and 2. In Experiment 1, three types of gel-based implants (i.e., 
gelatin, agarose, and collagen) containing either 50 × 106 or 100 × 106 testis cells were implanted surgically under the back skin of 
recipient mice (n = 3) via the creation of pockets in subcutaneous fascia by blunt dissection. Implants void of testis cells from each of 
the three gel types and a cell pellet (100 ×106 cells) without gels were also implanted as controls. The 10 implants in each mouse were 
labeled as GEL-50 or GEL-100 (gelatin with 50 × 106 or 100 × 106 cells), AGR-50 or AGR-100 (agarose with 50 × 106 or 100 × 106 
cells), COL-50 or COL-100 (collagen with 50 × 106 or 100 × 106 cells), GEL-0, COL-0, or AGR-0 (agarose, collagen, or gelatin with 
no cells, as negative controls), and CAG-100 (cell aggregate containing 100 × 106 cells without gel matrices, as a positive control). In 
Experiment 2, cell aggregates were injected into 8 sites (100 ×106 cells per implantation site) under the back skin of recipient mice (n = 
8), which were either castrated (n = 4) or intact (n = 4). The implant sites were assigned based on location on each side of the recipient 
as L1, L2, L3, and L4 or R1, R2, R3, and R4. For ease of analysis, the implantation sites were also grouped based on the relative 
craniocaudal location as Cranial (L1 and R1), CraMid (L2 and R2), MidCa (L3 and R3), and Caudal (L4 and R4). The implants were 
scanned using ultrasound biomicroscopy (UBM) at 2 wk for Experiment 1 and at both 1 and 2 wk for Experiment 2. The mice were 
euthanized and the implants retrieved at 2 wk post-implantation in both experiments. 
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5.3.3 Isolation of Testis Cells 
Isolation of testis cells was performed using methods that have been previously established in our 
laboratory (three-step enzymatic digestion, Yang et al., 2010), with minor modifications as 
described in Chapter 3.3.2. The final cell pellet, containing ~40% gonocytes and a mixture of testis 
somatic cells, was re-suspended in 30 mL of DMEM supplemented with 10% FBS and 1% 
antibiotics and underwent gentle pipetting to obtain a single cell suspension. 
5.3.4 Experiment 1 – Evaluation of Basic Gel-Based Matrices as Carriers for Implantation of 
Testis Cell Aggregates  
5.3.4.1 Preparation of Gel-Based Matrices 
Three types of basic (without additives) gel-based matrices were evaluated, which included 
agarose, gelatin, and collagen. Preliminary experiments were performed to determine the optimal 
composition for each gel matrix by assessing its physical properties at different temperatures as 
well as its effect on the viability of cultured testis cells (data not shown). The optimal composition 
was determined to be 10% (w/v) for gelatin, 0.05% (w/v) for agarose, and 5 mg/mL for collagen 
type I.  
Briefly, for the preparation of 10% gelatin, 1.0 g of gelatin (catalogue no. D2500, Sigma-Aldrich) 
was dissolved in 10 mL of DPBS containing 1% antibiotics and kept at room temperature (21 °C) 
for 30 min. The mixture was then heated on a magnetic stirring hot plate to 60-70 °C, transferred 
into a 15-mL test tube, and incubated in a 37 °C-water bath. At the same time, the cell suspensions 
were placed in an incubator for 10 min to bring the temperature up to 37 °C. The cell suspension 
was aliquoted into 1.5 mL micro-centrifuge tubes to a total of either 50 × 106 or 100 × 106 cells per 
tube. The aliquots were centrifuged for 5 min at 500×g at 16 °C, and the supernatant was removed, 
leaving behind the cell pellets. Immediately, 100 µl of 10% gelatin was mixed with the cell pellet 
and gently pipetted up and down to homogenize the mixture. The gelatin-cell mixture was then 
pipetted onto a sterile Parafilm in a petri dish and kept in a refrigerator (4 °C) for 10 min to solidify. 
Parafilm was used to prevent adherence of gel-based matrices to the dish. Prior to implanting the 
gelatin-based cell aggregates they were kept in an ice-cold container. 
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For the preparation of 0.05% agarose, 500 µg of agarose (catalogue no. 11388983001, Sigma-
Aldrich) was mixed with 10 mL of DPBS with 1% antibiotics, and the mixture was heated and 
stirred at 60 °C for 5 min. Once the mixture was homogenized, it was incubated at 37 °C for 5 min 
and immediately mixed with the cell pellet. The remaining procedures continued as described for 
gelatin.  
For the preparation of collagen, 200 µl of 5 mg/mL collagen type I (catalogue no. 50201, Ibidi, 
Fitchburg, WI, USA) was added to the cell pellet, and the mixture was homogenized before 
pipetting onto a Parafilm. The end product for all preparations was a sphere-shaped (~1.0 cm in 
diameter) gel-based testis cell aggregate.  
5.3.4.2 Implantation of Gel Matrix-Based Neonatal Testis Cell Aggregates via the Surgical 
Method 
The recipients were double-homozygous severe combined immunodeficient hairless outbred mice 
(SHO mice, Crl:SHO-PrkdcscidHrhr, strain code 474; Charles River, Montreal, Canada, n = 3), aged 
8 wk at time of surgery. The mice were housed in sterile Plexiglas micro-isolator individual cages, 
maintained under controlled photoperiod (lights on 0600-1800), and handled aseptically. Sterile 
water and food were provided ad libitum. The mice were acclimatized for 1 wk prior to the 
procedures, and anesthetized using 5% isoflurane in oxygen for induction and 2% isoflurane in 
oxygen for maintenance throughout the surgery. After the surgical preparation of the skin, the mice 
were castrated and received 10 longitudinal linear skin incisions on their backs. Using blunt 
dissection through each incision, a subcutaneous pocket was created and an implant was inserted 
into each pocket. For each mouse, the implants included a gelatin-based sphere with 50 × 106 cells 
(GEL-50), one with 100 × 106 cells (GEL-100), an agarose-based sphere with 50 × 106 cells (AGR-
50), one with 100 × 106 cells (AGR-100), a collagen-based sphere with 50 × 106 cells (COL-50), 
and one with 100 × 106 cells (COL-100). In addition, a gel-based sphere with no cells from each 
of the 3 matrices as negative controls (i.e., GEL-0, COL-0, AGR-0), and a cell aggregate containing 
100 × 106 cells without any matrices, as a positive control for cell aggregates (CAG-100), were 
also implanted (i.e., 10 implants per mouse). The incisions were sutured using 6-0 coated, non-
absorbable braided silk (Sofsilk, catalogue no. SS1639G, Syneture, Norwalk, USA). All 
experimental procedures involving animals were reviewed and approved by the University of 
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Saskatchewan’s Institutional Animal Care and Use Committee (Animal Use Protocol# 20080042). 
A schematic representation of the study design and designation of implant placement is illustrated 
in Fig. 5.1. 
5.3.5 Experiment 2 – Development of an Alternative Method for Implantation of Neonatal Testis 
Cell Aggregates 
5.3.5.1 Implantation of Neonatal Testis Cell Aggregates via an Injection Method 
Based on the results of Experiment 1, an injection method for TCI was evaluated in this experiment. 
The recipient mice and anesthesia procedure were as described for Experiment 1. The mice were 
either castrated (n = 4) or remained intact (n = 4), and each mouse received 8 implants in the form 
of injected cell aggregate. Testis cells were isolated as described above, maintained at 4 °C 
overnight, and centrifuged at 500×g for 5 min at 16 °C to obtain cell aggregates for injection. Cell 
aggregates were highly concentrated (100 × 106 cells per 0.1 mL), 0.8 mL of which was drawn into 
a 1-mL syringe and a 22-gauge needle was attached. The skin was lifted to create a tent, and 0.1 
mL of the cell aggregate was gently injected into the subcutaneous tissue. To keep track of implants 
at analyses, the implantation sites were categorized as being on the left (L) or right (R), and from 
1 through 4 (i.e., L1, L2, L3, and L4 or R1, R2, R3, and R4), corresponding to the craniocaudal 
positioning, respectively (i.e., Cranial, CraMid, MidCau, Caudal; Fig. 5.1). The mice were housed 
and cared for under similar conditions as described in Experiment 1. 
5.3.5.2 Ultrasound Biomicroscopy (UBM) Assessment 
We also evaluated the potential application of an ultrasound biomicroscope (UBM; 40 MHz, 
VEVO 3100, Visual Sonics, Toronto, ON, Canada), as a non-invasive tool for the assessment of 
implants in vivo. For Experiment 1, this assessment was performed at 2 wk post-TCI (prior to 
euthanasia) and, for Experiment 2, at 1- and 2 wk post-TCI. The mice underwent anesthesia using 
a mixture of ketamine at 100 mg/kg and xylazine at 10 mg/kg, injected intraperitoneally, were 
placed in sternal recumbency on the UBM stage and the ultrasound gel lubricant (EcoGel 200; 
catalogue no 40JB; Eco-Med Pharmaceutical Inc, Mississauga, ON, Canada) was applied on the 
skin. The transducer, which was prefixed onto a custom-designed holder, was lowered into contact 
with the surface of the skin covering the implant. The platform was then moved craniocaudally 
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until the implant was visualized, at which time the platform was steered slowly from cranial to 
caudal aspect of the implant and images were digitally recorded. The same procedure was repeated 
to image the remaining implants.  
Dimensions of each implant were measured using the 2D (B-mode) and 3D functions of UBM. We 
also used the color flow Doppler function to evaluate the blood vessels supplying the implants 
(performed only in Experiment 2). The machine settings, based on previous reports (Mircea et al., 
2009; Cervantes et al., 2013), used for obtaining images of implants included: transducer with a 
50-MHz central frequency (MX Transducer, MX700, Visual Sonics), power 100%, radio 
frequency 2 kHz, master gain 38 dB, delay 1.0 mm, field of view 9 mm × 10 mm, frame rate 19 
fps, and range 70 dB. At 50 MHz central frequency, the axial resolution was 30 µm and the 
maximum imaging depth was 10 mm. The fixed focal point was set at 4.5 mm from the transducer 
surface. 
To examine the accuracy/fidelity of UBM measurements of implants in live mice, we compared 
the UBM data with the measurements of implants retrieved post-mortem. The length and width of 
implants were calculated from the recorded UBM images and videos, and compared with those 
from the photographs of the implants after the mice were euthanized, and while the implants were 
still attached to the skin (measured using ImageJ, U.S. National Institutes of Health, Bethesda, 
Maryland, USA). The implant length (along the transverse plane or Y-axis) was calculated based 
on the UBM probe displacement from the cranial to caudal border, and the implant width (along 
the sagittal plane or X-axis) based on the lateromedial dimension. The implant thickness/height (Z-
axis) was measured as the vertical dimension between the ventral and dorsal borders of the implant, 
at the halfway point between the cranial and caudal borders. For UBM, the images were recorded 
continuously at 0.5 mm intervals (slices), thus multiplying the total number of images from an 
implant by the thickness of slices produced an estimate of the implant dimensions. 
5.3.5.3 Implant Retrieval and Gross Evaluation 
The implants were retrieved at 2 wk post-TCI in both experiments. Based on the previous reports 
(Honaramooz et al., 2007; Arregui et al., 2008b; Zhang et al., 2008), this duration was sufficient 
for the reorganization of the cells, and formation of testis cords. Mice were euthanized using an 
overdose of isoflurane anesthesia, followed by bilateral thoracotomy to ensure death. Necropsy 
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was performed and the implant recovery rates, dimensions, weights, and gross features were 
recorded. The vesicular glands of recipient mice were excised and weighed to calculate the 
vesicular gland index as follows: 
!"#$%&'()	+'(,-	$,-". = 0"$+ℎ2	34	5"#$%&'()	+'(,-#6$5"	7"$+ℎ2	34	2ℎ"	83&#"	 	× 	100 
5.3.6 Histological Evaluation  
The retrieved implants were fixed in Bouin’s solution overnight, rinsed with and preserved in 70% 
ethanol until processing in an automated tissue processor (Tissue Tek, Sakura Finetek USA Inc, 
Torrance, USA). Processed tissues were then paraffin embedded, sectioned at a thickness of 5 µm, 
and stained with hematoxylin and eosin (H&E) and Masson’s trichrome. Histological assessment 
was performed using a microscope equipped with digital photomicrography (Northern Eclipse 
Image Analysis software version 7.0, Empix Imaging, Mississauga, ON, Canada). The degree of 
de novo tissue formation was assessed by calculating the relative area of the grafts occupied by the 
seminiferous cords. In addition, the average number of gonocytes per 1,000 Sertoli cells was also 
counted in five randomly-selected fields per slide (at 400× magnification). For comparison, this 
relative number of gonocytes was also calculated for testis tissue samples of age-matched 1, 2, and 
3 wk old piglets. 
5.3.7 Statistical Analyses 
All data are presented as means ± standard error of mean (SEM). Unless stated otherwise, all data 
were analyzed using independent t-tests, one-way, or two-way analysis of variance (ANOVA) as 
appropriate. For percentages, the data were transformed using Arcsine function prior to analysis 
using ANOVA. The level of significance was set at P < 0.05. Data were analyzed using the SPSS 
(Version 22.0, SPSS Inc., Armonk, NY, USA).
  125 
5.4 Results 
5.4.1 Feasibility of Using UBM for Assessment of Implants  
As part of Experiment 1, we evaluated the feasibility of using UBM in monitoring the gel-based 
implants in vivo prior to their retrieval at 2 wk post-TCI. The implants were readily identifiable 
and clearly defined upon ultrasonography, allowing their measurements across the X, Y, and Z-
axes. As shown in Fig. 5.2, the implants had a hyperechoic line outlining the periphery, and their 
core showed different degrees of echogenicity, presumably indicative of differential cellular 
organization or testis cord formation among different types of implants.  
The degree of echogenicity appeared to be related to the original number of cells incorporated in 
the implants. In contrast to the relatively homogenous echogenicity seen in the cell-only implants 
(Fig. 5.2A), anechogenic texture (lack of echogenicity) was evident in the agarose-only implants 
(Fig. 5.2B). Echogenicity seemed to also differ depending on the gel composition. The 
echogenicity in the gelatin-based implants (Fig. 5.2C) was greater than that of the agarose-based 
implants (Fig. 5.2D), although both contained the same number of cells (i.e., 100 ´ 106 cells). 
The number of implanted cells also influenced the size of the implants since the same collagen-
based implants with fewer cells (50 ´ 106 cells, Fig. 5.2E) appeared smaller than those with a 
greater number of cells (100 ´ 106 cells, Fig. 5.2F). Judging from the heterogeneous texture of 
implants through UBM images, we predicted higher cellular organization and testis cord formation 
in the gelatin- and collagen-based implants. This was also dependent on the number of incorporated 
cells, and little or no cellular activity or tissue formation was evident in the agarose-based implants. 
However, not all implants could be found using UBM; the negative control implants (i.e., no-cell 
gelatin and no-cell collagen) were not detected, indicating they might have undergone complete 
absorption (Table 5.1). Finally, we also observed pulsatile movement at the periphery of the 
implants via UBM, suggesting the presence of blood vessels. However, this observation occurred 
only twice out of all observations (2/27). 
The UBM examination at 1- and 2 wk post-TCI in Experiment 2 allowed assessment of the implants 
over time. The results indicated that the encapsulation of the implant by a hyperechoic layer was 
also detectable at 1 wk. (Fig. 5.3). The implants at 1 wk post-TCI appeared less echogenic than 
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those at 2 wk (Fig 5.3A-B). Additional assessments included using the color Doppler mode and 3D 
imaging to visualize the blood supply, which appeared limited to the periphery of the implants at 
1 wk post-TCI but was extended into the implants at 2 wk (Fig. 5.3C-D).  
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Fig. 5.2. Representative in vivo images of gel-based implants obtained using ultrasound 
biomicroscopy (UBM). Depicted implants include (A) cell aggregates with 100 ´ 106 cells but no 
gels (CAG-100, as a positive control), (B) agarose with no cells (AGR-0, as a negative control for 
agarose), (C) gelatin with 100 ´ 106 cells (GEL-100), (D) agarose with 100 ´ 106 cells (AGR-100), 
(E) collagen with 50 ´ 106 cells (COL-50), and (F) collagen with 100 ´ 106 cells (COL-100). UBM 
was performed at 2 wk post-implantation using the B-mode. Note the presence of a capsule 
(arrowheads) surrounding the implants and the echogenic appearance presumed to represent 
cellular activity or testis cord formation. One or two asterisks (*) represent the varying opacity of 
implants (A-D). Evidence of cellular activity or testis cord formation was observed in collagen-
based implants in a cell number-dependent manner (E-F). (Scale bar: 1 mm).   
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Fig. 5.3. Representative in vivo images of cell injection implants obtained using ultrasound 
biomicroscopy (UBM). UBM was performed at 1- and 2 wk post-implantation, using the B- (A-B) 
and color Doppler modes (C-D). Note the changes in the size and shape of the implants (A-D). The 
distribution of blood vessels in the implants could be assessed by UBM via color Doppler mode 
(C-D). The blood vessels appeared as blue or red pseudo-colors indicating different directions of 
the blood flow; blue indicating the blood flowing away from the transducer (towards the implants) 
and red indicating the blood flow towards the transducer (away from the implants). Note the blood 
vessels were primarily present at the periphery of the implant at 1 wk and extended into the implants 
at 2 wk post-implantation. (Scale bar: 1 mm). 
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Table 5.1. The number of implants upon retrieval at 2 wk post-implantation in Experiment 1. 
Implants Cell no. (×106) Mouse 1 Mouse 2 Mouse 3 Total 
 
Collagen-based 
100 
50 
0 
+ 
+ 
- 
+ 
+ 
- 
+ 
- 
- 
3/3 
2/3 
0/3 
 
Gelatin-based 
100 
50 
0 
+ 
+ 
- 
+ 
+ 
- 
+ 
+ 
- 
3/3 
3/3 
0/3 
 
Agarose-based 
100 
50 
0 
+ 
+ 
+ 
+ 
+  
+ 
+ 
+ 
+ 
3/3 
3/3 
3/3 
Cell aggregates 100 + + + 3/3 
Total  8/10 8/10 7/10  
 
+ Indicates the implants were present at retrieval at 2 wk post-implantation.  
-  Indicates the absence of implants at retrieval at 2 wk post-implantation.  
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5.4.2 Fidelity of UBM Measures for Predicting the Size of Implants Prior to Retrieval 
The length and width of implants measured in vivo using UBM were consistently greater (by 21% 
and 18%, respectively, P < 0.05) than those measured using image analyses of post-mortem 
implants. There were positive correlations among the measurements (Table 5.2). 
5.4.3 Gross Evaluation of Implants 
In Experiment 1, upon opening the back skin, the implants were readily identifiable while being 
adhered to the subcutaneous layer of the skin. The presence of blood vessels leading to the implants 
and encapsulation of the implants by thin fibrous connective tissues were also detectable (Fig. 
5.4A-C). Some of the implants were not visible/retrieved, leading to a recovery rate of 8/10 
implants in two mice, and 7/10 in the third mouse (Table 5.1). While all collagen- and gelatin-only 
(negative control) implants were absent in all mice, all the implants with cells were retrieved, 
except for one implant (i.e., COL-50) in one mouse. The positive control implants (CAG-100) were 
present in all mice.  
In Experiment 2, at euthanasia, vascularization and encapsulation of the implants were observed to 
be similar to those in Experiment 1 (Fig 5.4D-F); however, 100% of implants were retrieved from 
all recipients (i.e., 64/64 implants). Less variation in size and shape was observed in implants 
retrieved in Experiment 2, compared with the implants in Experiment 1 with the same number of 
cells (100 × 106 cells; CAG-100). Overall, the implants from Experiment 2 were heavier (37.95 ± 
2.15 mg, n=64; P < 0.05) than comparable cell-only implants (100 × 106 cells, CAG-100) retrieved 
in Experiment 1 (19.1 ± 9.32 mg, n = 3). 
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Table 5.2. Relationships between the implant dimensions measured either in vivo using ultrasound 
biomicroscopy (UBM) or post-mortem after implants were visualized while still attached to the 
skin.  
Dimension Method 
Mean ± SEM 
(mm) 
Correlation 
r P-value 
Length 
In vivo 8.55 ± 0.25 
0.224 0.075 
Post-mortem 7.09 ± 0.22 
Width 
In vivo 6.15 ± 0.13 
0.250  0.047 
Post-mortem 5.20 ± 0.15 
 
Data are mean ± SEM (n = 64 implants).  
Pearson’s product-moment correlation coefficients (r) were calculated between the two methods of 
dimension measurements.  
Correlation coefficients were considered significant when P < 0.05. 
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Fig. 5.4. Representative photomacrographs showing implants before and after retrieval at 2 wk 
post-implantation in Experiments 1 and 2. The appearance of implants (A, D) under the skin, prior 
to retrieval, (B, E) still attached to the skin, and (E, F) after retrieval in Experiment 1 (A-C) and 
Experiment 2 (D-F). Note the presence of blood vessels directed toward the implants (B, E). 
Vesicular glands (SV) are also shown.  
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5.4.4 Histological Evaluation of Implants 
Histological examination of the implants in Experiment 1 showed the organization of cells and de 
novo formation of testis cords in the collagen- (Fig. 5.5C-D) and gelatin-based implants (Fig. 5.5G-
H), as well as cell-only implants (positive control/no-gel; Fig. 5.5A). Qualitatively, the 
development of cords was most complete in the gelatin-based implants. No cord development was 
observed in the agarose-based implants with 50 × 106 cells (AGR-50), where only necrotic cells 
were found (Fig. 5.5E). However, in the agarose-based implants with 100 × 106 cells (AGR-100), 
a small degree of cellular organization was observed but without formation of cords (Fig. 5.5F). 
No cellular activities were observed in the retrieved negative control implants for agarose (AGR-
0), which only contained a vacuolated/empty space (Fig. 5.5B).  
In Experiment 2, a number of common histological patterns were observable in all implants (Fig. 
5.6A-B). For instance, cross-sections of the implants collected at 2 wk post-TCI could be 
categorized into three zones/areas: 1) The external capsule made of fibrous connective tissue 
(capsular area); 2) areas of cellular activity or testis cord formation (tissue formation area); and 3) 
areas void of cellular activities in some implants, primarily associated with vacuolation/fluid-filled 
cavity in the center of the implant (vacuolar area). Vascularization was evident by the presence of 
blood vessels (visualized with the aid of Masson’s trichrome staining) both at the capsular and 
tissue formation areas (Fig. 5.6E-F), supporting the UBM observations (Fig. 5.3C-D). 
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Fig. 5.5. Representative histological photomicrographs of implants from Experiment 1 at 2 wk 
post-implantation. De novo testis cord formation was observed in (A) the positive control implant 
(CAG-100, cell aggregates with 100 × 106 but no gels). A similar development is present in (C-D) 
collagen (COL)-based and (G-H) gelatin (GEL)-based implants, and the degree of de novo testis 
cord formation is correlated with the number of cells (i.e., higher with 100 × 106 vs. 50 × 106 cells). 
In contrast, no or limited development was observed in agarose (AGR)-based implants, including 
(B) the negative control with agarose-only, and (E-F) agarose with 50 × 106 or 100 × 106 cells. 
(Scale bars: 50 and 100 µm, H&E staining). 
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Fig. 5.6. Representative histological photomicrographs of implants from Experiment 2 at 2 wk 
post-implantation. De novo testis cord formation is evident in implants at (A) low and (B) high 
magnifications. Morphology of intact testis tissue of (C) 1 wk and (D) 3 wk old piglets for 
comparison (H&E staining). Blood vessels (arrows) are observed at the (E) periphery of the 
implants and (F) within the areas of cord formation (Masson’s trichrome staining), consistent with 
ultrasound biomicroscopy observations.   
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5.4.5 The Effect of Gonadal Status of the Recipient Mice on Development of Implants  
The SHO mice used in this study are a new immunodeficient strain, which have not been previously 
used in TTX or TCI studies. Therefore, as an added comparison in Experiment 2, we subjected half 
of the recipient mice to castration while leaving the remaining mice intact, and compared the effect 
of gonadal status on the following parameters:  
5.4.5.1 Vesicular Gland Index and Implant Weight  
The weight of the vesicular glands relative to the body weight (vesicular gland index) did not differ 
between the castrated and intact groups of recipient mice (P > 0.05; 0.58 ± 0.04% vs. 0.52 ± 0.02%, 
respectively, n = 4 mice/group). Similarly, the weight of the implants did not differ between the 
castrated and intact mice (P > 0.05; 41.3 ± 2.8 mg vs. 34.60 ± 3.2 mg, respectively, n = 32 
implants/group).  
5.4.5.2 De Novo Formation of Testis Tissue  
Histomorphometric analyses were performed on cross-sectioned samples and the following criteria 
were measured: the total area of implant parenchyma (all areas excluding the capsule, P), the area 
of tissue formation (areas with evidence of cellular activity and tissue formation, T), and the area 
of complete cord formation (areas with complete cords only, C). The total parenchymal area (P) 
did not differ between implants from castrated and intact recipients (P > 0.05; 7.34 ± 0.55 mm2, n 
= 29 and 6.67 ± 0.47 mm2, n = 27, respectively). Similarly, the relative area of tissue formation to 
the total parenchymal area (T/P × 100) did not differ between the two groups (P > 0.05; 33.77 ± 
3.21% vs. 33.56 ± 3.86%, in castrated vs. intact, respectively). The relative area of complete cord 
formation (C/P × 100) also did not differ between the castrated and intact groups (P > 0.05; 26.37 
± 2.77% vs. 19.12 ± 2.36%). However, the relative area of complete cord formation to the area of 
tissue formation (C/T × 100) was greater in the castrated group (P < 0.05; 81.14 ± 4.53% vs. 57.04 
± 5.40%, respectively). The relative number of gonocytes per 1,000 Sertoli cells in the implants 
also did not differ between castrated and intact recipients (P > 0.05; 44 ± 5.8, n = 4 and 43 ± 3.5, 
n = 4, respectively). The combined relative number of gonocytes in all implants (44 ± 3.1, n = 8) 
was lower (P < 0.05) than the relative number of gonocytes in 1-, 2-, or 3 wk old pig testis reference 
samples (126 ± 8.2, 103 ± 3.3, or 87 ± 3.4, respectively, n = 5/age; Fig. 5.6C-D).  
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5.4.5.3 The Effect of Implantation Site  
When the implant weight data were analyzed for the effects of gonadal status (intact vs. castrated) 
and implantation site (Cranial vs. CraMid vs. MidCa vs. Caudal), no main effect of gonadal status 
(P > 0.05) or interactions were detected (P > 0.05). However, the main effect of implantation site 
was significant (P < 0.05) and the implants retrieved from the Cranial (L1 and R1; 52.2 ± 6.2 mg, 
n = 16) and CraMid sites (L2 and R2, 43.2 ± 3.3 mg, n = 16) were heavier (P < 0.05) than those 
from the caudal sites (L4 and R4; 22.6 ± 3.1 mg, n = 16) (Fig. 5.7). Moreover, the weight of 
implants retrieved from the right side (R1, R2, R3, and R4; 38.29 ± 3.4 mg, n = 16) did not differ 
(P > 0.05) from those of the left side (LI, L2, L3, and L4; 37.61 ± 2.7 mg, n = 16).  
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Fig. 5.7. Weight of the retrieved implants from Experiment 2 based on the site of implantation. 
Each mouse received 8 testis cell aggregate implants (4 on each side), which were labelled 
craniocaudally as: Cranial (L1 and R1), CraMid (L2 and R2), MidCa (L3 and R3), and Caudal (L4 
and R4). Data are mean ± SEM. Data with different letters differ significantly between groups (P 
< 0.05).  
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5.5 Discussion 
Testis cell implantation (TCI) from a range of donor species under the back skin of recipient mice 
has provided a unique model for the study of testis regeneration (Dufour et al., 2002; Gassei et al., 
2006; Honaramooz et al., 2007; Kita et al., 2007; Arregui et al., 2008b; Zhang et al., 2008; 
Campos-Junior et al., 2014). In the present study, we used neonatal porcine testis cells to examine 
several factors that can potentially affect the efficiency and consistency of TCI outcomes. The 
examined effects included increasing the proportion of gonocytes, comparing the number of 
implanted cells, employing different gel-based matrices, comparing implantation methods, using a 
new strain of recipient mice, comparing the gonadal status of the recipients, comparing the 
implantation sites, and using UBM to assess the growth and development of implants. 
First, we addressed the importance of testis cell composition and number for use in TCI. In earlier 
TCI studies (Honaramooz et al., 2007; Kita et al., 2007; Arregui et al., 2008b; Zhang et al., 2008), 
a conventional two-step digestion protocol (Honaramooz et al., 2002b; 2003) was used to isolate 
testis cells which yields a low proportion of germ cells (e.g., 4.5%) (Honaramooz et al., 2007). To 
date, all TCI studies have reported de novo-generated seminiferous cords/tubules that typically lack 
germ cells (i.e., few have germ cells but most only have Sertoli cells) and consequently TCI results 
have been associated with a low spermatogenic efficiency (Honaramooz et al., 2007; Kita et al., 
2007; Arregui et al., 2008b; Zhang et al., 2008; Dores and Dobrinski 2014). The low 
number/proportion of germ cells in the donor cells may be a contributing factor in the observed 
Sertoli cell-only tubules and low spermatogenic efficiency. The lack of a specialized cell isolation 
method to preferentially select germ cells was a major limitation. In response to this limitation, our 
lab has developed a 3-step enzymatic digestion strategy for neonatal donor testes which results in 
high numbers of testis cells containing ~40% gonocytes, which can be further enriched to 80-90% 
(Yang et al., 2010; Yang and Honaramooz 2011). Recently, we determined that for in vitro culture 
of neonatal testis cells, the proportion of 40% gonocytes were better suited compared with much 
lower or much higher gonocyte proportions (Chapter 3) (Awang-Junaidi and Honaramooz, 2018). 
Therefore, in the present study, we used a similar population of neonatal testis cells (with 40% 
gonocytes). The relative number of gonocytes (per 1,000 Sertoli cells) in 2 wk implants was lower 
than that in intact piglet testes of related ages (4% in implants vs. 13% in 1 wk, 10% in 2 wk, and 
9% in 3 wk old intact testes). There are no comparative data using pig donors at these ages to assess 
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how the number of gonocytes in the implants in the present study compare with those after 
conventional procedures.  
In the present study, we also addressed another limitation of conventional TCI, namely the 
inconsistency due to a lack of control over the actual number of implanted cells because of the 
inaccurate means of cell transfer (using pipet tips) and post-implantation leakage of cells from skin 
wounds (Honaramooz et al., 2007). This implantation of a defined number of testis cells using 
subcutaneous injection in the present study (Experiment 2) was aimed at overcoming this 
limitation, and the improved consistency of TCI outcomes (i.e., implant size, shape, and weight) 
supported this application. Additionally, our injection method can reduce cell preparation time 
(compared with gel-based implants), surgery time and costs, and the potential risk of infection. 
Therefore, the injection method is more efficient and suitable for the delivery or implantation of 
testis cell aggregates, while the conventional implantation technique is more suitable for implanting 
solid gel-based spheres or testis tissue fragments.  
There have been no standardized provisions for the assessment of testis tissues or cell aggregate 
implants prior to their retrieval from the recipients. In the present study, we addressed this 
limitation through the application of UBM. There are several reports of the use of UBM for 
visualization of organs (Hinton et al., 2008; Shen et al., 2008; Mancini et al., 2009), embryology 
(Foster, 2003; Spurney et al., 2006), oncology (Manning et al., 2008; Greco et al., 2010), clinical 
ophthalmology (Dada et al., 2011; Mannino et al., 2016), cardiology (Springer et al., 2005), and 
assessment of tissue repair (Töyräs et al., 2003; Schöne et al., 2016). However, to our knowledge, 
this is the first attempt to evaluate the feasibility of UBM to monitor the development of testis cell 
aggregate implants in a recipient mouse model. Based on our results, not only is UBM simple and 
non-invasive, it also provides high-resolution data and allows real-time in vivo assessment of 
implants over time without the need of sacrificing the recipients at different time points. UBM 
provided valuable information such as the survival and development of implants prior to their 
retrieval. Varying cellular activity or tissue formation among different types of implants were 
indicated through changes in echogenicity. In addition, the response of the recipients towards 
implants (i.e., through assessment of neovascularization and encapsulation) could be used as a 
biocompatibility indicator. Our UBM assessment findings were also consistent with our gross 
observations of implants (i.e., their survival, morphology, and the presence of blood vessels) and 
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their histological attributes (i.e., the degree of cellular activities and tissue formation). Furthermore, 
the UBM estimations of implant size and growth prior to their retrieval were correlated with the 
post-mortem measurements. The decreasing trend in length (21%) and width (18%) of post-mortem 
retrieved implants would have been expected since the shape and dimensions of the implants 
change after detachment from the surrounding tissues and skin. Therefore, our results paved the 
way for the use of UBM for non-invasive and repeated pre-retrieval assessment of implants in 
future TCI and testis tissue xenografting (TTX) studies; thereby, reducing the number of recipient 
mice needed for such studies. 
Here, we also investigated the addition of different gel matrices (i.e., gelatin, agarose, or collagen) 
as a binder or carrier of neonatal testis cell aggregates (Experiment 1). This approach, known as 
cell microencapsulation, has been widely used in tissue engineering, including transplantation of 
mesenchymal stem cells, and has also been reported in regenerative medicine (Liu and Chang, 
2010) Lund et al., 2008; Gasperini et al., 2014; Tzouanas et al., 2014). The rationale for 
encapsulation of cells by gel-based matrices is to provide a scaffold to facilitate cell movements 
and interaction by mimicking the in vivo 3D arrangement of cells, and provide a semi-permeable 
medium that allows the exchange of beneficial molecules (e.g., oxygen, nutrients, and growth 
factors), while eliminating waste products. In addition, the bio-inert attribute of these gel-based 
matrices also provides a temporary protective barrier that prevents immediate absorption of 
implanted cells or their rejection (Murua et al., 2008). In the present study, de novo tissue formation 
by neonatal testis cell aggregates encapsulated with certain basic gel based-matrices (gelatin and 
collagen) points to the potential of using these known matrices as an economical alternative to 
commercially available matrices with an unknown composition of growth factors.  
In Experiment 1, not all implants were retrieved because some had undergone complete absorption. 
Almost all of these untraceable implants were from the gel-only controls (no cells). No signs of 
rejection were observed in either experiment. De novo testis tissue formation in implanted gel-
based matrices containing cells indicates that the added gel-based matrices are safe, biocompatible, 
and biodegradable. From a qualitative standpoint based on gross morphology and histological 
assessment, we concluded that collagen and gelatin are more suitable as an encapsulation and 
binding agent than agarose. 
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Neovascularization or angiogenesis is a key step in successful incorporation of any graft or implant 
in the new environment. In this present study, the presence of blood vessels as early as 1 wk after 
implantation was observed through UBM, and subsequently at gross and histological evaluations. 
The presence of peripheral blood vessels at 1 wk post-implantation and within the implants at 2 wk 
post-implantation are evidence of angiogenic progression, indicating that these vessels were of the 
recipient origin. Timely formation of blood vessels ensures the survival of implanted cells and 
support of the developing tissues. Although the exact mechanisms of neovascularization in this 
model have not been determined, it is likely initiated due to the ischemic conditions at the time of 
implantation, triggering the release of vascular endothelial growth factors (VEGF), as a potent 
promoter of new blood vessel formation and migration (Ferrara, 2000; Neufeld et al., 1999). VEGF 
is upregulated in hypoxic conditions to restore the inadequate supply of oxygen to the tissues 
(Shweiki et al., 1992). When VEGF was used in a TTX study, it promoted a better development of 
grafts by increasing the graft weight, the number of seminiferous tubules, and presence of advanced 
germ cells (Schmidt et al., 2006). The promising results of the present TCI study provide an 
excellent model for the examination of various growth factors on the development of testis tissue.  
Severe combined immunodeficient (SCID) mice have been widely used in TTX studies where the 
lack of both T- and B lymphocytes provides a more conducive environment for the development 
of grafts (Ito et al., 2002), without compromising the outcomes (Rathi et al., 2006; Goossens et al., 
2008; Watanabe et al., 2009). To our knowledge, hairless SCID mice (also designated SHO) have 
not been used as recipients in TTX or TCI. This mouse strain is a promising new model because in 
addition to being immunodeficient to the same degree as conventional SCID mice, has the 
advantage of being hairless which allows better visualization of developing implants and grafts, 
similar to nude mice. In the present study, we also evaluated the effect of castration on the outcomes 
of neonatal testis cell implantation in this new recipient model. Immediately after castration of the 
recipient, serum levels of gonadotropins increase, which theoretically should stimulate the 
development of newly grafted testis tissues (Honaramooz et al., 2002a; Schlatt et al., 2002a, b; 
Paris and Schlatt, 2007; Rodriguez-Sosa and Dobrinski, 2009). However, a comprehensive study 
using SCID and nude mice showed that the recipient gonadal status had no significant effects on 
the development of neonatal testis tissue (Shinohara et al., 2002; Abbasi and Honaramooz, 2010b). 
This was also the case in the present study using SHO mice.  
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The vesicular glands, as with other accessory male glands, rely for their maintenance on continued 
exposure to testosterone, and thereby become considerably smaller as early as 2 wk after castration 
(Schlatt et al., 2002a). The size of the vesicular glands hence provides a bioindicator for the levels 
of circulating testosterone (Honaramooz et al., 2007; Arregui et al., 2012). While in intact recipient 
mice the circulating testosterone can be from both endogenous (own testes) and xenogeneic 
sources, any circulating testosterone in castrated mice is solely from the implants. Thus, the 
difference in the testosterone levels between these two groups would be reflected in the vesicular 
glands mass. In the present study, no effects of castration on the vesicular gland indices were 
observed at 2 wk post-implantation, indicating that the implants were capable of supplying 
sufficient testosterone to the host.  
In the present study, we found that the implantation site can affect the growth of implants, where 
implants located more cranially on the back of mice grew larger compared with those of the caudal 
region. This rather surprising observation has not been previously reported and the reasons for such 
a difference are not known. However, differences in relative abundance of blood vessels or relative 
laxity of the subcutaneous tissue between different regions of the back skin might be a potential 
cause. Due to the observed effect of implantation site on the growth of implants, randomization of 
implants sampling can be recommended for future studies to reduce the potential confounding 
effects of the implantation site within the same mouse.  
5.6 Conclusions 
In conclusion, in the present study, we established an improved method for implantation of neonatal 
porcine testis cell aggregates which allows more consistent outcomes for de novo testis tissue 
formation. The use of gel matrices as a binder for cell implants led to inconsistent tissue 
development, and the outcomes were gel-type and cell number-dependent. The injection approach 
offers a simple and less invasive technique and results in more consistency and greater de novo 
testis tissue formation. Finally, UBM was found to be applicable as a non-invasive monitoring tool, 
allowing the prediction of implantation outcomes.
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TRANSITION 
Subcutaneous injection of porcine testis cell aggregates under the back skin of recipient mice as 
described in Chapter 5 offers an efficient model for de novo formation of testis tissue and results 
in more consistent implantation outcomes. Therefore, we used this model in Chapter 6 to study the 
effects of brief pre-implantation exposure of testis cells to various growth factors on the 
development of testis tissue in the resultant implants.
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CHAPTER 6 
EFFECTS OF GROWTH FACTORS ON DE NOVO REGENERATION OF PORCINE 
TESTIS TISSUE AFTER ECTOPIC IMPLANTATION OF TESTIS CELLS IN MICE 7 
6.1 Abstract 
The role of growth factors during normal testis development is difficult to assess in situ, especially 
in non-rodents. Ectopic implantation of neonatal pig testis cell aggregates under the back skin of 
recipient mice results in de novo formation/regeneration of testis tissue, hence provides a powerful 
model for the study of testis formation. In the present study, we used this model to study the effects 
of exposing donor porcine testis cell aggregates to various growth factors. Each recipient mouse (n 
= 7 mice/group) was implanted with eight porcine testis cell aggregates (~100 ´ 106 cells/implant) 
that were exposed to a given dose of different growth factors. A total of 11 groups were examined: 
EGF (20 ng/mL of cell aggregates: EGF-L or 2µg/mL: EGF-H), GDNF (20 ng/mL: GDNF-L or 2 
µg/mL: GDNF-H), FGF2: 1 µg/mL, FGF9: 5 µg/mL, VEGF: 3.5 µg/mL, LIF: 5 µg/mL, SCF: 3.5 
µg/mL, RA: 3.5×10-5 M, or no growth factors (Control). Two randomly-selected implants were 
removed from each mouse at 1, 2, and 4 wk, and the remaining implants were retrieved at 
euthanasia at 8 wk post-implantation. The overall implant recovery rate was 95% and did not differ 
among groups. The main effects of treatments on de novo tissue morphogenesis were enhanced 
implant weight (FGF2 and LIF), implant area (FGF2, EGF-L, and SCF), and seminiferous cord 
area (FGF2 and GDNF-L). RA promoted the formation of enlarged cords, GDNF-H led to irregular 
cords, and FGF2 resulted in the highest ratio of regular cords and lowest ratio of aberrant cords. 
RA also promoted the number of gonocytes in the implants. The use of higher doses of EGF and 
GDNF did not improve the results compared with their lower doses. Overall, the use of FGF9 and 
VEFG had no effects on formation of cords. Rete testis formation occurred earlier in the implants 
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treated with EGF-L, GDNF-H, FGF2, FGF9, or LIF. The results show that even brief pre-
implantation exposure of testis cells to growth factors can have profound effects on the formation 
of testis tissue using the testis cell aggregate implantation model. 
6.2 Introduction  
Ectopic implantation of testis cell aggregates from neonatal donor piglets in recipient mice was 
shown to result in de novo formation/regeneration of testis tissue (Honaramooz et al., 2007). 
Similar results have also been obtained using other donor species (Dufour et al., 2002; Gassei et 
al., 2006; Kawasaki et al., 2006, 2010; Arregui et al., 2008). In this testis cell implantation (TCI) 
model, cells obtained after enzymatic dissociation of donor testes are implanted under the back 
skin of immunodeficient mice. The heterogeneous population of donor testis cells undergo 
autonomous rearrangements to form seminiferous cords that are morphologically similar to those 
of the intact testis. Over time, the newly-developed testis tissue can further develop into a 
functional testis tissue, capable of supporting spermatogenesis and steroidogenesis (Honaramooz 
et al., 2007). This unexpected morphogenic capacity of dissociated testis cells to regenerate a 
functional testis tissue suggests that factors involved in the process of testis development are 
retained even shortly after birth. Therefore, this unique in vivo culture system offers a promising 
model for the study and manipulation of various potential factors involved in testis development 
and formation. This can include the study of putative growth factors and molecular cues in the 
process, which otherwise are inherently difficult to study in situ, especially in non-rodent target 
species. 
Testis tissue morphogenesis is a complex process which involves coordinated endocrine, paracrine, 
and autocrine signaling (Lamb, 1993; Huleihel and Lunenfeld, 2004). Several paracrine, growth, 
and differentiation factors are believed to play a key role in tissue patterning and organogenesis 
during the gonadal development. For instance, the presence of fibroblast growth factor 9 (FGF9) 
is crucial during sex determination (DiNapoli et al., 2006; Kim et al., 2006a), where it regulates 
Sertoli cell proliferation and testis cord formation, leading to the suppression of genes that are 
responsible for ovarian development (Park and Jameson, 2005; Jameson et al., 2012). Disruption 
of FGF9 and its receptors have been shown to result in termination of testis development, which 
can lead to sex reversal. The vascular endothelial growth factor (VEGF), in addition to being vital 
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for vasculature development in the embryo (Carmeliet et al., 1996; Ferrara et al., 1996), contributes 
to the formation of testis cords, as well as promotion and coordination of cell migration from the 
mesonephros to the developing gonad (Bott et al., 2006; Baltes-Breitwisch et al., 2010; Cool et al., 
2011). 
The basic fibroblast growth factor 2 (FGF2) and epidermal growth factors (EGF) regulate Leydig 
cell proliferation and steroidogenesis (Gonzalez et al., 1990; Sordoillet et al., 1991, 1992; Han et 
al., 1993). On the other hand, certain growth factors are thought to act primarily on germ cells, 
including the glial cell-derived neurotrophic factor (GDNF), leukemia inhibitory factor (LIF), stem 
cell factor (SCF), and retinoic acid (RA) (De Miguel et al., 1996; Mauduit et al., 1999; Meng et 
al., 2000; Kubota et al., 2004a; Hofmann et al., 2005; Wu et al., 2005; Aponte et al., 2006; Zhou 
et al., 2008; Chung et al., 2009). The GDNF produced by Sertoli cells is an integral part of the 
stem cell niche within the seminiferous tubules, and promotes the self-renewal of spermatogonial 
stem cells (SSC) (Meng et al., 2000; Viglietto et al., 2000; Chuma et al., 2005; Hofmann et al., 
2005). The SCF and LIF exert their action on germ cells throughout life, ensuring the survival, 
proliferation, and differentiation of developing germ cells (Matsui et al., 1991; Pesce et al., 1993; 
Mauduit et al., 1999; Yan et al., 2000a; Aponte et al., 2008). Additionally, RA is responsible for 
maintaining the pool of fetal gonocytes and promoting their differentiation to spermatogonia after 
birth (Wang and Culty, 2007; Zhou et al., 2008; Manku et al., 2015). Role of the aforementioned 
factors in testis development and function has been deciphered primarily using knockout mice and 
in vitro models, with considerably less data on non-rodent species. 
The limited literature on the ectopic TCI model has thus far been primarily focused on describing 
the potential of this model, survival of the implants, formation of testis tissue, and progression of 
spermatogenesis. The lack of a defined protocol, inconsistency in results, and the low rate of 
spermatogenic efficiency have limited the application of this potentially powerful model (Gassei 
et al., 2006; Kita et al., 2007; Arregui et al., 2008a; Campos-Junior et al., 2014; Honaramooz et 
al., 2007; Arregui et al., 2008a; Dores and Dobrinski, 2014). A single previous study has employed 
this model to examine the effect of a growth factor on post-implantation testis tissue formation, 
where treatment with VEGF led to improved outcomes ( Schmidt et al., 2006b; Dores and 
Dobrinski, 2014). In this latter study, the beneficial effects of VEGF were attributed to its 
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angiogenic promoting effect, because it is believed that in the early days post-implantation, the 
implants are likely exposed to ischemic conditions, before blood supply is established.  
Despite the regeneration of a functional testis tissue, the implants resulting from this model 
commonly display low spermatogenic efficiency, because most seminiferous cords/tubules lack 
germ cells (Honaramooz et al., 2007; Arregui et al., 2008a; Watanabe et al., 2009; Campos-Junior 
et al., 2014). The reasons for the observed low number of germ cells in the newly developed tubules 
are not clear, but a low proportion of germ cells in the donor cell populations or subsequent loss of 
germ cells during development have been proposed as likely causes (Honaramooz et al., 2007; 
Arregui et al., 2008a). For example, in a study where the donor cell aggregates comprised of ~5% 
germ cells, only ~11% of the resultant seminiferous tubules contained complete spermatogenesis 
at 30 wk post-implantation (Honaramooz et al., 2007). To address the potential lack of sufficient 
germ cells in the donor cell populations, our lab has previously established a three-step enzymatic 
testis cell isolation protocol that yields ~40% germ cells from donor neonatal pig testes (Yang et 
al., 2010). We have recently also examined several potential factors that can improve the 
consistency of the results and spermatogenic efficiency of the TCI model (Chapter 5). Taking 
advantage of the improved TCI model, the present study was designed to investigate the effect of 
various growth factors (i.e., EGF, GDNF, FGF2, FGF9, VEGF, LIF, SCF, and RA) on de novo 
formation of porcine testis tissue.  
6.3 Materials and Methods 
6.3.1 Animal and Experimental Design 
A total of 165 male piglets of ~2 wk of age were used as donors of testis cells to be implanted 
under the back skin of recipient mice. Each recipient mouse (n = 7 mice/group, total n = 77) 
received eight cell aggregate implants (each containing 100 ´ 106 cells). Immediately prior to 
implantation (within an hour), cell aggregates were exposed to a designated growth factor/dose. In 
total, there were 11 groups as follows: EGF (20 ng/mL of cell aggregates: EGF-L or 2µg/mL: EGF-
H), GDNF (20 ng/mL: GDNF-L or 2 µg/mL: GDNF-H), FGF2: 1 µg/mL, FGF9: 5 µg/mL, VEGF: 
3.5 µg/mL, LIF: 5 µg/mL, SCF: 3.5 µg/mL, RA: 3.5×10-5 M, or no growth factors (Control). Two 
randomly-selected implants were removed from each mouse at 1, 2, and 4 wk, and the remaining 
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implants retrieved at euthanasia at 8 wk post-implantation. The growth factors used, number of 
recipients, and implants in each group are summarized in Table 6.1. The recipient mice were 
double-homozygous severe combined immunodeficient hairless outbred mice (SHO), their 
housing, handling, anesthesia, and cell aggregate injections were as described in Chapter 5.3.4.2, 
Chapter 5.3.5.1, and shown in Figure 6.1A. All recipient mice were males and remained intact 
(were not castrated). 
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Table 6.1.  Summary of the growth factors, recipients, and implants in each treatment group.  
 
Growth factors 
 
Catalogue no. 
 
Manufacturer 
 
Dose 
No. 
implants/mouse  
(n) 
No. 
mice/group 
(n) 
Total no. 
implants/group 
(n) 
Epidermal Growth 
Factor (EGF) 
236-EG-200 R&D Systems, 
Inc., 
Minneapolis, 
USA. 
20 ng/mL 
(low)  
2 µg/mL 
(high) 
8 
8 
7 
7 
56 
56 
Glial Cell Derived 
Neurotrophic 
Factor (GDNF) 
212-GD-010 “ 20 ng/mL 
(low)  
2 µg/mL 
(high) 
8 
8 
7 
7 
56 
56 
Fibroblast Growth 
Factor basic 146 aa 
(FGF2)  
233-FB-025 “ 1 µg/mL 8 7 56 
Fibroblast Growth 
Factor 9 (FGF9) 
273-F9-025 “ 5 µg/mL 8 7 56 
Vascular 
Endothelial Growth 
Factor 165 (VEGF)  
293-VE-010 “ 3.5 µg/mL 8 7 56 
Leukemia 
Inhibitory Factor 
(LIF) 
7734-LF-025 “ 5 µg/mL 8 7 56 
Stem Cell Factor 
(SCF)/c-Kit Ligand 
255-SC-010 “ 3.5 µg/mL 8 7 56 
Retinoic Acid (RA) 0695 Tocris Bio-
Techne,  
Ontario, CA 
3.5 × 10-5 M 8 7 56 
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Fig. 6.1. Representative photomacrographs demonstrating the recipient mice undergoing ectopic 
implantation of testis cell aggregates. (A) Testis cell aggregates were injected under the back skin 
of immunodeficient mice, where each injection site received ~100 ´ 106 cells in a volume of 0.1 
mL. (B) Each mouse received eight subcutaneous implants, four on each side of the midline. (C) 
Two randomly-selected implants were retrieved at 1, 2, and 4 wk post-implantation, followed by 
the final retrieval at 8 wk at the time of euthanasia. (D) Individual implants after retrieval.  
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6.3.2 Testis Collection and Preparation 
Donor testes were obtained through aseptic castration of 2 wk old Yorkshire-cross piglets from the 
Prairie Swine Centre, performed 24 h prior to each implantation day (15 pairs of donor testes/group 
of mice; hence n=165 piglets). The testes were prepared and processed for the isolation of testis 
cells as described in Chapter 3.3.1.  
6.3.3 Isolation of Testis Cells 
Isolation of testis cells was performed using a three-step enzymatic digestion method that has been 
established in our laboratory (Yang et al., 2010; Yang and Honaramooz, 2011). Briefly, the testis 
parenchyma was pooled to obtain a sufficient number of cells. For the ease and efficiency of 
isolation, the parenchyma was divided equally into 5 portions, where each portion was transferred 
into a 14 mL polypropylene round-tube and thoroughly minced with fine scissors for 10 min. Other 
detailed were as described in Chapter 3.3.2. The resultant cell pellet was resuspended and stored at 
4 °C overnight.  
6.3.4 Cell Aggregate Preparation  
On the day of implantation, the cells were resuspended, filtered, centrifuged at 500×g at 16 °C for 
10 min, and the media was discarded to yield a compact cell aggregate. The volume of cell 
aggregates was standardized to 8 mL in a 50 mL falcon test tube, the total dose of a designated 
growth factor in 0.5 mL was added, and the suspension was gently pipetted to ensure homogeneity. 
Most growth factors were used as a single dose, while EGF and GDNF were used in two doses 
(Table 6.1). Except for the RA, all growth factors were of the human recombinant origin (Table 
6.1). Preparation of growth factors was according to the manufacturers recommendations. For the 
controls, the cell aggregates were mixed with 0.5 mL of sterile Dulbecco’s phosphate-buffered 
saline (DPBS; catalogue no. 20-031-CV; Mediatech, Manassas, VA, USA). 
6.3.5 Cell Aggregate Implantation 
The mouse anesthesia and preparation for cell implantation were as described in Chapter 5.3.5.1. 
Approximately 0.8 mL of the designated cell aggregates for each mouse was aspirated into a 1-mL 
syringe, the skin was lifted to create a ‘tent’ (Fig. 6.1C), the needle (22-gauge) was inserted 
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subcutaneously on either side of the back skin, and 0.1 mL of the cell aggregates was injected into 
each site. The cell aggregates were prepared to contain ~100 × 106 cells per 0.1 mL. 
6.3.6 Retrieval of Implants 
Two implants were randomly retrieved from each mouse at 1, 2, and 4 wk post-implantation, 
performed under general anesthesia (as described in Chapter 5.3.5.3). A transverse linear skin 
incision was created adjacent to the edge of an implant, and the implant was gently severed from 
the skin and surrounding subcutaneous tissue. The incision was then closed with metal wound clips 
(Michel clips; catalogue no. 12-460-179; Miltex Inc., York, PA, USA) (Fig. 6.1E). The remaining 
implants were retrieved at 8 wk post-implantation at the time of euthanasia; performed using an 
overdose of isoflurane, followed by bilateral thoracotomy to ensure death.  
6.3.7 Tissue Processing and Histology 
The retrieved implants were fixed, processed, embedded in paraffin blocks, sectioned, and stained 
with hematoxylin and eosin (H&E) as described in Chapter 5.3.6.  
6.3.8 Gross and Histological Analysis 
The weight of each implant was recorded immediately after retrieval. During the final implant 
retrieval at euthanasia, the vesicular glands were also removed and their weight index calculated 
(%; relative to body weight). The histology slides were subjected to histomorphometric analysis, 
where each mouse (unless stated otherwise) was treated as the experimental unit. From each 
implant, digital micrographs were captured using a light microscope equipped with digital 
photomicrography (Northern Eclipse Image Analysis software version 7.0; Empix Imaging, 
Mississauga, ON, Canada). The obtained images included 40´ magnification for general 
observation of the implants (1 image) and 400´ magnification (5 randomly-selected fields) for 
detailed morphometric analysis. The histomorphometric evaluations of implants included their 
general development, seminiferous cords (SC), and prevalence of germ cells. The collected data 
included the number of recovered implants, implants showing de novo morphogenesis, SC 
development, rete testis-like structures (RT), and fluid-filled cavities (FFC); expressed as their 
prevalence and percentage (%). The surface area measurements included the total implant area 
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(mm2), the total area occupied by SC (%; relative to total implant area), the relative area of SC by 
category (i.e., % of regular SC, irregular SC, enlarged SC, and aberrant SC; relative to total SC 
occupied area). The relative number of gonocytes (per 1,000 Sertoli cells) in 2 wk samples was 
also counted in five randomly-selected fields per slide (at 400× magnification). All the 
measurements and counting were performed using ImageJ software (National Institutes of Health, 
Bethesda, Maryland, USA).  
6.3.9 Statistical Analyses 
All data are presented as mean ± standard error of mean (SEM). Unless otherwise stated, the 
statistical analyses were performed using repeated measures analysis of variance (ANOVA) and 
Chi-square tests. For percentage expression, the data were transformed using the Arcsin function 
prior to analysis. The level of significance was set at P < 0.05. Data were analyzed using the SPSS 
(Version 22.0, SPSS Inc., Armonk, NY, USA).  
 
 
  
 
155 
6.4 Results 
6.4.1 Gross Evaluations 
6.4.1.1  Recipient Mouse Body Weight and Vesicular Gland Index 
Five out of the 77 recipient mice died prior to the scheduled time of euthanasia; they were from 
different groups and died at various time points post-implantation. The body weight (BW) and 
vesicular gland (VG) index of the mice, recorded at the time of euthanasia (8 wk post-
implantation), did not differ among all groups (P > 0.05, treatment vs. control or low vs. high dose) 
(Table 6.2).  
6.4.1.2  Implant Recovery and Implant Weight  
We retrieved a total of 563 identifiable implants from the remaining 596 potential implants, which 
included recovery of some samples from the mice that died prematurely. Therefore, the overall 
implant recovery rate was ~95%, which ranged between 84% and 98%, but did not differ among 
the groups (P > 0.05, Table 6.2). The effect of time on implant weight was significant for all 
treatment groups (P < 0.05), except EGF-H, which only showed a tendency when compared with 
the control (P = 0.054; Fig. 6.2 and 6.3). The implant weight increased over time in most groups, 
except in EGF-H, GDNF-H, and RA groups. The effect of treatment on implant weight was 
significant only for FGF2 and LIF groups (P < 0.05), where the implant weight in FGF2 group at 
4 wk (99.3 ± 8.3 mg) was greater than that of the control (66.5 ± 10.1 mg; P < 0.05; Fig. 6.3A and 
6.3D). Interactions were also observed between the effects of time and treatment for implants 
weight in control vs. EGF-H, EGF-L vs. EGF-H, GDNF-L vs. GDNF-H and control vs. RA groups 
(P < 0.05; Fig. 6.2B, 6.2C, 6.2F, and 6.3F, respectively). Among these groups, unlike the control, 
the implant weight in EGF-H and RA groups did not differ over time (P > 0.05). Weight of implants 
in the EGF-H group was greater than EGF-L at 1- and 2 wk, and than control at 2 wk, while in the 
RA group was less than control at 8 wk (P < 0.05; Fig. 6.2 and 6.3). The weight of implants 
retrieved at 8 wk negatively correlated with the VG index in EGF-H and GDNF-L groups, as well 
as overall (Table 6.3).   
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Table 6.2. The recipient mouse body weight, vesicular gland index, and the relative number of 
implants retrieved at the time of euthanasia. 
 
Group 
Mouse BW 
(g) 
VG index  
(%) 
No. implant 
retrieved/total (%) 
Control 32.32 ± 1.2  0.69 ± 0.40 42/46 (91) 
EGF-L 33.62 ± 0.9 0.61 ± 0.10 53/54 (93) 
EGF-H 34.99 ± 1.4  0.77 ± 0.04 55/56 (98) 
GDNF-L 32.60 ± 1.3 0.70 ± 0.10  47/50 (94) 
GDNF-H 31.79 ± 0.5  0.78 ± 0.03 47/56 (84) 
FGF2 33.56 ± 1.1 0.67 ± 0.03 54/56 (96) 
FGF9 33.73 ± 0.7 0.79 ± 0.05 55/56 (98) 
VEGF 33.95 ± 0.9 0.64 ± 0.10 52/54 (96) 
LIF 34.20 ± 0.9 0.69 ± 0.04 53/56 (95) 
SCF 32.04 ± 0.5 0.73 ± 0.04 52/56 (93) 
RA 30.90 ± 0.8 0.77 ± 0.01 53/56 (95) 
  Total 563/596 (94.5) 
 
Mouse body weight (BW: g); vesicular gland index (VG: % weight of VG/BW); epidermal growth factor (EGF); 
glial-derived neurotrophic factor (GDNF); fibroblast growth factor (FGF2); fibroblast growth factor 9 (FGF9); 
vascular endothelial growth factor (VEGF); leukemia inhibitory factor (LIF); stem cell factor (SCF); retinoic acid 
(RA). 
Each group was compared with the control.  
The high (H) and low (L) doses of the same growth factor groups were compared with each other. 
BW and VG index data were analyzed using independent t-tests.  
Implant % were analyzed using the Chi-square tests.  
The data did not differ (P > 0.05) among all compared groups.  
  
 
 
Fig. 6.2. The weight of implants (mg) in (A-C) the epidermal growth factor (EGF) and (D-F) glial-derived neurotrophic growth factor (GDNF) 
groups over time. Two doses of each growth factor were evaluated, low dose (20 ng/mL of cells): (A) EGF-L and (D) GDNF-L, and high dose 
(2 mg/mL of cells): (B) EGF-H and (E) GDNF-H. The weight of implants was compared with the control and between the doses (low vs. high) 
(C) and (F). The growth factors were added to the neonatal porcine testis cell aggregates (~100 ×106 cells) before implantation under the back 
skin of recipient mice (n = 7 per group). The control implants received no growth factor. Implants were retrieved at 1, 2, 4, and 8 wk post-
implantation. Data are mean ± SEM. ab Data with different letters between treatments differ significantly (P < 0.05). xy Data with different 
letters over time differ significantly (P < 0.05). ***The main effect of time was significant (P < 0.05), but no individual group differed (P > 
0.05) at post-hoc analysis. 
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Fig. 6.3. The weight of implants (mg) in the (A) basic fibroblast growth factor (FGF2), (B) fibroblast growth factor 9 (FGF9), (C) vascular 
endothelial growth factor (VEGF), (D) leukemia inhibitory factor (LIF), (E) stem cell factor (SCF), and (F) retinoic acid (RA) groups over 
time. The implants weight was compared with the control and over time. The growth factors were added to the neonatal porcine testis cell 
aggregates (~100 ×106 cells) before implantation under the back skin of recipient mice (n = 7 per group). The control implants received no 
growth factor. Implants were retrieved at 1, 2, 4, and 8 wk post-implantation. Data are mean ± SEM. ab Data with different letters between 
treatments differ significantly (P < 0.05). xyz Data with different letters over time differ significantly (P < 0.05). ***The main effect of treatment 
was significant (P < 0.05), but no individual group differed (P > 0.05) at post-hoc analysis.
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Table 6.3. Relationships among the recipient mouse vesicular gland index, implant weight, implant 
area, and seminiferous cord area at euthanasia (8 wk post-implantation) in EGF and GDNF groups 
of implants. 
 
Vesicular gland (VG) index (% weight of VG/body weight); epidermal growth factor (EGF); glial-derived 
neurotrophic factor (GDNF).  
The high (H) and low (L) doses of the same growth factor groups were compared with each other. 
Each group was also compared with the control.  
Pearson's correlation coefficients (r) were considered significant when P < 0.05.  
 
Group 
(No. mice) 
 
Variable 
VG Index  
(%) 
Implant weight 
(mg) 
Implant area  
(mm2) 
SC area  
(mm2) 
r P r P r P r P 
 
Overall 
(n = 72) 
VG Index - - -0.29 0.01 -0.12 0.28 -0.18 0.12 
Implant weight -0.29 0.01 - - 0.32 0.00 0.01 0.97 
Implant area -0.12 0.28 0.32 0.00 - - 0.37 0.01 
SC area -0.18 0.12 0.01 0.97 0.37 0.01 - - 
 
Control 
(n = 5) 
VG Index - - 0.02 0.98 0.41 0.37 0.24 0.61 
Implant weight 0.02 0.98 - - -0.83 0.02 -0.88 0.01 
Implant area 0.41 0.37 -0.83 0.02 - - 0.89 0.01 
SC area 0.24 0.61 -0.88 0.01 0.89 0.01 - - 
 
EGF-L 
(n = 6) 
VG Index - - -0.57 0.19 -0.07 0.89 -0.36 0.42 
Implant weight -0.57 0.19 - - -0.64 0.12 -0.51 0.25 
Implant area -0.07 0.89 -0.64 0.12 - - 0.92 0.00 
SC area -0.36 0.42 -0.51 0.25 0.92  0.00 - - 
 
EGF-H 
(n = 7) 
VG Index - - -0.79 0.04 -0.70 0.08 -0.42 0.04 
Implant weight -0.79 0.04 - - 0.53 0.22 0.45 0.31 
Implant area -0.70 0.08 0.53 0.22 - - -0.16 0.74 
SC area -0.42 0.04 0.45 0.31 -0.16 0.74 - - 
 
GDNF-L 
(n = 7) 
VG Index - - -0.86 0.01 0.35 0.45 0.27 0.56 
Implant weight -0.86 0.01 - - 0.05 0.92 0.04 0.93 
Implant area 0.35 0.45 0.05 0.92 - - 0.01 0.98 
SC area 0.27 0.56 0.04 0.93 0.01 0.98 - - 
 
GDNF-H 
(n = 6) 
VG Index - - 0.64 0.12 0.92 0.00 -0.32 0.49 
Implant weight 0.64 0.12 - - 0.47 0.28 -0.47 0.28 
Implant area 0.92 0.00 0.47 0.28 - - -0.48 0.28 
SC area -0.32 0.49 -0.47 0.28 -0.48 0.28 - - 
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6.4.2 Histological Evaluations 
6.4.2.1  Implant Area 
An effect of time on implant area, measured at the widest cross-section of the samples, was 
observed in all groups (P < 0.05; Fig. 6.4 and 6.5). Overall, the implant area of 1 and 2 wk samples 
was smaller (P < 0.05) than that of 4 and 8 wk samples. An effect of treatment on implant area was 
observed in EGF-L, FGF2, and SCF groups, and in GDNF-L vs. GDNF-H groups (P < 0.05; Fig. 
6.4A, 6.5A, 6.5E, and 6.4F, respectively). Among groups, the implant area in EGF-L and SCF 
groups at 8 wk was larger than that in control (7.60 ± 0.4 mm2; P < 0.05; Fig. 6.4A and 6.5E). 
Interactions were observed between the effects of time and treatment for implants area in control 
vs. GDNF-H, EGF-L vs. EGF-H, and GDNF-L vs. GDNF-H (P < 0.05; Fig. 6.4E, 6.4C, and 6.4F, 
respectively). The area of implants was larger in EGF-H than EGF-L at 2 wk and larger in GDNF-
H than control at 1 wk, while at 8 wk it was smaller in GDNF-H than both GDNF-L and control 
(P < 0.05; Fig. 6.4). At 8 wk, the overall area of implants positively correlated with the implants 
weight (r = 0.32; P < 0.05). Among individual groups, this correlation was strongly negative in the 
control (r = - 0.83; P < 0.05), while it was strongly positive in LIF (r = 0.88; P < 0.05; Tables 6.3 
and 6.4). The implant area and VG index were correlated only in GDNF-H group (r = 0.92; P < 
0.005) and VEGF (r = -0.87; P < 0.05; Table 6.3 and 6.4). 
6.4.2.2  General Development/Regeneration of Testis Tissue 
Upon histological examination, a total of 500 out of 563 retrieved implants (89%) had at least some 
level of de novo regenerated testis parenchyma. Typical development observed in implants at 1 wk 
included enclosure within a defined connective tissue capsule, and the presence of random cellular 
arrangements (Fig. 6.6A). In some implants at 1 wk post-implantation, the formation of 
seminiferous cords (SC) was also evident, which first appeared at the periphery of implants. At 2 
wk post-implantation, individual implants typically had both random cellular arrangements and SC 
formations at the same time (Fig. 6.6B). At 4 wk, the area covered by random cellular arrangements 
was reduced and, especially at 8 wk, was replaced by cordal/tubular structures, and occasionally 
by rete testis-like formations (Fig. 6.6C-D). The overall percentage of implants with regenerated 
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testis tissue ranged from 82% to 93%, which did not differ among groups or over time (P > 0.05; 
Table 6.5).  
  
 
 
Fig. 6.4. The implant areas (mm2) measured at the widest cross-section in (A-C) epidermal growth factor (EGF) and (D-F) glial-derived 
neurotrophic factor (GDNF) samples over time. Two doses of each growth factor were evaluated, low dose (20 ng/mL of cells): (A) 
EGF-L and (D) GDNF-L, and high dose (2 mg/mL of cells): (B) EGF-H and (E) GDNF-H. The implant areas were compared with the 
control and between the doses (low vs. high) (C) and (F). The growth factors were added to the neonatal porcine testis cell aggregates 
(~100 ×106 cells) before implantation under the back skin of recipient mice (n = 7 per group). The control implants received no growth 
factor. Implants were retrieved at 1, 2, 4, and 8 wk post-implantation. Data are mean ± SEM. ab Data with different letters between 
treatments differ significantly (P < 0.05). xyz/X’Y’ Data with different letters over time differ significantly (P < 0.05).  
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Fig. 6.5. The implant areas (mm2) measured at the widest cross-section in the (A) basic fibroblast growth factor (FGF2), (B) fibroblast 
growth factor 9 (FGF9), (C) vascular endothelial growth factor (VEGF), (D) leukemia inhibitory factor (LIF), (E) stem cell factor (SCF), 
and (F) retinoic acid (RA) groups over time. The implant areas were compared with the control and over time. The growth factors were 
added to the neonatal porcine testis cell aggregates (~100 ×106 cells) before implantation under the back skin of recipient mice (n = 7 
per group). The control implants received no growth factor. Implants were retrieved at 1, 2, 4, and 8 wk post-implantation. Data are 
mean ± SEM. ab Data with different letters between treatments differ significantly (P < 0.05). xyz Data with different letters over time 
differ significantly (P < 0.05). 
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Table 6.4. Relationships among the recipient mouse vesicular gland index, implant weight, implant 
area, and seminiferous cord area at euthanasia (8 wk post-implantation) in FGF2, FGF9, LIF, SCF, 
and RA groups of implants. 
 
Group 
(No. mice) 
 
Variable 
VG Index  
(%) 
Implant weight  
(mg) 
Implant area  
(mm2) 
SC area  
(mm2) 
r P r P r P r P 
 
FGF2 
(n = 7) 
VG Index - - 0.18 0.70 0.69 0.09 -0.18 0.70 
Implant weight 0.18 0.70 - - 0.43 0.34 0.19 0.68 
Implant area 0.69 0.09 0.43 0.34 - - 0.46 0.30 
SC area -0.18 0.70 0.19 0.68 0.46 0.30 - - 
 
FGF9 
(n = 7) 
VG Index - - -0.27 0.56 -0.05 0.92 0.21 0.65 
Implant weight -0.27 0.56 - - 0.26 0.57 -0.26 0.58 
Implant area -0.05 0.92 0.26 0.57 - - -0.68 0.09 
SC area 0.21 0.65 -0.26 0.58 -0.68 0.09 - - 
 
VEGF 
(n = 6) 
VG Index - - 0.19 0.69 -0.87 0.11 0.25 0.59 
Implant weight 0.19 0.69 - - -0.09 0.85 0.25 0.59 
Implant area -0.87 0.11 -0.09 0.85 - - -0.48 0.27 
SC area 0.25 0.59 0.25 0.59 -0.48 0.27 - - 
 
LIF 
(n = 7) 
VG Index - - 0.44 0.32 0.24 0.61 -0.02 0.97 
Implant weight 0.44 0.32 - - 0.88 0.01 0.14 0.77 
Implant area 0.24 0.61 0.88 0.01 - - 0.42 0.35 
SC area -0.02 0.97 0.42 0.35 0.42 0.35 - - 
 
SCF 
(n = 7) 
VG Index - - -0.37 0.41 0.05 0.92 0.26 0.58 
Implant weight -0.37 0.41 - - 0.32 0.49 -0.16 0.73 
Implant area 0.05 0.92 0.32 0.49 - - 0.45 0.31 
SC area 0.26 0.58 -0.16 0.73 0.45 0.31 - - 
 
RA 
(n = 7) 
VG Index - - 0.06 0.90 -0.69 0.09 -0.46 0.30 
Implant weight 0.06 0.90 - - 0.21 0.65 0.35 0.44 
Implant area -0.69 0.09 0.21 0.65 - - 0.16 0.73 
SC area -0.46 0.30 0.35 0.44 0.16 0.73 - - 
 
Vesicular gland (VG) index (% weight of VG/body weight); fibroblast growth factor (FGF2); fibroblast growth 
factor 9 (FGF9); vascular endothelial growth factor (VEGF); leukemia inhibitory factor (LIF); stem cell factor 
(SCF); retinoic acid (RA).  
Each group was compared with the control.  
Pearson's correlation coefficients (r) were considered significant when P < 0.05. 
Data for the control group is already included in Table 6.3. 
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Fig. 6.6. Representative histological photomicrographs demonstrating de novo morphogenesis of 
porcine testis tissue after implantation of porcine testis cell aggregates under the back skin of 
recipient mice. Each image represents a typical morphology observed at 1, 2, 4, and 8 wk post-
implantation. (A) The morphogenesis at 1 wk was characterized by random cellular formations, 
demarcated in encapsulated areas. Note the initial formation of seminiferous cords starting from 
the periphery of the implants (white arrows). (B) More defined formation of seminiferous cords 
seen at 2 wk post-implantation; overall morphology of the cords starting to resemble seminiferous 
cords in intact testis tissue. The area occupied by the cords also continuously increased. (C) The 
random cellular formations diminished at 4 wk, and the implant area was almost entirely occupied 
by seminiferous cords. (D) The testis tissue underwent extensive morphological changes over time. 
The presence of large and irregularly shaped seminiferous cords become especially prominent at 8 
wk post-implantation. Note also the presence of the rete testis-like structures, which initially 
developed in the center of implants and then branched radially over time (yellow arrows). (H&E 
Staining, Scale bar: 200 µm).  
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Table 6.5. The prevalence of testis tissue regeneration among implants of different groups and over 
time. 
 
Group 
No. implants with regenerated testis tissue/total implants (%) 
1 wk 2 wk 4 wk 8 wk Overall 
Control 10/13 (77) 10/11(91) 9/10 (90) 8/8 (100) 37/42 (88) 
EGF-L 14/14 (100) 13/14 (93) 10/13 (77) 12/12 (100) 49/53 (93) 
EGF-H 14/14 (100) 12/14 (86) 8/13 (62) 13/14 (93) 47/55 (86) 
GDNF-L 14/14 (100) 9/11 (82) 9/10 (90) 11/12 (92) 43/47 (92) 
GDNF-H 9/11 (82) 9/13 (69) 10/12 (83) 11/11 (100) 39/47 (83) 
FGF2 11/12 (92) 12/14 (86) 12/14 (86) 14/14 (100) 49/54 (91) 
FGF9 13/13 (100) 11/14 (79) 13/14 (93) 12/14 (86) 49/55 (89) 
VEGF 12/14 (86) 13/14 (93) 11/12 (92) 12/12 (100) 48/52 (92) 
LIF 10/13 (77) 13/13 (100) 11/13 (85) 14/14 (100) 48/53 (91) 
SCF 9/14 (64) 13/14 (93) 9/12 (75) 12/12 (100) 43/52 (83) 
RA 12/13 (92) 11/14 (79) 12/13 (92) 13/13 (100) 48/53 (91) 
Total 128/145 (88.2) 126/146 (85.1) 114/136 (83.8) 132/136 (97.1) 500/563 (88.8) 
 
Data are the number and % of implants showing de novo morphogenesis of testis tissue among the retrieved samples 
at each time point.  
Epidermal growth factor (EGF); glial-derived neurotrophic factor (GDNF); fibroblast growth factor (FGF2); 
fibroblast growth factor 9 (FGF9); vascular endothelial growth factor (VEGF); leukemia inhibitory factor (LIF); 
stem cell factor (SCF); retinoic acid (RA).  
The high (H) and low (L) doses of the same growth factor groups were compared with each other. 
Each group was also compared with the control.  
The data were compared using the Chi-square tests. 
The data did not differ (P > 0.05) among all compared groups. 
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6.4.2.3 Formation of Seminiferous Cords (SC)  
6.4.2.3.1 First Appearance and Prevalence of SC in Implants  
Implants displaying SC formation appeared as early as 1 wk post-implantation (earliest) in implants 
from recipient mice of all groups, except RA, in which the earliest implants with SC were observed 
at 2 wk (Table 6.6). Compared with the control, first appearance of SC in implants was advanced 
in all groups, except LIF and RA groups. All implants in all group contained SC by 4 wk, except 
those in RA group with some implants showing SC as late as 8 wk. Although, the overall number 
of implants with SC did not differ among groups (P > 0.05), 1 wk implants in RA group contained 
no SC (0%), which was different from the control (30%, P < 0.05), and those in EGF-L group had 
less SC (14%) than EGF-H (64%, P < 0.01). At 2 wk, more implants in RA and FGF2 groups had 
developed SC than in controls (91% and 92%, respectively vs. 50%; Table 6.6).  
6.4.2.3.2 SC Area in Implants  
The area occupied by SC in implants (%, relative to the total implant area) increased at each 
examined time point (i.e., from 2 to 4 wk, and from 4 to 8 wk) in all groups (P < 0.05; Fig. 6.7 and 
6.8). An effect of treatment on the SC area was observed for GDNF-L, FGF2 groups and in GDNF-
L vs. GDNF-H groups (P < 0.05; Fig. 6.7D, 6.8A, and 6.7F, respectively). The SC area in 2 and 4 
wk GDNF-L implants was larger than both the control and GDNF-H groups (Fig. 6.7D and 6.7F). 
Overall, there was a positive correlation between SC area and implant area (r = 0.37; P < 0.05). 
Among the groups, this correlation was strongly positive for the control (r = 0.89; P < 0.01) and 
EGF-L groups (r = 0.92; P < 0.01). However, SC area in control implants had a strongly negative 
correlation with implants weight (r = -0.88; P < 0.05; Table 6.3). 
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Table 6.6. The prevalence and first appearance of seminiferous cord formations among implants 
from different groups. 
 
Group 
No. implants with SC/total implants (%) First appearance (wk) 
1 wk 2 wk 4 wk 8 wk Overall Earliest Median Latest 
Control 3/10 (30) 5/10 (50) 9/9 (100) 8/8 (100) 25/37 (68) 1 4 4 
EGF-L 2/14 (14) 10/13 (77) 10/10 (100) 12/12 (100) 34/49 (69) 1 2 4 
EGF-H 9/14 (64)†† 6/12 (50) 8/8 (100) 13/13 (100) 36/47 (77) 1 2 4 
GDNF-L 9/14 (64) 8/9 (89) 9/9 (100) 11/11 (100) 37/43 (86) 1 2 4 
GDNF-H 5/9 (56) 6/9 (67) 10/10 (100) 11/11 (100) 32/39 (82) 1 2 4 
FGF2 4/11 (36) 11/12 (92)* 12/12 (100) 14/14 (100) 41/49 (84) 1 2 4 
FGF9 5/13 (39) 9/11 (82) 13/13 (100) 12/12 (100) 39/49 (80) 1 2 4 
VEGF 5/12 (42) 10/13 (77) 11/11 (100) 12/12 (100) 38/48 (79) 1 2 4 
LIF 3/10 (30) 8/13 (62) 10/11 (91) 14/14 (100) 35/48 (73) 1 4 8 
SCF 3/9 (33) 8/13 (62) 9/9 (100) 12/12 (100) 32/43 (74) 1 2 4 
RA 0/12 (0)* 10/11(91)* 12/12 (100) 13/13 (100) 35/48 (73) 2 4 4 
Total 48/128 
(37.5) 
91/126 
(72.2) 
113/114 
(99.1) 
132/132  
(100) 
384/500 
(76.8) 
   
 
Data are the prevalence of seminiferous cord (SC) formations and their first appearance among implants showing de 
novo morphogenesis of testis tissue at each time point.  
Epidermal growth factor (EGF); glial-derived neurotrophic factor (GDNF); fibroblast growth factor (FGF2); 
fibroblast growth factor 9 (FGF9); vascular endothelial growth factor (VEGF); leukemia inhibitory factor (LIF); 
stem cell factor (SCF); retinoic acid (RA).  
The high (H) and low (L) doses of the same growth factor groups were compared with each other. 
Each group was also compared with the control.  
The data were compared using the Chi-square tests 
The first appearance of SC was assessed based on their first occurrence; earliest, the midpoint of occurrence; median, 
and the last occurrence from all implant retrieved in a single recipient.  
* P < 0.05 compared to the control. 
†† P < 0.01 compared to the lower dose. 
  
  
 
 
Fig. 6.7. The area occupied by seminiferous cords (SC) relative to the total implant area (%), measured at the widest cross-section of 
samples over time in (A-C) epidermal growth factor (EGF) and (D-F) glial-derived neurotrophic factor (GDNF) groups. Two doses of 
each growth factor were evaluated, low dose (20 ng/mL of cells): (A) EGF-L and (D) GDNF-L, and high dose (2 mg/mL of cells): (B) 
EGF-H and (E) GDNF-H. The SC% areas were compared with the control and between the doses (low vs. high) (C) and (F). The growth 
factors were added to the neonatal porcine testis cell aggregates (~100 ×106 cells) before implantation under the back skin of recipient 
mice (n = 7 per group). The control implants received no growth factor. Implants were retrieved at 1, 2, 4, and 8 wk post-implantation, 
although the SC area developed in implants retrieved at 1 wk was excluded in this analysis. Data are mean ± SEM. ab Data with different 
letters between treatments differ significantly (P < 0.05). xyz Data with different letters over time differ significantly (P < 0.05).  
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Fig. 6.8. The area occupied by seminiferous cords (SC) relative to the total implant area (%),measured at the widest cross-section of 
samples over time in the (A) basic fibroblast growth factor (FGF2), (B) fibroblast growth factor 9 (FGF9), (C) vascular endothelial 
growth factor (VEGF), (D) leukemia inhibitory factor (LIF), (E) stem cell factor (SCF), and (F) retinoic acid (RA) groups. The SC% 
areas of each group were compared with the control. The growth factors were added to the neonatal porcine testis cell aggregates (~100 
×106 cells) before implantation under the back skin of recipient mice (n = 7 per group). The control implants received no growth factor. 
Implants were retrieved at 1, 2, 4, and 8 wk post-implantation, although the SC area developed in implants retrieved at 1 wk was excluded 
in this analysis. Data are mean ± SEM. ab Data with different letters between treatments differ significantly (P < 0.05). xyz Data with 
different letters over time differ significantly (P < 0.05). *** The main effect of treatment was significant (P < 0.05), but no individual 
group differed (P > 0.05) at post-hoc analysis. 
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6.4.2.3.3 Classification of SC 
Upon histological examination, SC within the retrieved implants displayed various morphology 
which could be classified into four types: 1) regular SC, referring to those with a normal 
morphology, typical of SC in the donor neonatal porcine testis tissue (diameter: 48.7 ± 0.2 µm, 
range: 34.4-57.4 µm, n = 500 SC; Fig. 6.9A); 2) irregular SC, with obvious branching, not 
normally observed in the donor testis tissue (149.7 ± 1.6 µm, 76.8-259.2 µm, n = 500; Fig. 6.9B); 
3) enlarged SC, characterized by considerably larger diameter than age-matched regular SC (132.4 
± 1.0 µm, 63.3-237.2 µm, n = 500; Fig. 6.9C); and 4) aberrant SC, or SC-like structures completely 
or partially enclosed by a cuboidal cell lining (94.7 ± 1.6 µm, 38.6-199.9 µm , n = 500; Fig. 6.9D). 
Relative prevalence of each SC type within implants ranged from 0% to 100%. When the relative 
prevalence of SC types within implants of all examined time points were combined (i.e., 2, 4, and 
8 wk, n = 822), regular and enlarged SC were more prevalent (~30% each, P < 0.005) than irregular 
and aberrant SC (23% and 18%, respectively) (Fig. 6.10A). Similarly, the overall area of implants 
covered by regular SC was greatest (39 ± 2%, P < 0.0005), followed irregular and enlarged SC (26 
± 2% and 25 ± 2%, respectively), and aberrant SC (10 ± 1%) (Fig. 6.10C). 
(a) Regular SC 
The overall prevalence of the regular type of SC was 100% (41/41 implants) at 1 wk, and 97% 
(88/91) at 2 wk, but dropped (P < 0.0005) to 45% of implants at 4 wk post-implantation. Among 
different groups at 4 wk, this prevalence was lower (0%, P < 0.0005) in both GDNF-H and RA 
groups than in control (78%), and also lower in GNDF-H than in GNDF-L group (0% vs. 78%, P 
< 0.0005). At 8 wk, the prevalence of regular SC was higher in FGF2, VEGF, LIF, and SCF groups 
than in control (P < 0.05; Fig. 6.10B and Table 6.7). 
The overall area occupied by regular SC decreased over time (P < 0.0005), from 91% at 2 wk to 
21% and 19% at 4 and 8 wk, respectively (P < 0.005). Among individual groups at 4 wk, this area 
was smaller (P < 0.01) in FGF9, GDNF-H, and RA groups than in control, and also smaller (P< 
0.005) in GDNF-H than GDNF-L group. At 8 wk, this area was larger (P < 0.005) in FGF2 group 
than in control, and greater in EGF-L than EGF-H group (Fig. 6.10D and Table 6.7). 
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 (b) Irregular SC 
The first irregular SC was observed at 2 wk in only ~1% of implants (1/91), but their prevalence 
rapidly increased (P < 0.005) to 70% and 83% at 4 and 8 wk, respectively. Consequently, compared 
with regular SC, the prevalence of irregular SC was lower (P < 0.005) at 2 wk, but higher (P < 
0.005) at 4 and 8 wk post-implantation. Irregular SC were conspicuously absent in RA (0% of 
implants) at 4 wk and therefore lower (P < 0.005) than the control (89%). On the other hand, this 
prevalence at 8 wk was 100% for both GDNF-L and RA, and hence higher than the control (63%; 
P < 0.005; Fig. 6.10B and Table 6.7). 
The overall area of implants occupied by irregular SC increased over time (P < 0.0005), from 1 
wk (1%) to 4 and 8 wk (35%), where at 8 wk it was highest among all SC types (P < 0.0005; Fig. 
6.10D). Among individual groups at 8 wk, this area was larger (P < 0.005) in both EGF-H and 
GDNF-H groups than in their respective low-dose groups (Fig. 6.10D and Table 6.7). 
(c) Enlarged SC 
The overall prevalence of enlarged SC in implants was highest at 4 wk (97%), followed by 8 wk 
(89%, P < 0.05), and was lowest at 2 wk (20%, P < 0.0005) (Fig. 6.10B). Compared with regular 
SC, enlarged SC were also less prevalent at 2 wk (P < 0.0005), but most prevalent at both 4 and 8 
wk (P < 0005). At 2 wk, no enlarged SC were observed in implants of RA, GDNF-L, EGF-H, and 
FGF9 groups, while their prevalence ranged between 13% and 60% among other groups. At 2 wk, 
more implants had enlarged SC in EGF-L than in EGF-H (P < 0.04). At 8 wk, multiple groups had 
enlarged SC in all (100%) their implants (i.e., GDNF-L, FGF2, LIF, SCF, and RA) and therefore 
differed from the control (63%; P < 0.005; Fig. 6.10B and Table 6.7). 
The overall area of implants containing enlarged SC was larger (P < 0.005) at 4 wk (43%) than at 
2 wk (8%) and 8 wk (23%). At 4 wk, enlarged SC covered the largest area (P < 0.0005) among all 
SC types. Among individual groups, this area was larger in RA (100%) than in the control (28%, 
P < 0.0005; Fig. 6.10D and Table 6.7). 
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(d) Aberrant SC 
The aberrant type of SC first appeared at 4 wk in 22% of combined implants but this prevalence 
increased to 91% at 8 wk (P < 0.0005). Compared with regular SC, the prevalence of aberrant SC 
was lower at 4 wk (P < 0.0005) and higher at 8 wk (P < 0.0005). At 4 wk, while no aberrant SC 
(0%) were observed in implants of the control, GDNF-L, or RA groups, this prevalence was higher 
(P < 0.05) in EGF-H (30%), SCF (44%), and FGF9 (69%) groups, as compared with the control. 
At 8 wk, implants of all groups had aberrant SC, ranging from 71% to 100%, which did not differ 
among groups (P < 0.05; Fig. 6.10B and Table 6.7). 
The area of aberrant SC in combined implants at 4 wk was only 1%, but increased to 23% at 8 wk 
(P < 0.0005). Compared with the area of other SC types at 4 wk, aberrant SC covered the least area 
(P < 0.05). Among the groups at 8 wk, the area of aberrant SC was smaller (P < 0.05) in FGF2 
(5%), LIF (10%), and RA (10%) groups than in the control (35%; Fig. 6.10D and Table 6.7).  
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Fig. 6.9. Representative histological photomicrographs demonstrating typical morphology of 
seminiferous cords (SC) classified into: (A) regular (rSC), (B) irregular (irSC), (C) enlarged (eSC), 
and (D) aberrant seminiferous cords (abSC). Additional observed structures in the implants 
included (E) rete testis-like structure (RT) and (F) fluid-filled cavities (FFC). (H&E Staining, Scale 
bar: 50µm (A-E) and 200 µm (F)). Also see Appendix B.1 for representative normal morphology 
of testis tissue cross-sections from pigs at different developmental stages.  
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Fig. 6.10. The prevalence (%) of different types of seminiferous cords (SC) as well as their relative 
area (%, compared with the total implant area), measured at the widest cross-section of samples. 
(A) The overall prevalence (%) of different types of SC in all implants, and (B) their prevalence at 
each time point. (C) The overall relative area occupied by different types of SC in all implants, and 
(D) their relative area at each time point. The data for the prevalence and area were analyzed using 
Chi-Square test and one-way ANOVA, respectively. Data are the relative number of observations 
(% ± SEM). * The regular type of SC as the basis of comparison. abc Data with different letters 
between treatments differ significantly (P < 0.05). xyz Data with different letters differ significantly 
over time (P < 0.05). 
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Table 6.7. The prevalence of each type of seminiferous cords and their relative area among 
implants of different groups. 
 
 
 
Group 
 
 
 
Wk 
Type of SC 
Regular Irregular Enlarged Aberrant 
No.  
(%) 
Area 
(%) 
No.  
(%) 
Area  
(%) 
No.  
(%) 
Area  
(%) 
No.  
(%) 
Area  
(%) 
 
Control 
 
2 5/5 (100) 90 ± 10 0/5 (0) 0 1/5 (20) 10  0/5 (0) 0 
4 7/9 (78) 32 ± 9 8/9 (89) 36 ± 8 9/9 (100) 33 ± 7 0/9 (0) 0  
8 1/8 (13) 6 5/8 (63) 31 ± 12 5/8 (63) 28 ± 9 7/8 (88) 35 ± 12 
 
EGF-L 
 
2 9/10 (90) 78 ± 11 0/10 (0) 0  5/10 (50) 22 ± 8 0/10 (0) 0 
4 5/10 (50) 29 ± 11 9/10 (90) 42 ± 10 9/10 (90) 28 ± 7 3/10 (30) 4 ± 1 
8 6/12 (50) 24 ± 9 6/12 (50) 16 ± 7 7/12 (58) 15 ± 6 12/12 (100) 45 ± 10 
 
EGF-H 
 
2 6/6 (100) 100 0/6 (0) - (-) 0/6 (0)  0  0/6 (0) 0 
4 5/8 (63) 10 ± 6 4/8(50) 36 ± 14 8/8 (100)† 53 ± 14 3/8 (38)* 1 ± 0.4 
8 3/13 (23) 4 ± 3† 11/13 (85)  49 ± 9†† 11/13 (84) 14 ± 4 13/13 (100) 37 ± 10 
 
GDNF-L 
 
2 8/8 (100) 100 0/8 (0) 0 0/8 (0) 0 0/8 (0) 0 
4 7/9 (78) 46 ± 11 6/9 (67) 36 ± 12 9/9 (100) 18 ± 3 0/9 (0) 0 
8 4/11 (36) 14 ± 7 11/11 (100)* 29 ± 4 11/11 (100)* 27 ± 6 10/11 (91) 31 ± 9 
 
GDNF-H 
 
2 6/6 (100) 92 ± 8 0/6 (0) 0  1/6 (17) 8 0/6 (0) 0 
4 0/10 (0)**†† 0**†† 9/10 (90) 59 ± 10 9/10 (90) 33 ± 10 1/10 (10) 0.30 
8 2/11 (19) 13 ± 9 10/11(91) 52 ± 10† 10/11 (91) 24 ± 8 9/11 (82) 12 ± 3 
 
FGF2 
 
2 11/11 (100) 98 ± 1 0/11 (0) 0 3/11 (27) 2 ± 1 0/11 (0) 0 
4 6/12 (50) 22 ± 9 9/10 (90) 30 ± 9  12/12 (100) 47 ± 7  2/12 (17) 1 ± 1 
8 14/14 (100)** 53 ± 6** 12/14 (86) 21 ± 5 14/14 (100)* 20 ± 3 12/14 (86) 5 ± 1** 
 
FGF9 
 
2 9/9 (100) 100 0/9 (0) 0 0/9 (0) 0 0/9 (0) 0 
4 5/13 (39) 11 ± 4* 12/13 (92) 33 ± 6 13/13 (100) 52 ± 6  9/13 (69)** 4 ± 1 
8 3/12 (25) 9 ± 5 9/12 (75) 33 ± 7 10/12 (83) 21 ± 5  12/12 (100) 37 ± 10 
 
VEGF 
 
2 9/10 (90) 70 ± 12 1/10 (10) 10  6/10 (60) 21 ± 9 0/10 0 
4 5/11 (46) 32 ± 12 6/11 (55) 33 ± 11 11/11 (100) 35 ± 7 2/11 (18) 1 ± 1 
8 7/12 (58)* 21 ± 8 11/12 (92) 32 ± 7 10/12 (83) 19 ± 4 11/12 (92) 29 ± 7 
 
LIF 
 
2 7/8 (88) 88 ± 13 0/8 (0) 0  1/8 (13) 13  0/8 (0) 0  
4 5/10 (50) 24 ± 8 10/10 (100) 54 ± 10 8/10 (80) 22 ± 9 1/10 (10) 1  
8 9/14 (64)* 29 ± 9 11/14 (79) 37 ± 9 14/14 (100)* 24 ± 4  10/14 (71) 10 ± 3* 
 
SCF 
 
2 8/8 (100) 99 ± 1 0/8 (0) 0 1/8 (13) 1 0/8 (0) 0 
4 6/9 (67) 35 ± 12 8/9 (89) 35 ± 9 9/9 (100) 27 ± 6 4/9 (44)* 3 ± 2 
8 7/12 (58)* 26 ± 9 11/12 (92) 26 ± 6 12/12 (100)* 28 ± 4 11/12 (92) 20 ± 5 
 
RA 
 
2 10/10 (100) 100 0/10 (0) 0 0/10 (0) 0 0/10 (0) 0 
4 0/12 (0)** 0** 0/12 (0)** 0** 12/12 (100) 100** 0/12 (0) 0 
8 0/13 (0) 0 13/13 (100)* 58 ± 6 13/13 (100)* 32 ± 7 13/13 (100) 10 ± 3* 
 
Data are the prevalence (%) of different types of seminiferous cord (SC) and their relative area (%, compared with the 
total implant area), measured at the widest cross-section of samples. 
Epidermal growth factor (EGF); glial-derived neurotrophic factor (GDNF); fibroblast growth factor (FGF2); fibroblast 
growth factor 9 (FGF9); vascular endothelial growth factor (VEGF); leukemia inhibitory factor (LIF); stem cell factor 
(SCF); retinoic acid (RA).  
The high (H) and low (L) doses of the same growth factor groups were compared with each other. 
Each group was also compared with the control.  
Data are mean ± SEM.  
The data were compared using the Chi-square and independent t-tests for the prevalence and area data, respectively. 
* P < 0.05 compared to the control. 
** P < 0.01 compared to the control. 
† P < 0.05 compared to the lower dose treatment. 
†† P < 0.01 compared to the lower dose treatment. 
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6.4.2.3.4 Predominant Type of SC Per Group  
We also combined the area covered by the same type of SC from different time points to determine 
the predominant type of SC per treatment group. Since SC development in most implants first 
appeared at 2 wk, we compared the overall area of SC types among groups by combing data from 
2, 4, and 8 wk (1st approach). Because the high prevalence of regular SC at 2 wk masked the overall 
effect of other SC types, we also determined the predominant SC type for each group by combining 
the data from only 4 and 8 wk (2nd approach) (Table 6.8).  
Analysis using the 1st approach showed that, with few exceptions, the overall area occupied by 
various types of SC in a given treatment group differed (P < 0.05), where regular SC were the 
predominant type, making up 34-56% of all SC in EGF-L, GDNF-L, FGF2, FGF9, VEGF, LIF, 
and SCF groups (P < 0.05). The exceptions included a lack of a difference for the overall area of 
SC types in EGF-H and control groups (P > 0.05), and the predominance of irregular SC and 
enlarged SC types in GDNF-H and RA groups, respectively (P < 0.05; Table 6.8). 
Using the 2nd approach, the overall area occupied by various types of SC differed in most treatment 
groups (P < 0.05), in which the predominant SC type was distributed among irregular SC (in EGF-
H, GDNF-H, and LIF), enlarged SC (in FGF9 and RA), and regular SC (in FGF2), while regular 
and irregular SC had covered equal areas (each 30% in SCF; P < 0.05). The overall area of SC 
types did not differ in implants of the control, EGF-L, GDNF-L, and VEGF groups (P > 0.05). RA 
was the only group that lacked regular SC (0%) and instead had the highest area of enlarged SC 
among all groups, and differed from the control (P < 0.005; Table 6.8).  
6.4.2.4  Relative Number of Gonocytes 
The number of gonocytes relative to the number of Sertoli cells was calculated in 2 wk implants, 
because at this time point the implants had the most number of regular SC. The relative number of 
gonocytes in control was 15 ± 2 per 1,000 Sertoli cells, and while it was numerically higher in all 
other groups, it was significantly higher only in RA (27 ± 3) compared with the control (P < 0.05; 
Fig. 6.11).  
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Table 6.8. The predominant type of seminiferous cords per group, calculated based on two 
different approaches. 
 
 
Group 
1st Approach: Overall at 2, 4, and 8 wk  2nd Approach: Overall at 4 and 8 wk 
 
P 
Type of SC (%)  
P 
Type of SC (%) 
Regular Irregular Enlarged Aberrant Regular Irregular Enlarged Aberrant 
Control 0.10 36 ± 8 26 ± 6 26 ± 5 13 ± 6 0.36 20 ± 6 33 ± 7 31 ± 5 17 ± 7 
EGF-L 0.01 41 ± 7a 19 ± 5b 22 ± 5b 17 ± 5b 0.84 26 ± 7 28 ± 6 21 ± 5 25 ± 7 
EGF-H 0.41 27 ± 8 34 ± 7 23 ± 6 16 ± 6 0.01 6 ± 3b*†† 44 ± 8a 29 ± 7ab 20 ± 7b 
GDNF-L 0.00 49 ± 8a 23 ± 5b 17 ± 3b 12 ± 4b 0.28 28 ± 7 32 ± 6 23 ± 3 17 ± 6 
GDNF-H 0.00 26 ± 8a 43 ± 7a† 27 ± 6ab 5 ± 2b 0.00 7 ± 5c†† 55 ± 7a†† 32 ± 7b 6 ± 2c 
FGF2 0.00 56 ± 6a 18 ± 4b 23 ± 4b 2 ± 1c* 0.00 39 ± 6a* 25 ± 5a 32 ± 4a 3 ± 1b* 
FGF9 0.03 34 ± 7a 24 ± 4ab 27 ± 5ab 15 ± 4b 0.00 10 ± 3a 33 ± 5b 37 ± 5b 20 ± 6ab 
VEGF 0.00 39 ± 7a 25± 4ab 25 ± 5ab 11 ± 2b 0.22 26 ± 5 32 ± 7 26 ± 6 15 ± 3 
LIF 0.00 42 ± 7a 33 ± 6ab 20 ± 4bc 4 ± 2c 0.00 27 ± 6ab 44 ± 7a 23 ± 4b 6 ± 2b 
SCF 0.00 49 ± 8a 22 ± 5b 20 ± 3b 9 ± 3b 0.00 30 ± 7ab 30 ± 5a 28 ± 3ab 13 ± 4b 
RA 0.00 29 ± 8ab 22 ± 5bc 46 ± 7a* 4 ± 1b 0.00 0c  30 ± 7b 64 ± 8a** 5 ± 2bc 
 
Data are the predominant type of seminiferous cords (SC) per group, defined as the combined relative area (%) covered 
by the same type of SC from different time points, measured at the widest cross-section of samples. 
Two different approaches were used to calculate the values. 
Epidermal growth factor (EGF); glial-derived neurotrophic factor (GDNF); fibroblast growth factor (FGF2); fibroblast 
growth factor 9 (FGF9); vascular endothelial growth factor (VEGF); leukemia inhibitory factor (LIF); stem cell factor 
(SCF); retinoic acid (RA).  
Data are mean ± SEM.  
The high (H) and low (L) doses of the same growth factor groups were compared with each other: independent t-test.. 
Each group was also compared with the control: independent t-test..  
Data from within the treatment groups were compared among SC types: one way ANOVA.  
* P < 0.05 compared to the control. 
** P < 0.01 compared to the control. 
† P < 0.05 compared to the lower dose treatment. 
†† P < 0.01 compared to the lower dose treatment.   
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Fig. 6.11. The relative number of gonocytes (per 1,000 Sertoli cells) in implants retrieved from 
different groups. (A) The gonocyte numbers were compared among implants treated with the 
epidermal growth factor (EGF) or glial-derived neurotrophic factor (GDNF) at either low doses 
(20 ng/mL of cells; EGF-L and GDNF-L), or high doses (2 mg/mL of cells; EGF-H and GDNF-
H). The gonocyte numbers were compared with the control and between the doses (low vs. high). 
(B) The gonocyte numbers were also compared among implants treated with the basic fibroblast 
growth factor (FGF2), fibroblast growth factor 9 (FGF9), vascular endothelial growth factor 
(VEGF), leukemia inhibitory factor (LIF), stem cell factor (SCF), or retinoic acid (RA). The 
relative number of gonocytes in each group was compared with the control. The growth factors 
were added to the neonatal porcine testis cell aggregates (~100 ×106 cells) before implantation 
under the back skin of recipient mice (n = 7 per group). The control implants received no growth 
factor. Implants were retrieved at 1, 2, 4, and 8 wk post-implantation, although the relative number 
of gonocytes was determined only in the implants retrieved at 2 wk. Data are expressed as mean ± 
SEM. ab Data with different letters differ significantly (P < 0.05). N.S No significant difference (P 
> 0.05 ) was observed between the low vs. high dose.  
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6.4.2.5  Rete Testis-Like Formation 
In addition to the formation of SC, the implanted cells underwent reorganizations to form structures 
resembling the rete-testis (RT) and efferent ductules. The RT formations were typically observed 
at the center of implants, over time branched out radially, and were lined by cuboidal epithelial 
cells (Fig. 6.9E). Although not significantly different among groups (P > 0.05), RT appeared as 
early as 2 wk in implants of about half of the groups, the median point for RT appearance was 4 or 
8 wk, and by 8 wk (latest) most but not all retrieved implants had RT. When data from different 
time points were pooled for each group, the prevalence of RT did not differ (P > 0.05) among 
groups, and RT was evident in 27-56% of implants in all groups. However, at 4 wk, more implants 
in GDNF-H group (100%) had RT than in control (67%), and more in EGF-L (80%) than in its 
high dose group (P < 0.05; Table 6.9).  
6.4.2.6  Fluid-Filled Cavities 
Fluid-filled cavities (FFC) were atypical morphological features observed in some implants, 
characterized by a space void of cellular organizations (originating from implanted cells), filled 
with fluid or occasionally with red blood cells (RBC) (Fig. 6.9F). The FFC were observed in ~10% 
of all implants (49/500) that displayed regeneration of testis tissue. The majority of FFC were only 
present at 1 wk, comprising 32% (41/128) of implants at this time point, or 84% (41/49) of all 
implants with FFC. Over time, the number and the diameter of FFC decreased (P < 0.05); they 
were present in 5% (6/126) of 2 wk implants or 12% of all implants with FFC, in 2% (2/114) of 4 
wk implants or 4% of all implants with FFC, and none among the 8 wk implants. However, the 
overall prevalence of FFC, or that of individual groups vs. control, or among high vs. low dose 
groups did not differ (P > 0.05; Table 6.10).  
  
 
Table 6.9. The prevalence and first appearance of rete testis formations among implants from different groups. 
 
Group 
No. implants with RT/total implants (%) First appearance (wk) 
1 wk 2 wk 4 wk 8 wk Overall Earliest Median Latest 
Control 0/10 (0) 0/10 (0) 6/9 (67) 7/8 (88) 13/37 (35) 4 4 NA 
EGF-L 0/14 (0) 3/13 (23) 8/10 (80) 12/12 (100) 23/49 (47) 2 8 8 
EGF-H 0/14 (0) 0/12 2/8 (25)† 13/13 (100) 15/47 (32) 4 8 8 
GDNF-L 0/14 (0) 0/9 (0) 8/9 (89) 11/11 (100) 19/43 (44) 4 8 8 
GDNF-H 0/9 (0) 1/9 (11) 10/10 (100)* 11/11 (100) 22/39 (56) 2 4 4 
FGF2 0/11 (0) 2/12 (17) 8/12 (67) 14/14 (100) 24/49 (49) 2 8 8 
FGF9 0/13 (0) 2/11 (18) 10/13 (77) 12/12 (100) 24/49 (49) 2 4 8 
VEGF 0/12 (0) 0/13 (0) 6/11 (55) 12/12 (100) 18/48 (38) 4 8 8 
LIF 0/10 (0) 1/13 (8) 5/11 (46) 13/14 (93) 19/48 (40) 2 4 NA 
SCF 0/9 (0) 0/13 (0) 8/9 (89) 12/12 (100) 20/43 (47) 4 8 8 
RA 0/12 (0) 0/11 (0) 3/12 (25) 10/13 (77) 13/48 (27) 4 8 NA 
Total 0/128 (0) 9/126 (7.14) 74/114 (64.91) 127/132 (96.21) 210/500 (42)    
 
Data are the prevalence of rete testis (RT) formations and their first appearance among implants showing de novo morphogenesis of testis tissue at each time point.  
Epidermal growth factor (EGF); glial-derived neurotrophic factor (GDNF); fibroblast growth factor (FGF2); fibroblast growth factor 9 (FGF9); vascular endothelial 
growth factor (VEGF); leukemia inhibitory factor (LIF); stem cell factor (SCF); retinoic acid (RA).  
The high (H) and low (L) doses of the same growth factor groups were compared with each other. 
Each group was also compared with the control.  
The data were compared using the Chi-square tests 
The first appearance of RT was assessed based on their first occurrence; earliest, the midpoint of occurrence; median, and the last occurrence from all implant 
retrieved in a single recipient.  
* P < 0.05 compared to the control. 
† P < 0.05 compared to the lower dose.  
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Table 6.10. The prevalence of fluid-filled cavities among implants of different groups and over 
time. 
 
Group 
No. implants with FFC/total implants (%) 
1 wk 2 wk 4 wk 8 wk Overall 
Control 2/10 (20) 2/10 (20) 0/9 (0) 0/8(0)  4/37 (11) 
EGF-L 8/14 (57) 0/13 (0) 0/10 (0) 0/12 (0) 8/49 (16) 
EGF-H 2/14 (14) 0/12 (0) 0/8 (0) 0/13 (0) 2/47 (4) 
GDNF-L 7/14 (50) 0/9 (0) 0/9 (0) 0/11(0) 7/43 (16) 
GDNF-H 4/9 (44) 0/9 (0) 0/10 (0) 0/11(0) 4/39 (10) 
FGF2 0/11 (0) 0/12 (0) 0/12 (0) 0/14 (0) 0/49 (0) 
FGF9 6/13 (46) 1/11 (9.10) 0/13 (0) 0/12 (0) 7/49 (14) 
VEGF 7/12 (58) 0/13(0) 0/11(0) 0/12 (0) 7/48 (15) 
LIF 3/10 (30) 0/13 (0) 0/11(0)  0/14 (0) 3/48 (6) 
SCF 2/9 (22) 3/13 (23)  0/9 (0)  0/12 (0) 5/43 (12) 
RA 0/12 (0) 0/11(0) 2/12 (17) 0/13(0) 2/48 (4) 
Total 41/128 (32.03) 6/126 (4.76) 2/114 (1.75) 0/132 (0) 49/500 (9.8) 
 
Data are the number and % of implants showing fluid-filled cavities (FFC) among the retrieved samples at each time 
point.  
Epidermal growth factor (EGF); glial-derived neurotrophic factor (GDNF); fibroblast growth factor (FGF2); 
fibroblast growth factor 9 (FGF9); vascular endothelial growth factor (VEGF); leukemia inhibitory factor (LIF); 
stem cell factor (SCF); retinoic acid (RA).  
The high (H) and low (L) doses of the same growth factor groups were compared with each other. 
Each group was also compared with the control.  
The data were compared using the Chi-square tests. 
The data did not differ (P > 0.05) among all compared groups. 
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6.5 Discussion 
In the present study, we investigated the effects of several growth factors on de novo 
morphogenesis of testis tissue after implantation of neonatal porcine testis cell aggregates in mice. 
With the exception of VEGF (Schmidt et al., 2006b; Dores and Dobrinski, 2014), the examined 
growth factors had not been previously studied using the TCI model. Hence, there was a lack of 
background information on choosing suitable doses of these growth factors, their efficient mode of 
treatment, or the expected outcomes. The growth factors we evaluated in this study are known to 
play an important role in testis development (Sordoillet et al., 1991; Mauduit et al., 1999; DiNapoli 
et al., 2006; Kim et al., 2006a; Zhou et al., 2008; Baltes-Breitwisch et al., 2010; Cool et al., 2011; 
Svingen and Koopman, 2013). Some of these growth factors, such as GDNF, FGF2, EGF, and LIF 
have long been used for in vitro maintenance and propagation of SSC (Kanatsu-Shinohara et al., 
2003; Kubota et al., 2004a; Ryu et al., 2005; Kanatsu-Shinohara et al., 2007; Aponte et al., 2008). 
Due to a lack of comparable in vivo studies, the doses of growth factors applied in the present study 
were chosen to be higher than those commonly used in vitro, taking into account the obvious 
differences between the two systems and the brief exposure of growth factors to cells prior to 
implantation. For example, our doses of EGF, GNDF, and FGF2 were 2–100 fold higher than those 
used for in vitro SSC culture systems (Kanatsu-Shinohara et al., 2003; Kubota et al., 2004a; 
Kanatsu-Shinohara et al., 2007). For VEGF, which had been used in the ectopic TCI model with 
modest effects, we aimed to augment potential effects, simulating overexpression of VEGF; hence, 
its dose was 35 fold higher than the previously used dose/cell (Dores and Dobrinski, 2014). In 
addition, the higher dose was also deemed crucial to ensure sufficient amounts of VEGF being 
applied given the short exposure to the high number of cells used in our study. 
In this chapter, we applied the modifications for testis cell implantation that we established in 
Chapter 5. The injection technique for testis cell implantation allowed manipulation of the cell 
number, effective and accurate placement of cells in the implantation site, and minimized the 
potential cell leakage experienced using the conventional surgical implantation technique 
(Honaramooz et al., 2007). Using our improved protocol, ~100 ´106 testis cells were injected per 
implantation site in this study, which is 2–50 fold higher than the previously used numbers (Arregui 
et al., 2008a; Watanabe et al., 2009; Campos-Junior et al., 2014; Dores and Dobrinski, 2014). The 
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overall implant recovery rate in our study was very high (95% of 596 implants), which compares 
favorably and exceeds comparable earlier reports using donor pig testis cells (78–82% of 96 
implants) (Honaramooz et al., 2007; Campos-Junior et al., 2014) or donor sheep testis cells (92% 
of 96 implants) (Arregui et al., 2008a). This high recovery rate alone indicates that our 
modifications have been effective, especially considering that we used a much higher number of 
recipient mice in our study than in previous studies (77 mice vs. typically up to 12). In a single 
previous study using the same model to evaluate the effect of VEGF (Dores and Dobrinski, 2014), 
the proportion of developed implants (92%) treated with VEGF was similar, albeit their use of a 
cell carrier (Matrigel matrix) for implantation and different cell numbers.  
From the perspective of gross and histological evaluations, FGF2 had significant effects on the 
implant weight, implant area, and SC area; these parameters were consistently higher than in the 
control at all retrieval points. These findings, coupled with the positive correlations between all the 
parameters (although not significantly), lead to the conclusion that FGF2 has an effect on de novo 
morphogenesis of testis tissue, by giving rise to larger implants and greater SC formation. 
Proliferative and protective (improved survival) effects of FGF2 on pig Sertoli cells have been 
demonstrated in several in vitro studies (Jaillard et al., 1987; van Dissel-Emiliani et al., 1996). 
Therefore, we speculate that in our in vivo model, FGF2 also exerts its effects on the somatic cells 
of implants, especially Sertoli cells, by promoting their proliferation. The protective role of FGF2 
on Sertoli cells may also have helped to maintain the Sertoli cell pool to support the initiation of 
seminiferous cord formation. It has also been shown that FGF2 is abundantly expressed in the 
testis, where it peaks in the prepubertal testis and decreases over time (Mullaney and Skinner, 1992; 
Cancilla et al., 2000; Abd-Elmaksoud et al., 2005). Thus, in our study, the effects of FGF2 were 
potentiated because in addition to the exogenous FGF2 (from our treatment), endogenous FGF2 
was already highly expressed in the implanted testis cells since they were from neonatal donors.  
Several growth factors showed a significant overall effect on at least one of the evaluated gross or 
histological parameters (i.e., implant weight, implant area, or SC area), including the effects of LIF 
on implant weight, EGF-L and SCF on implant area, and GDNF-L on SC area. Therefore, we 
further analyzed the data for potential correlations and focused on the outcomes at 8 wk post-
implantation. For LIF, the overall treatment effect on the implant weight was significant, and there 
were correlations between implant weight and area. For EGF-L, the implant area was significantly 
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correlated with the SC area. The effects of EGF, LIF, and SCF are thought to be on both the somatic 
and germ cells components of the testis (Dolci et al., 1991; Sordoillet et al., 1991; De Miguel et 
al., 1996; Levine et al., 2000; Piquet-Pellorce et al., 2000; Yan et al., 2000a, b; Wahab-Wahlgren 
et al., 2003; Tu et al., 2007; Rastegar et al., 2015). Thus, we suggest that the observed effects of 
these growth factors in our in vivo model could be due to a combination of their effects on both 
somatic and germ cells for the promotion of de novo morphogenesis. Such potential effects of EGF-
L and LIF on de novo testis tissue morphogenesis can be delineated in the future studies. 
Based on the SC area alone, we concluded that GDNF-L has a significant effect on the development 
of SC. Measuring SC area is a more reliable criteria than implant area for assessing de novo testis 
tissue morphogenesis because it excludes non-tubular compartments within the implant. Aside 
from its important role in SSC self-renewal in the testis (Meng et al., 2000; Kubota et al., 2004b, 
2011; Oatley et al., 2007), GDNF has been shown to have proliferative effects on immature Sertoli 
cells in vitro (Hu et al., 1999; Yang and Han, 2010). In addition, GDNF has been identified as one 
of the factors that promote tubulogenesis during testis and even kidney development (Popsueva et 
al., 2003; Costantini and Shakya, 2006). Therefore, we propose that the observed effects of GDNF 
in our in vivo model is exerted through its promotion of Sertoli cell proliferation and tubulogenesis, 
giving rise to implants with improved SC development. 
Here, we highlighted the presence of different types of SC and their developmental pattern over 
time (in terms of both prevalence and area). In the limited available literature on the ectopic TCI 
model, detailed examination of SC morphology in de novo testis tissue formation is lacking, instead 
the endpoints have been focused on spermatogenic efficiency. We observed that SC can be found 
in different patterns; while initially regular SC are the predominant type at 2 wk, enlarged and 
irregular SC develop and become more prominent at 4 and 8 wk post-implantation. The 
development of enlarged seminiferous tubules has been described previously in the TTX model, 
where the enlargements coincided with the increased size of the seminiferous tubular lumen 
(Schlatt et al., 2002b; Rathi et al., 2005). The absence of efferent ducts in the grafts leading to 
accumulation of the Sertoli cell secretions has been proposed as the causative mechanism (Schlatt 
et al., 2002b; Arregui et al., 2008a). However, many of the implants in the present study developed 
both efferent ducts and rete testis-like structure. Since we retrieved the implants prior to their 
potential development of a seminiferous lumen, we could not determine whether these structures 
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would contribute to the absorption of such secretions. Moreover, the nature of enlarged SC in early 
implants is different from that of the late stage grafts, and the cause of their formation remains to 
be elucidated in future studies. Reasons for the development of irregular SC are not known but can 
be attributed to the less than optimal conditions in which the implants are being formed. Similarly, 
the causes of aberrant SC formation remain unknown but given that they are usually seen in the 
proximity of rete testis, it could be hypothesized that the hyperplastic rete testis cells entrap some 
of the neighboring parenchyma undergoing SC development. This is further supported by the 
presence of cuboidal epithelial lining, typical of rete testis cells, surrounding the aberrant SC.  
Several growth factors were found to enhance the development of a specific type of SC. 
Considering both approaches for determining the predominant type of SC among groups, we 
propose that FGF2, GDNF-H, and RA enhance the formation of regular, irregular, and enlarged 
SC, respectively. This is also generally supported by evaluations of the prevalence of different SC 
types and implant area. Compared with the control, FGF2 treatment led to development of most 
regular and least aberrant SC. The RA treatment led to the presence of enlarged SC in 100% and 
~32% of implants at 4 and 8 wk, respectively. Meanwhile, in the GDNF-H group, irregular SC 
were seen in >90% of the implants at 4 and 8 wk, where they occupied >50% (range 52-59%) of 
the implant area.  
This was the only histomorphometric study using the TCI model that evaluated the survival of 
gonocytes in implants. We evaluated the effect of various growth factors on the relative number of 
gonocytes using only 2-wk samples, because gonocytes were morphologically more distinctive at 
this time point, compared with those in implants of earlier or later stages. Compared with the 
control, RA was the only group that increased the relative number of gonocytes in SC. There are 
no comparable in vivo studies, but our results seem to contrast several in vitro studies (i.e., organ 
or cell culture) showing an apoptotic effect of RA on neonatal gonocyte numbers, although mitosis 
had also resumed in the remaining gonocytes (Livera et al., 2000a; Boulogne et al., 2003). In the 
postnatal testis, gonocytes migrate to the seminiferous basement membrane prior to their 
resumption of mitosis and differentiation to SSC; failure to migrate leads to gonocyte apoptosis 
(Roosen-Runge and Leik, 1968; Orwig et al., 2002a). To achieve migration, gonocytes must 
actively interact and bind to Sertoli cells; a process that has been shown to be promoted by RA 
(Griswold et al., 1989; Orth and Jester, 1995; Vernet et al., 2006). In the pig, gonocyte migration 
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occurs at 4-8 weeks. Considering that the donor pigs were already 2 wk old and the examined 
implants were 2 wk post-implantation, the timing of RA treatment in our study may have coincided 
with intrinsic timing of events at this stage of testis development. Therefore, although the 
mechanism for the observed effect of RA in our study is unknown, it could be hypothesized that 
RA is involved in either direct promotion of gonocyte survival or indirect promotion of the 
gonocyte-Sertoli cell interactions during the SC morphogenesis. 
A limitation of the earlier TCI studies was the low proportion of germ cells among the donor cells 
(e.g., 4.5%), resulting in de novo formation of seminiferous cords/tubules that typically lacked 
germ cells (Honaramooz et al., 2007; Kita et al., 2007; Arregui et al., 2008b; Zhang et al., 2008; 
Dores and Dobrinski 2014). In the present study, the implanted testis cells had ~40% gonocytes; 
however, the number of gonocytes in implants examined at 2 wk was low, ranging from ~1.5% to 
2.6% relative to Sertoli cells. Therefore, there is an obvious disconnect between the ratio of 
gonocytes at implantation and that at retrieval, even as early as 2 wk after implantation. This may 
be due to either a massive reduction in gonocyte numbers or a substantial increase in the relative 
number of somatic cells. In the short-term in vitro culture study (Chapter 3), we observed a rapid 
expansion of somatic cells to full confluency within a week, while gonocyte numbers did not 
increase nearly as much. Therefore, the observed decrease in gonocyte ratio in implants of the 
present study is more likely due to the much higher rate of somatic cell proliferation that overtakes 
gonocyte numbers. In a study by Dores and Dobrinski (2014), implantation of testis cells with 
relative enrichment of spermatogonia (i.e., 25% vs. 3-4%) did not improve the spermatogenic 
efficiency, defined as the number of seminiferous tubules containing germ cells at 40 wk post-
implantation. There are no comparable data from the previous studies, but judging from the 
histological images presented in some of these earlier studies (Honaramooz et al., 2007; Arregui 
et al., 2008), the relative number of gonocytes in the present study appears to be improved. Thus, 
the ideal proportion of gonocytes among donor cells to be implanted would need to be further 
investigated. On the other hand, the relative number of gonocytes in the present study are almost 
half of that in our previous study in Chapter 5 (~2% vs. ~4%). We used the same testis cell isolation 
protocol for both studies, but the donor pigs were 2 wk old in the present study and 1 wk old in 
Chapter 5: therefore, at least part of the difference between these results is due to using donors of 
different age. This is supported by a study using TTX, where the development of grafts was donor 
age-dependent, even among very young donors (Schmidt et al., 2006a).  
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The development of rete testis or rete testis-like structures during de novo testis tissue 
morphogenesis has not been previously reported. In this study, the rete testis was one of the 
frequently occurring features (observed in ~40% of all implants), regardless of the treatment. 
Although there were generally no differences in the prevalence of rete testis formation among the 
groups, this formation occurred earlier in the implants treated with EGF-L, GDNF-H, FGF2, FGF9, 
or LIF. The expression of EGF, FGF2, and their receptors (EGFRs and FGFRs) have been localized 
in the straight tubules and rete testis of bulls (Abd-Elmaksoud et al., 2005; Kassab et al., 2007). In 
addition to GDNF, as describe previously, EGF, FGF2, and FGF9 are involved in promoting 
tubulogenesis in the developing gonad and kidney (Taub et al., 1990; Humes and Cieslinski, 1992; 
Castrillon et al., 2000; Popsueva et al., 2003; Combes et al., 2009; Svingen and Koopman, 2013; 
Li et al., 2014). Given that previous reports failed to mention the development of rete testis in 
implants, it is unclear whether this widespread rete testis formation in the present study was due to 
the contamination of the parenchymal testis cell isolates with the mediastinal cells or other 
mechanisms. Therefore, these findings should be further investigated. In addition, the relationship 
between the rete testis development and formation of aberrant SC would also warrant further 
studies.  
In the present study, the FFC were a non-pathological feature found in many implants, likely 
occurring as a result of the remnant fluid within the cell aggregates (i.e., from the added media or 
growth factor diluents). In addition, the needle insertion may have also caused bleeding, which 
explains the presence of RBC within FFC observed through histological assessments. The FFC 
were transient, with high prevalence at 1 wk post-implantation, where they were present in >50% 
of the samples in multiple groups.  
In addition, overall, the use of FGF9 and VEGF in the present study had no discernable effect on 
de novo testis tissue morphogenesis. This was surprising, because these two growth factors have 
been shown to have important roles during fetal testis development (Ergün et al., 1997; Willerton 
et al., 2004; Kim et al., 2006a; Cool et al., 2011), and exert supportive effects on both somatic and 
germ cells in vitro (El Ramy et al., 2005; DiNapoli et al., 2006; Schmidt et al., 2006b; Caires et 
al., 2009). We also found that the use of a higher dose of EGF and GDNF was not advantageous, 
and in the case of GDNF, in fact, led to a lower implant development. This observation reinforced 
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the fact that the expected outcomes of studies using growth factors are not simply a function of 
their relative dose.  
6.6 Conclusions 
In this exploratory study, the effects of multiple growth factors on de novo testis tissue 
morphogenesis were evaluated for the first time. Our findings suggest that even brief pre-
implantation exposure of testis cells to growth factors can have profound and long-term effects on 
the development of both somatic and germ cells in the implants. Growth factors also caused unique 
SC formation patterns which may influence the spermatogenic and steroidogenic efficiency of the 
implants. Therefore, our findings provided a basis for future studies using the TCI model where 
background information was lacking.  
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CHAPTER 7 
GENERAL DISCUSSION AND FUTURE DIRECTIONS 
7.1 General Discussion 
In vitro and in vivo culture systems are two important tools in the study of testicular function and 
spermatogenesis. The knowledge obtained from the studies based on these two systems has 
significantly improved our understanding of the factors involved in the regulation of testis 
development and spermatozoa production. The studies presented in this thesis were designed to 
focus on in vitro and in vivo culture systems for the development of testis cells and tissue using 
pigs as a model. The following is a discussion of the common themes and findings among different 
experiments as well as general conclusions that can be drawn from them.  
7.1.1 Optimized Culture Conditions for Maintenance, Proliferation, and Colony Formation of 
Porcine Gonocytes  
Through a step-wise approach, optimized culture conditions for the short-term maintenance, 
proliferation, and colony formation of porcine gonocytes were established (Chapter 3). These 
optimized conditions were then utilized to study the in vitro development of porcine testis cells in 
a prolonged culture (Chapter 4). One of the most important findings to emerge from the first study 
(Chapter 3), aside from the optimized culture conditions, was that gonocytes require the presence 
of feeder cells (which were present in the form of ~60% mixed testis somatic cells) for their survival 
and growth in vitro. This finding was further supported by the poor cell growth when we attempted 
to culture an enriched population of gonocytes (~80-90%). The observed requirement of feeder 
cells presence for gonocyte growth in culture was consistent with previously reports (van Dissel-
Emiliani et al., 1993). On the other hand, the ‘floating’ nature of gonocytes, especially during the 
first few days of culture (Chapter 3), indicated that infrequent media changes can avoid the 
unnecessary losses of gonocytes during media changes. This conclusion was strongly supported by 
evidence of highly viable floating gonocytes (>85% viability) in the removed media after several 
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days of culture, which increased the number of gonocytes settling on the somatic cell monolayer 
after the infrequent media change routine was adapted. Overall, these findings contributed in 
several ways to our understanding of neonatal porcine gonocytes and provided a basis for future in 
vitro studies. 
7.1.2 Development of Neonatal Porcine Testis Cells and Colonies In Vitro 
Using the optimized culture conditions established in our first in vitro study (Chapter 3), we 
evaluated the in vitro behavior, colony formation, and ultrastructure of gonocytes, with the aid of 
various imaging techniques (i.e., live-cell imaging, SEM and TEM) and fluorescent labeling in a 
second in vitro study (Chapter 4). To our knowledge, this latter study was the first to trace the 
development of neonatal porcine testis cells in real-time and thoroughly examine their 
ultrastructural changes over time. However, given that our optimized culture conditions (Chapter 
3) were using a basic culture system, it was not clear whether they could support the development 
of neonatal porcine testis cells in a prolonged culture.  
In Chapter 4, we highlighted the unique organization of somatic cells to form areas of circular 
arrangements, which we presumed to be a preferred site for the establishment of gonocyte colonies. 
We are not certain whether the formation of these circular structures is indeed as a result of somatic 
cell-germ cell interactions. Currently, there are no closely-related studies to support our 
assumption. The most intriguing observation in this study was the formation of EBLC by 
gonocytes, which was tracked stage-by-stage (i.e., singles, paired, clusters, morula-like colonies, 
and EBLC) via live-cell imaging. The formation of the EBLC, or commonly reported as embryoid 
bodies, is a common feature of gonocytes and other MGSC in vitro, and their developmental stages 
have been well described (van Dissel-Emiliani et al., 1993; Hasthorpe et al., 2000; Goel et al., 
2007, 2009; Han et al., 2009; Kuijk et al., 2009; Matsui et al., 2014). Real-time observations 
revealed that the formation of EBLC relies on the ability of gonocytes to establish contact with 
each other, leading to their aggregation, and creation of a center for the attraction of more gonocytes 
to form bigger colonies and finally EBLC. This is achieved via their active movement, assisted by 
the cytoplasmic projections, which based on SEM examinations could be categorized into 
lamellipodia, filopodia, membrane blebs, and membrane ruffles. The formation of cytoplasmic 
projections in migrating cells is driven by the polymerization of actin cytoskeletal, promoted by 
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the expression of GDNF (Korn et al., 1987; Dovere et al., 2013; Tang and Gerlach, 2017), as was 
confirmed in this study by F-actin fluorescent labeling.  
The multinucleated nature of EBLC and the events leading to their transformation via cellular 
fusion were proposed in this study for the first time. In fact, these multinucleated EBLC also 
possessed extensive cytoplasmic projections and motility at a slow rate. The present study adds to 
a growing body of research that indicates the importance of cytoplasmic projection (or pseudopods) 
during the migration of gonocytes to the basement membrane of seminiferous tubules prior to their 
differentiation into SSC (McGuinness and Orth, 1992; Nagano et al., 2000; Orwig et al., 2002a). 
We also noted the presence of round gonocytes among the populations of gonocytes with 
cytoplasmic projections. These immotile and non-viable gonocytes, confirmed using live-cell 
imaging and trypan-blue assays, respectively, represent the cells that had undergone apoptosis or 
were dead. This finding complimented the previous observations by Orwig et al., (2002a) that 
compared the developmental competency of two subpopulations of gonocytes (pseudopod vs. 
round gonocytes), using a germ cell transplantation assay.  
One of the ultimate goals of in vitro culture systems for MGSC is to expand their numbers while 
maintaining their ‘stemness’ long-term. Using the same basic culture system developed in Chapter 
3, we were able to propagate gonocytes up to ~9 fold by the end of our study in Chapter 4 (4 wk). 
The pluripotent nature of the propagated gonocytes and EBLC, as shown by the expression of 
POU5F1, suggests that they have the capacity to undergo infinite self-renewal, and potentially give 
rise to any cells and tissues of the three germinal layers. These findings might also have clinical 
implications in fertility preservation, where high numbers of MGSC are required for efficient germ 
cell transplantation and cell-based therapy. Therefore, our findings in Chapter 4 adequately 
addressed the question posed earlier in this section as to whether basic culture conditions can 
support the maintenance and propagation of gonocytes in a prolonged culture condition.  
7.1.3 The Ectopic Testis Cell Implantation (TCI) Model  
The experiments designed in Chapter 5 focused on the development of an efficient technique for 
implantation of testis cells in an ectopic implantation model. In a pioneering study by Honaramooz 
et al., (2007), a surgical implantation technique was developed, which coupled with the low number 
of germ cells in the population of donor cells resulted in inconsistent implant development with 
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low spermatogenic efficiency. The issue of low number of germ cells among the donor cells had 
been addressed by the establishment of a three-step enzymatic digestion method in our lab and was 
applied in Chapter 3. Two implantation approaches were examined in two separate experiments, 
the conventional surgical approach (but with the added gel-based matrices as a cell carrier) and a 
subcutaneous injection method of cell aggregates (without cell carriers). Other examined variables 
included the cell number and the implantation site. This study was the first study to examine various 
gel-based matrices (i.e., gelatin, collagen, and agarose) for cell implantation, which adds to the 
literature where the only other studies had used the commercially available Matrigel matrix 
(Watanabe et al., 2009; Dores and Dobrinski, 2014). This study found that both approaches offer 
advantages over the conventional implantation technique used in the previous reports (Honaramooz 
et al., 2007; Arregui et al., 2008b). The use of gel-based matrices as a cell carrier enables 
manipulation of the number of cells to be implanted (50 - 100 ´ 106 cells per implant/site) and 
efficient placement of cells at the implantation site. Although de novo morphogenesis of testis 
tissue from the gel-based matrix implants (i.e., gelatin and collagen) was not compromised and 
performed slightly better than the control, the consistency of the outcomes, control over the 
transferred cells, as well as being less invasive led us to adopt the subcutaneous injection technique 
for our next experiments in Chapter 6.  
In these experiments (Chapter 5), we also examined for the first time the potential of ultrasound 
biomicroscopy (UBM) for monitoring the implants prior to their retrieval. The use of UBM via 2D 
and 3D modes allowed visualization of the implants, estimation of their degree of tissue formation, 
and neovascularization in situ. However, the most obvious advantage of using UBM is that it allows 
basic measurements of implants (e.g., length, width, and height), through which the data could be 
manipulated to derive other useful information (e.g., volume and cross-sectional area), with the aid 
of its software. As proof of principle, we compared the UBM measurements (i.e., length and width) 
with physical measurements when the implants were retrieved, and found high fidelity between the 
two methods. This finding has significant implications for future studies in the areas of testis cell 
implantation as well as testis tissue xenografting, where UBM could be used to assess the 
development of implants and grafts over time, potentially reducing the number of required samples 
and recipient mice.  
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The findings in Chapter 5 also highlighted for the first time the effect of implantation site on the 
development of testis cell implants. The developmental potential of implants as indicated by their 
weight decreased from cranial to caudal sites. This important finding will influence the way we 
sample implants in the future, especially during the early period post-grafting, pointing to a need 
to also randomize our sampling based on the implant site. Finally, we also evaluated the effect of 
gonadal status on the development of testis cell implants and found no apparent gross or 
histomorphometric differences between the intact and castrated recipients, consistent with previous 
reports (Shinohara et al., 2002; Abbasi and Honaramooz, 2010b). Learning from the latter two 
findings from Chapter 5, we randomized our sampling and used intact recipient in our subsequent 
study in Chapter 6. 
7.1.4 The Effect of Growth Factors on De Novo Porcine Testis Tissue Morphogenesis In Vivo 
The final study in this thesis (Chapter 6) provides the first comprehensive assessment of the effect 
of growth factors on de novo morphogenesis of porcine testis tissue in an ectopic implantation 
model. In this study, we examined the effect of brief exposure of cell aggregates to various growth 
factors (i.e., EGF, GDNF, FGF2, FGF9, VEGF, SCF, LIF, or RA). The selected growth factors are 
known to have a significant role in testis development (De Miguel et al., 1996; Mauduit et al., 
1999; Meng et al., 2000; Kubota et al., 2004a; Wu et al., 2005; Hofmann et al., 2005; Aponte et 
al., 2006; Bott et al., 2006; DiNapoli et al., 2006; Kim et al., 2006a; Wang and Culty, 2007; Zhou 
et al., 2008; Chung et al., 2009; Baltes-Breitwisch et al., 2010; Cool et al., 2011; Manku et al., 
2015). Due to a lack of background in vivo studies, the dosage of each growth factor was set higher 
than those applied in vitro, and where there was widespread disagreement in the range of such 
doses, a low and a high dose group were included (i.e., EGF-L, EGF-H and GDNF-L, GDNF-H). 
The growth factors were added to the testis cell aggregates immediately prior to implantation, using 
the subcutaneous injection technique that was optimized in Chapter 5. 
This exploratory study showed that indeed the TCI model could be used to examine potential 
factors involved in testis development because de novo morphogenesis of the testis tissue could be 
manipulated in the presence of growth factors. The FGF2 appeared to be the only growth factor to 
have an impact on both the physical and histological development of implants, while several other 
growth factors had an effect on either parameter (i.e., LIF, SCF, EGF, and GDNF-L). We 
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speculated that these growth factors enhanced de novo testis tissue morphogenesis via promoting 
the survival of implanted testis cells and later by regulating their proliferation and differentiation, 
reflected by their roles in the testis development in situ (Gonzalez et al., 1990; Sordoillet et al., 
1991, 1992; Matsui et al., 1991; Pesce et al., 1993; Han et al., 1993; De Miguel et al., 1996; 
Mauduit et al., 1999; Meng et al., 2000; Yan et al., 2000a; Hirai et al., 2004; Wu et al., 2005; 
Hofmann et al., 2005; Aponte et al., 2006, 2008; Chung et al., 2009a). We found unique 
temporospatial changes in the morphology of SC, where the prevalence of regular, enlarged, 
irregular, and aberrant types of SC changed over time, which were accentuated by different growth 
factors. The accumulation of secretions from Sertoli cells was suggested as a cause of the formation 
of dilated/enlarged SC (Arregui et al., 2008b). However, the presence of efferent ductules and rete 
testis in the developed tissue, reported for the first time here in this study, might debunk that 
assumption. Adding to this interesting finding was the tendency of certain growth factors to support 
the development of rete testis and/or a specific type of SC. The exact mechanism underlying these 
morphological changes and their association with specific growth factors remain to be explored. 
Other than VEGF, which has been examined in a single study using the same model (Dores and 
Dobrinski, 2014), there are no closely-related studies to compare with our observations. Therefore, 
this large-scale study provided several important findings to further our insights into de novo testis 
tissue morphogenesis, and many more leads into the potential effects of various growth factors to 
guide future research in this field.  
One of the limitations of the TCI model was the low spermatogenic efficiency, likely as a 
consequence of the low number of donor germ cells in the developed implants (Honaramooz et al., 
2007; Arregui et al., 2008a; Campos-Junior et al., 2014; Dores and Dobrinski, 2014). Thus, in this 
study, we addressed this problem by implanting cell aggregates of high germ cell proportions 
(~40% gonocytes). Although direct comparison of results is not possible, in previous studies most 
SC in implants lacked germ cells, while we observe gonocytes in almost all SC. Despite being 
higher than in the previous reports, the relative number of gonocytes was lower in the implants 
than in intact age-matched testes. The RA treatment appeared to be the only growth factor to have 
a significant effect on the relative number of gonocytes. The hypoxic conditions, prior to the 
establishment of blood supplies, have been proposed as a causative factor for germ cell losses in 
implants (Schmidt et al., 2006b; Arregui et al., 2014; Dores and Dobrinski, 2014). However, 
considering the fact that adding VEGF, as an angiogenesis promoter, had no apparent effect on the 
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relative number of gonocytes, we propose that germ cell losses post-implantation are not because 
of the hypoxic effects on germ cells but likely due to other intrinsic factors that remain to be 
elucidated. For instance, reduced proportion of gonocytes may in fact have nothing to do with their 
losses but instead with the disproportional proliferation rate of somatic cells over gonocytes. 
Finally, the data in Chapter 6 showed no advantage of using higher doses of EGF and GDNF over 
lower doses on the development of implants. In fact surprisingly, this development in the high dose 
groups appeared repressed and even less than the control. The reasons for such observations are 
not clear but indicate the need for more extensive studies using this model to elucidate the effect 
of each growth factor in more details.  
7.2 Future Directions 
7.2.1 Manipulation of Culture Conditions for Long-Term Maintenance and Propagation of 
Porcine Gonocytes  
The optimized culture system developed in this thesis (Chapter 3) can be further examined and 
potentially modified for use in long-term maintenance and propagation of gonocytes. This basic 
culture system could be utilized as a tool to examine the effects of other conditions that are known 
to have beneficial effects (i.e., survival, self-renewal, or proliferation) on gonocytes. Such 
conditions can include the use of other media and serum alternatives (e.g., DMEM/F12 or KSR), 
growth factors (such as some of those described in Chapter 6), hormones (e.g., LH, FSH, 
testosterone, or progesterone), and other additives (e.g., amino acids, proteins, or vitamins). For 
this purpose, the already established culture systems, such as those for long-term maintenance and 
propagation of SSC, could be used as a study baseline (Kanatsu-Shinohara et al., 2003, 2005, 
2008a; Kubota et al., 2004b; Ryu et al., 2005). To address the concern of the negative effect of 
testis somatic cells on the pluripotency of gonocytes, mitotically inactivated cells (e.g., STO and 
MEF) should also be considered as alternative feeder cells. A study performed by Lee et al., (2013) 
showed that porcine SSC could be optimally cultured at 31 °C, demonstrating marked pluripotency 
compared with those cultured at 34 °C and 37 °C. Thus, the effect of temperature on gonocytes 
could be re-examined by testing lowered temperatures (i.e., <35 °C), along with the addition of 
analyses for DNA synthesis and proliferation to the routine evaluations for growth rate.  
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7.2.2 Motility and Pluripotency of Porcine Gonocytes and EBLC 
Establishment of the cytoplasmic projections is crucial for the survival and migration of gonocytes 
(McGuinness and Orth, 1992; Nagano et al., 2000; Orwig et al., 2002a). Thus, identifying the 
molecular cues regulating the formation of these projections is of high importance in the study of 
gonocytes. Two candidate growth factors, GDNF and SCF/c-kit ligand (Orth et al., 1997; Basciani 
et al., 2008; Dovere et al., 2013) have been proposed to promote the development of actin 
cytoskeleton and migration of gonocytes to the basement membrane of the SC, and could be 
included in deciphering the motility of gonocytes in vitro. In addition, live-cell imaging could be 
utilized to further understand the kinetics of gonocyte proliferation and migration in vitro. It will 
be interesting to see whether improving the population of motile gonocytes (with cytoplasmic 
projections/pseudopods) would indeed benefit their stem cell potential for application in germ cell 
transplantation, because the efficiency of gonocyte migration and subsequent colonization of the 
SC are thought to rely on the number of motile gonocytes (Orwig et al., 2002a).  
The MGSC can be manipulated to produce pluripotent stem cells and offer a useful tool for cell-
based therapy and regenerative medicine (Geijsen and Jones, 2008). The application of pluripotent 
stem cells of MGSC origin for human use is favored over the iPSC of somatic cell origin, due to 
their autologous nature, their superior genomic integrity, and close resemblance to ESC (Ko et al., 
2009; Kim and Izpisua Belmonte, 2011). In addition, the pluripotent state of MGSC could be 
induced spontaneously under specific culture conditions (Kanatsu-Shinohara et al., 2004b; Ko et 
al., 2009), without the need of forced biophysical reprograming such as that for the iPSC 
(Takahashi et al., 2007; Lowry et al., 2008; Kim et al., 2016). However, the progress in germline-
derived pluripotent stem cells (GPS) has been hindered by the poor understanding of factors behind 
this spontaneous pluripotency, and the inefficiency of the isolation and propagation of MGSC (Kim 
and Izpisua Belmonte, 2011). Accordingly, the neonatal porcine gonocytes offer a great advantage 
to be used as a model to study GPS, especially now that they can be isolated, enriched, and 
propagated efficiently with the available technologies described or established in this thesis. Future 
studies should focus on how to improve and identify the molecular cues regulating the pluripotency 
of gonocytes. The SCF and LIF are two growth factors that have been proposed to be essential for 
the maintenance of gonocyte pluripotency in vitro (Kanatsu-Shinohara et al., 2007; Tu et al., 2007). 
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Comprehensive investigation of the role of these and other growth factors in regulating the 
pluripotency of gonocytes will provide insight into GPS.  
In this study, the pluripotency of gonocytes and EBLC was determined using a single marker, 
POU5F1. Future studies should examine the expression of other pluripotency markers, such as the 
SSEA-1 and NANOG homeobox (NANOG). The multipotency of gonocytes and EBLC could be 
investigated in vitro by providing specific culture conditions that direct their transformation into 
any cells and tissues of the three germinal layers, as previously shown for SSC from adult mouse 
testes (Guan et al., 2006). Transfer of cultured gonocytes and EBLC in vivo is another approach 
that could be performed in the future to assess their multipotency. Teratoma formation, as an 
indicator of multipotency, has been observed after subcutaneous implantation of cultured piglets 
gonocytes (Hoei-Hansen et al., 2005; Tu et al., 2007; Goel et al., 2009; Niu et al., 2016). 
7.2.3 Incorporating UBM in TTX and TCI Studies 
Future studies could utilize UBM for monitoring the development of grafts/implants in between 
designated retrieval points. In addition to visualizing gross features of grafts/implants (i.e., size, 
shape, and dimension), the UBM data could be extrapolated to gain additional information on the 
development of grafts/implants. The ability to detect blood vessels at implantation sites should be 
incorporated in the study of angiogenesis and hemodynamics of grafts/implants. The ability of the 
UBM to measure the oxygen saturation level should be further studied to assess the hypoxic 
environment and its effect on graft/implant survival. With the aid of a software, 3D remodeling of 
grafts/implants and their blood supply could also be constructed. Future studies should also explore 
the relationship/correlation between the echogenicity of implants and their histology. This will be 
useful as a preliminary indicator of de novo morphogenesis, especially during the early phases of 
grafting/implanting. The UBM also allows for image-guided injections in future studies, especially 
in the studies designed to evaluate the application of a series of treatments over time (i.e., growth 
factors, drugs, or hormones) to the grafts/implants.  
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7.2.4 Utilizing De Novo Morphogenesis of Testis Tissue for the Study of Testiculogenesis and 
Spermatogenesis  
Despite the lack of extensive background information and poor spermatogenic efficiency, de novo 
morphogenesis of testis tissue remains one of the only and most promising bioassays for the study 
of testis development and spermatogenesis. This model has a unique advantage for elucidating the 
molecular cues and cellular interactions during the process of testis development, where it offers 
an accessible route for manipulating both the somatic and germ cell components of the testis. 
However, further studies are needed to standardize the protocols and improve the consistency of 
the outcomes, before this bioassay can be fully utilized. Nevertheless, the effect of growth factors 
on de novo morphogenesis of testis tissue should be further investigated for future studies. The 
findings presented in this thesis, provide a basis for designing future experiments to examine new 
growth factors, dosage/regimen of treatment, as well as assessment criteria. The growth factors that 
displayed significant effects on gross and/or histomorphometric evaluations in this study (i.e., 
FGF2, RA, GDNF, LIF, SCF, and EGF) could be further studied in detail. We also suggest re-
examining other growth factors that were not found effective, using other treatment 
doses/regimens. One of the approaches that could be implemented to evaluate the effect of a given 
growth factor is by performing loss-of-function or gain-of-function studies. Future studies should 
also manipulate the growth factor dose, regimen, interval, and duration of exposure. Finally, it 
would also be interesting to uncover the underlying factors leading to the temporospatial changes 
of the SC and their long-term effect on the spermatogenic efficiency and tissue function. The source 
and mechanism of the rete testis and efferent ductules development in the implants and their impact 
on the structural growth of the resultant testis tissue should also be investigated. 
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APPENDIX A 
SUPPLEMENTARY VIDEOS 
Video 1 Organization of neonatal porcine testis cells in prolonged culture at 0–24 h 
(00:04s), 25–48 h (00:09s), 17–120 h (00:15s), D7 (00:20s), D14 d (00:27s), 
D21 (00.33s) and D28 (00:39s) (time-lapse:15 fps). Images were taken every 
1 hr for 24 hr from day 0 to day 3, every 2 hr for 24 hr from day 4 to day 7 
and finally every 1 hr for 24 hr at days 14, 24 and 28. 
  
Video 2 Cytoplasmic projections and amoeboid-like movement of gonocytes at 1-wk 
(a) in the media (00:04s) and (b) on top of somatic cell monolayer (00:12s). 
The images were taken every 2.5 sec for 30 sec (time-lapse: 1 fps) and 5 min 
for gonocytes (time lapse: 4 fps) floating in the media and on the somatic 
monolayer, respectively.  
  
Video 3 The stages in the formation of embryoid body-like colony (EBLC) formation. 
The images were taken every 2.5 sec for 5 min (time-lapse: 4 fps). (a) 
Gonocytes first settled on the somatic cell monolayer either singles or paired 
(00:04s). (b) Continuous migration of gonocytes towards each other results in 
the formation of morula-like (grape-like) colonies (00:11s). (c) The morula-
like colonies increased in size over time (00:18s). (d) The EBCL formed after 
~14 d of culture (00:24s). Cytoplasmic fusions of adjacent gonocytes seemed 
to transform the morula-like colonies into an embryoid body-like colony 
(00:34s). (e-f) Continued fusion of migrating gonocytes increased the mass 
of the EBLC (00:44s). (g) Note the presence of extensive cytoplasmic 
projections possessed by EBLC which seemed to assist with its movement, 
and further attachment of migrating gonocytes (00:56s). (h) Higher 
magnification of active movement of cytoplasmic projections of EBLC 
(01:06).  
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APPENDIX B 
A PRELIMINARY STUDY OF HISTOMORPHOMETRY AND 
IMMUNOHISTOCHEMICAL EXPRESSION PATTERNS OF FACTORS ASSOCIATED 
WITH TESTIS DEVELOPMENT IN PORCINE TESTIS  
Background: This study was conducted as part of this PhD research, but due to the preliminary 
nature of its results, it was not included as a separate chapter. The main objective of this study was 
to gain insight into the histomorphometry and expression patterns of various factors associated 
with testis development.  
Methodology: Testis tissue samples of prenatal (82 dpc, n=3), neonatal (1, 2, 3, and 4 wk of age, 
n=5/age), prepubertal (9 and 14 wk of age, n=5/age), and sexually mature (n=4) Yorkshire-cross 
pigs were subjected to hematoxylin and eosin (H&E) staining and immunohistochemistry. 
Expression patterns of five factors that were deemed potentially associated with the testis tissue 
development were examined using horseradish peroxidase (HRP) immunoassay. These factors 
included sex determining region Y (SRY), SRY-box 9 (SOX9), fibroblast growth factor 9 (FGF9), 
prostaglandin D2 synthase (PGD2), and anti-Müllerian hormone (AMH). 
Results: The histomorphometric and immunohistochemistry finding are presented in Appendix 
B.1 through B.4. The immunohistochemistry results remain inconclusive due to inconsistencies we 
observed among the samples. The major issue was the presence of background staining, which is 
a common challenge when working with testis tissue. Preliminary results of the localization of the 
examined factors are summarized in Appendix B.4. These observations need to be further validated 
after optimization of staining protocols.  
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APPENDIX B.1 
 
Representative histological photomicrographs of cross-sections of the testis tissue of pigs at 
different developmental stages. (A) 82 days of fetal age, (B) 1 wk of age, (C) 2 wk of age, (D) 3 
wk of age, (E) 4 wk of age, (F) 9 wk of age, (G) 14 wk of age, and (H) mature pig. H&E staining 
(scale bar = 50 µm). 
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APPENDIX B.2 
 
The distribution of gonocytes in prenatal (82 dpc) and neonatal (1, 2, 3, and 4 wk of age) testis 
tissue of pigs. (A) A stacked graph demonstrating the proportion (%) of gonocytes residing at the 
center (Ct) and the periphery (Pr) of the seminiferous cords. (B) Identification of gonocytes 
using PGP 9.5 immunohistochemistry (1:1000 dilution). (Scale bar = 20 µm.
  
  
 
APPENDIX B.3 
 
Histomorphometric analysis of the somatic and germ cells in the porcine testis tissues of different ages.  
 
 
Variable 
Pig Age 
Prenatal 
(82 dpc) 
n=3 
Neonatal Prepubertal  
Mature 
n=4 
1 wk 
n=5 
2 wk 
n=5 
3 wk 
n=5 
4 wk 
n=5 
9 wk 
n=5 
14 wk 
n=5 
Number of SC or ST/mm2 214.13 ± 3.8a 88.48 ± 2.4b 87.27 ± 1.9bc 83.92 ± 1.7bc 79.90 ± 0.8c 57.78 ± 2.0d 32.98 ± 0.9e  12.45 ± 0.5f 
SC or ST area (%) 32.75 ± 1.4a 34.78 ± 0.6ab 35.44 ± 0.9ab 35.54 ± 0.9ab 39.78 ± 0.5b 48.61 ± 1.0c 49.11 ± 2.0c 67.86 ± 1.4d 
Diameter of SC or ST (µm) 34.56 ± 0.4a 39.10 ±0.3b 39.86 ± 0.3b 42.85 ± 0.3bc 46.84 ± 0.4c 70.65 ± 0.5d 90.03 ± 1.0e 210.30 ± 2.2f 
Diameter of ST lumen (µm) ** - - - - - - 22 36 ± 0.6a 91.74 ± 1.7b 
 
Gonocytes  
Center (%) 75.67 ± 2.2a,x 66.04 ± 2.6b,x 46.73 ± 1.6c 44.92 ± 1.2c,x 42.15 ± 1.1c,x - - - 
Periphery (%) 24.33a,y 33.96b,y 53.27c 55.08c,y 57.85c,y - - - 
Number/1,000 SC 190 ± 6.3a 132.6 ± 5.9b 102.8 ± 3.3c 86.8 ± 3.4c 49.8 ± 4d    
Most advanced germ cell stage Gonocytes Spermatogonia Spermatogonia Spermatogonia Spermatogonia Spermatogonia Secondary 
spermatocytes 
Sperm 
 
SC = Seminiferous cords; ST = Seminiferous tubules.  
Data are mean ± SEM.  
One way ANOVA (or independent-samples t-test **) was used for statistical analyses, and P<0.05 was considered as significant. 
abcdef/xy Within each row/column, data with different superscripts differ significantly (P < 0.05). 
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APPENDIX B.4 
Summary of localization of different factors associated with testis development in the porcine testis tissue of different ages. 
 
 
Factor 
Pig Age 
Prenatal 
(82 dpc) 
n=3 
Neonatal Prepubertal  
Mature 
n=4 
1wk 
n=5 
2 wk 
n=5 
3 wk 
n=5 
4 wk 
n=5 
9 wk 
n=5 
14 wk 
n=5 
SRY + /SC,GC + /SC,GC +/ SC,GC +/ SC,GC - - - - 
SOX9 +/SC,GC,LC +/ SC,GC, LC + /SC,GC +/ SC,GC, LC + /SC,GC, LC +/SC,GC,LC +/ SC,GC,LC +/SC,GC,LC  
FGF9 +/SC,GC +/SC,GC +/SC,GC +/SC,GC +/SC,GC +/LC +/LC +/LC 
PGD2 +/ SC +/SC +/ SC +/ SC +/SC +/SC +/LC +/LC 
AMH +/SC +/SC +/SC +/SC +/SC +/SC +/SC - 
 
The examined factors included the sex determining region Y (SRY); SRY-box 9 (SOX9); fibroblast growth factor 9 (FGF9); 
prostaglandin D2 synthase (PGD2); and anti-Müllerian hormone (AMH).  
The immunohistochemistry was performed using the OneStep polymer HRPO (only horseradish peroxidase) staining system.  
The expression of these factors was evaluated qualitatively, and recorded as presence (+) or absence (-).  
The cellular localization were recorded as Sertoli cells (SC), germ cells (GC), or Leydig cells (LC). 
 
 
250 
